Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3016417	p-amylp	u/l (u/l)	32415	78635	0.00%
3016417	p-amylp	— (—)	9805	16457	100.00%	Distribution not available
3016417	s-amylp	u/l (u/l)	198	218	0.00%
3016417	pa-amyl	u/l (u/l)	73	167	0.00%
3016417	s-amylp	— (—)	56	61	100.00%	Distribution not available
3016417	-amylp	u/l (u/l)	43	60	0.00%	Distribution not available
3016417	-amylp	— (—)	12	13	100.00%	Distribution not available
3016417	pa-amyl	— (—)	7	10	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Any event in cancer register

6306

22002

1.77

322.46

2.9

2.4

38.09

41.90

u/l

0.72

5509

18711

Noninfective enteritis and colitis

3496

17851

2.11

322.35

3.2

2.5

38.32

44.77

u/l

0.68

3071

15300

Neoplasms

5144

15100

1.89

319.78

2.9

2.3

35.31

43.68

u/l

1.36

4501

12877

Medical observation and evaluation for suspected diseases and conditions

4733

13038

1.95

319.38

2.8

2.3

34.92

43.57

u/l

2.39

4034

11231

Alcohol use disorder, ICD-based

3114

15350

2.20

319.06

3.5

2.5

41.32

51.17

u/l

0.77

2642

13226

Symptoms and signs involving cognition, perception, emotional state and behaviour

6730

27995

1.72

317.83

2.7

2.5

34.95

46.58

u/l

2.32

5706

24047

Low back pain

5396

22362

1.83

316.03

2.8

2.4

44.67

45.88

u/l

0.05

4600

19253

Psychiatric diseases

6769

20373

1.74

314.66

2.7

2.4

44.02

49.30

u/l

0.27

5765

17553

Colectomy operation

1536

5663

3.16

312.68

3.3

2.4

39.91

46.23

u/l

0.32

1387

4820

Recurrent or chronic depression

2885

9477

2.29

312.34

2.8

2.4

35.08

42.65

u/l

1.89

2468

8241

Malignant neoplasm of pancreas, including Hilmo

848

2166

4.82

312.16

7.1

2.2

98.53

37.59

u/l

0.88

745

1807

Selective serotonin reuptake inhibitors

6860

21708

1.72

311.93

2.6

2.4

47.45

46.85

u/l

0.02

5824

18724

Hypertension, essential

5303

17081

1.85

309.72

3.2

2.3

46.49

43.83

u/l

0.10

4532

14749

Asthma (mode)

5239

15819

1.86

309.49

2.6

2.3

33.05

46.98

u/l

3.32

4426

13603

Other functional intestinal disorders

3362

14032

2.41

307.65

3.1

2.3

39.20

50.20

u/l

0.66

2915

11883

Any gastric operation

7162

10242

3.86

307.65

3.0

1.5

48.26

32.91

u/l

1.51

6255

8397

All chronic kidney diseases

3974

15915

2.20

307.65

3.9

2.3

45.39

45.49

u/l

0.01

3518

13516

Covid-19 confirmed case

2925

13334

2.42

307.65

3.4

2.4

38.37

49.37

u/l

0.93

2448

11385

Neurotic, stress-related and somatoform disorders

6820

25874

1.96

307.65

2.9

2.4

40.66

45.17

u/l

0.25

5844

22222

All anxiety disorders

4977

18872

2.25

307.65

2.9

2.4

43.02

42.39

u/l

0.02

4263

16241

Mental and behavioural disorders due to psychoactive substance use

4533

21560

2.09

307.65

3.3

2.5

49.10

46.22

u/l

0.10

3864

18578

All kidney diseases

8136

27196

2.20

307.65

3.3

2.3

47.69

42.76

u/l

0.31

7075

23176

Acute pancreatitis (for exclusion)

2142

6782

3.81

307.65

6.5

2.3

185.95

32.50

u/l

4.06

1939

5822

Other diseases of the digestive system

2579

11303

2.53

307.65

3.5

2.4

47.02

49.94

u/l

0.11

2267

9613

Colorectal adenocarcinoma

1731

5580

3.60

307.65

2.3

2.2

35.74

47.18

u/l

0.68

1565

4698

Other septicaemia

2904

12296

2.49

307.65

4.0

2.2

83.88

39.72

u/l

0.89

2516

10477

All pneumoniae

7570

28237

1.90

307.65

3.0

2.4

50.52

43.02

u/l

0.31

6457

24233

Symptoms and signs involving the circulatory and respiratory systems

7077

20576

1.80

307.65

2.7

2.4

33.39

50.81

u/l

3.39

6070

17652

Colorectal cancer

2079

6726

3.50

307.65

2.4

2.2

35.15

45.26

u/l

0.74

1888

5681

Nephropathy related operations

1382

3931

4.46

307.65

6.4

2.4

46.27

50.89

u/l

0.13

1271

3397

Mental and behavioural disorders due to alcohol

3827

18644

2.12

307.65

3.4

2.5

52.02

46.26

u/l

0.17

3258

16075

Diarrhoea and gastroenteritis of presumed infectious origin

8215

27499

2.11

307.65

3.0

2.3

40.73

46.27

u/l

0.58

7050

23526

L04AD Calcineurin inhibitors

1270

3470

4.69

307.65

6.6

2.4

39.99

51.78

u/l

0.41

1176

3002

Other bacterial diseases

7975

25285

2.30

307.65

3.4

2.3

57.10

42.11

u/l

0.73

6859

21616

Codes for special purposes

3993

20582

2.09

307.65

3.2

2.4

36.45

45.70

u/l

1.29

3400

17639

Condition for Implicit Sepsis (Organ dysfunction codes)

6704

24732

1.99

307.65

3.1

2.3

42.67

42.10

u/l

0.03

5753

21159

Provisional assignment of new diseases of uncertain etiology

3992

20551

2.09

307.65

3.2

2.4

36.45

45.72

u/l

1.29

3399

17613

Pain in joint

4200

10663

2.70

307.65

2.6

2.1

40.19

40.02

u/l

0.01

3554

9035

Septicaemia

3251

13585

2.45

307.65

3.9

2.2

79.14

39.46

u/l

0.89

2806

11588

First line medication for Crohn's disease

8271

25009

1.89

307.65

3.3

2.2

36.96

45.53

u/l

1.53

7211

21287

Implicit bacterial Sepsis

3693

13661

2.58

307.65

3.5

2.3

51.11

41.97

u/l

0.31

3167

11642

Unspecified privation

1153

3487

4.06

307.65

3.1

2.5

65.05

51.65

u/l

0.17

998

3007

4789

20553

2.22

307.65

3.6

2.4

76.87

39.31

u/l

1.36

4097

17695

GASTRO-related operations

7162

10242

3.86

307.65

3.0

1.5

48.26

32.91

u/l

1.51

6255

8397

Other anxiety disorders

3876

14602

2.52

307.65

3.0

2.4

44.15

42.47

u/l

0.05

3343

12580

Paralytic ileus and intestinal obstruction

2429

7832

3.58

307.65

3.6

2.3

36.36

59.71

u/l

1.37

2149

6634

Intestinal infectious diseases

7430

29909

2.01

307.65

3.2

2.3

41.34

45.50

u/l

0.39

6433

25521

Personality disorders, excluding more controls

2032

7781

2.88

307.65

2.9

2.3

38.46

41.52

u/l

0.22

1717

6763

Pure hypercholesterolaemia

5376

18711

2.00

307.65

2.7

2.4

45.22

47.66

u/l

0.11

4547

16019

Heart failure, not strict

5270

20033

1.90

307.65

3.5

2.4

51.03

46.07

u/l

0.14

4517

17133

Anxiety disorders, excluding more controls

6438

20878

2.15

307.65

2.9

2.4

41.07

49.24

u/l

0.47

5519

17992

Dialysis, with operation codes

1453

4003

4.60

307.65

6.0

2.4

47.30

37.62

u/l

0.91

1329

3453

Use of hypnotics and sedatives

7416

26240

1.70

307.65

2.9

2.4

38.38

46.54

u/l

1.20

6344

22544

Examination and observation for other reasons

6244

12936

3.13

307.65

3.1

2.3

52.99

43.66

u/l

0.36

5375

11147

Ascites

791

1665

6.02

307.65

4.1

1.9

37.15

40.63

u/l

0.34

712

1393

Asthma, excluding more controls

5244

14765

1.95

307.65

2.6

2.3

32.48

47.56

u/l

3.45

4447

12706

Other disorders of urethra and urinary system

4842

19297

1.92

307.65

2.8

2.3

34.53

42.44

u/l

2.12

4073

16468

General symptoms and signs

8378

21100

2.12

307.65

3.1

2.2

38.52

47.89

u/l

1.01

7259

17997

Diverticular disease of intestine

5811

16297

2.48

307.65

2.7

2.3

40.57

52.06

u/l

0.92

4994

13832

Chronic gastritis

2209

9230

2.67

307.65

3.1

2.3

32.18

48.51

u/l

1.34

1895

7826

Other diseases of pancreas

925

2207

5.43

307.65

6.8

1.8

268.88

31.91

u/l

1.79

830

1874

Other antidepressants

7359

21635

1.83

307.65

2.8

2.4

44.65

46.92

u/l

0.11

6250

18662

Bacterial infection, other or unspecified

5401

17770

2.89

307.65

3.7

2.2

51.17

41.48

u/l

0.46

4643

15148

Adenocarcinoma and papilloma adenocarcinoma of rectum

988

2464

5.02

307.65

2.0

2.2

31.60

56.98

u/l

0.70

908

2065

Chronic pancreatitis

1451

3424

5.46

307.65

7.9

1.9

186.38

31.57

u/l

1.77

1245

2951

Asthma, unspecified (mode)

3867

14645

2.12

307.65

2.7

2.3

34.86

44.57

u/l

1.59

3260

12570

Other bacterial diseases

8327

25729

2.21

307.65

3.4

2.2

53.01

41.90

u/l

0.52

7149

22058

Anxiety (asthma-related co-morbidities)

4896

17067

2.41

307.65

2.9

2.4

43.30

42.76

u/l

0.02

4198

14726

Malignant neoplasm of rectum, including Hilmo

1324

3356

4.93

307.65

2.1

2.2

32.01

52.21

u/l

0.79

1202

2830

Exposure to unspecified factor

7853

30113

2.00

307.65

2.8

2.4

38.08

46.18

u/l

1.20

6723

25788

4620

19999

2.27

307.65

3.6

2.4

77.31

39.35

u/l

1.31

3958

17220

Disorders of gallbladder, biliary tract and pancreas

10266

23192

3.16

307.65

4.1

1.9

76.48

31.92

u/l

5.24

9063

19604

Pain (limb, back, neck, head abdominally)

5448

11062

2.64

307.65

2.8

2.1

47.59

40.11

u/l

0.37

4689

9355

Malignant neoplasm of digestive organs

3765

9804

3.52

307.65

3.8

2.3

48.49

44.13

u/l

0.17

3394

8280

Condition for Implicit Sepsis (Organ dysfunction codes)

6325

24164

1.97

307.65

3.1

2.3

44.47

42.21

u/l

0.11

5436

20667

Gastrointestinal diseases

4461

7340

3.28

307.65

2.7

1.5

49.79

30.51

u/l

1.16

3885

6133

Mood [affective] disorders

7851

28026

1.93

307.65

2.9

2.4

40.18

46.05

u/l

0.40

6647

24110

Cholangitis (primary sclerosing, PSC)

841

1585

7.37

307.65

8.1

1.8

42.97

32.03

u/l

2.47

802

1343

Headache

4818

19337

2.12

307.65

2.9

2.2

39.03

48.41

u/l

0.57

4150

16483

ILD medications: prednisolone, methylprednisolone, prednisone

7974

25993

1.80

307.65

3.2

2.3

44.63

45.49

u/l

0.05

6909

22156

Malignant neoplasm of rectum

999

2502

5.00

307.65

2.0

2.2

31.39

37.33

u/l

1.55

921

2095

Malignant neoplasm, wide definition for exclusion

6165

20306

1.88

307.65

2.9

2.4

37.60

41.58

u/l

0.74

5395

17276

Pneumonia, organism unspecified

6742

26197

1.91

307.65

3.0

2.4

54.74

42.50

u/l

0.50

5733

22492

Diseases of oesophagus, stomach and duodenum

8464

26120

2.07

307.65

3.1

2.3

44.55

44.97

u/l

0.02

7316

22350

Other or unspecified ileus, impaction or obstruction

1731

5332

3.78

307.65

3.7

2.3

37.44

49.80

u/l

0.71

1547

4523

Dental caries

2221

7872

3.05

307.65

4.4

2.4

60.30

55.18

u/l

0.08

1944

6827

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

7314

28117

1.88

307.65

3.0

2.4

51.23

43.04

u/l

0.34

6227

24139

GI-bleeding

2548

11298

2.49

307.65

3.5

2.4

47.05

49.94

u/l

0.11

2238

9618

Bacterial infection, other or unspecified

5064

16737

2.97

307.65

3.7

2.2

52.40

41.40

u/l

0.50

4353

14254

Fever of other and unknown origin

4613

17393

2.58

307.65

3.7

2.2

51.64

48.38

u/l

0.11

4062

14799

Mood disorders

7861

28054

1.92

307.65

2.9

2.4

40.16

46.09

u/l

0.40

6653

24134

Substance abuse

4435

21141

2.12

307.65

3.4

2.5

49.52

46.36

u/l

0.10

3775

18216

Other diseases of biliary tract

1032

2368

5.67

307.65

8.3

1.8

96.43

32.00

u/l

1.25

952

1997

Intestinal infectious diseases

9250

27191

2.08

307.65

3.0

2.3

45.36

44.79

u/l

0.03

7935

23260

Intestinal adhesions without obstruction

884

2233

4.90

307.65

3.6

2.2

38.13

61.62

u/l

0.55

804

1911

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2523

3976

3.39

307.65

2.7

1.8

54.21

49.39

u/l

0.10

2188

3316

Pain in throat and chest

7019

19929

2.27

307.65

2.9

2.4

33.10

50.98

u/l

3.34

6070

17113

Caries of dentine

1900

6986

2.96

307.65

4.5

2.3

63.45

53.26

u/l

0.15

1670

6070

Intestinal stricture

2824

10961

2.94

307.65

3.5

2.4

37.93

50.69

u/l

0.92

2517

9340

Human immunodeficiency virus [HIV] disease resulting in other conditions

499

478

40.63

307.65

2.5

3.1

27.74

138.97

u/l

0.61

494

426

Depression or dysthymia

4770

13931

2.00

307.65

2.8

2.4

44.57

50.18

u/l

0.20

4026

12092

Implicit Sepsis

5959

22018

2.21

307.65

3.2

2.3

44.44

42.49

u/l

0.09

5116

18781

Malaise and fatigue

4701

14096

3.00

307.65

3.3

2.1

38.58

50.32

u/l

0.87

4032

11968

Substance abuse, excluding more controls

4435

17000

2.41

307.65

3.4

2.4

49.52

50.06

u/l

0.02

3775

14697

Benign neoplasm of colon, rectum, anus and anal canal

4592

21532

1.99

307.65

2.8

2.5

45.21

47.35

u/l

0.11

3927

18347

Implicit viral Sepsis

2353

9777

2.68

307.65

3.5

2.3

57.78

39.56

u/l

0.43

2028

8320

Codeine

6980

18836

2.14

307.65

2.8

2.1

42.90

49.24

u/l

0.34

5915

16180

Certain infectious and parasitic diseases

5331

12675

2.23

307.65

2.6

2.1

44.14

43.19

u/l

0.04

4542

10839

Persons encountering health services for other counselling and medical advice, not elsewhere classified

8899

25115

2.05

307.65

3.0

2.3

39.22

47.64

u/l

0.89

7709

21431

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1018

2565

4.95

307.65

2.1

2.2

31.51

56.10

u/l

0.71

937

2151

Other medical care

3508

14813

2.32

307.65

3.4

2.2

42.80

45.88

u/l

0.21

3054

12588

Anxiety disorders

6881

26063

1.96

307.65

2.9

2.4

40.58

45.08

u/l

0.25

5898

22382

Codeine or tramadol medication

8244

26635

1.78

307.65

2.8

2.4

43.31

46.16

u/l

0.16

6986

22898

Persons encountering health services for specific procedures, not carried out

1289

2525

7.22

307.65

4.2

2.3

101.13

57.80

u/l

0.34

1130

2167

Pain, not elsewhere classified

2285

8920

2.84

307.65

3.4

2.1

42.08

54.82

u/l

0.46

1983

7586

Cholecystectomy

6476

23616

2.63

307.65

3.5

2.3

45.97

44.14

u/l

0.15

5725

20001

Special screening examination for infectious and parasitic diseases

2193

6072

2.92

307.65

2.3

2.2

33.62

48.84

u/l

1.86

1920

5251

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

6798

21832

2.00

307.65

3.0

2.3

46.80

44.86

u/l

0.07

5798

18731

Abdominal and pelvic pain

9292

15797

3.26

307.65

3.0

2.0

53.60

40.52

u/l

0.74

8108

13179

Asthma

5407

15718

1.90

307.65

2.6

2.3

32.93

46.85

u/l

3.30

4577

13512

Bleeding

5830

24108

1.82

307.65

3.3

2.4

51.16

43.89

u/l

0.36

5033

20546

Opioids

7787

19136

2.26

307.65

3.0

2.1

41.81

49.01

u/l

0.45

6689

16437

Persons encountering health services for specific procedures and health care

8781

26464

2.13

307.65

3.3

2.2

46.20

42.67

u/l

0.17

7557

22621

Metabolic disorders

7215

23211

2.02

307.65

3.1

2.4

37.60

45.32

u/l

1.19

6161

19938

Benzodiazepine use

7354

29724

1.79

307.65

2.8

2.4

37.76

46.58

u/l

1.48

6221

25545

Bacterial Sepsis

3824

14208

2.53

307.65

3.5

2.3

51.37

44.50

u/l

0.22

3269

12101

Symptoms and signs involving the digestive system and abdomen

9051

15799

3.15

307.65

3.1

2.0

49.48

40.52

u/l

0.47

7906

13179

Diarrhoea and gastroenteritis of presumed infectious origin

5759

25378

2.20

307.65

3.3

2.4

42.84

45.44

u/l

0.18

4990

21654

Persons encountering health services in other circumstances, wide

8850

25243

1.91

307.65

3.0

2.3

40.27

47.54

u/l

0.69

7648

21534

Other soft tissue disorders, not elsewhere classified

7139

22762

1.95

307.65

2.9

2.4

58.48

42.68

u/l

0.66

6129

19532

Diseases of liver

3178

12549

2.89

307.65

3.8

2.4

51.15

45.94

u/l

0.13

2793

10732

Cholelithiasis, broad definition with cholecystitis

7810

21430

2.71

307.65

3.4

1.8

40.31

32.02

u/l

3.96

6848

18084

Parasetamol

5291

14458

1.95

307.65

2.8

2.2

49.24

42.42

u/l

0.30

4550

12464

Transplanted organ and tissue status

1216

3068

5.20

307.65

6.8

2.4

50.75

54.19

u/l

0.07

1113

2655

Diseases of the digestive system

3470

17132

2.18

307.65

3.6

2.4

45.16

46.65

u/l

0.08

3009

14589

Depression

7314

27068

1.95

307.65

2.9

2.4

40.13

46.50

u/l

0.41

6201

23305

Anaemias

2069

3093

4.94

307.65

3.9

1.8

41.16

42.83

u/l

0.13

1821

2688

Implicit bacterial Sepsis

3395

12662

2.64

307.65

3.6

2.3

52.84

42.45

u/l

0.32

2909

10789

Complications of procedures, not elsewhere classified

5846

27825

1.84

307.65

3.1

2.4

73.97

39.68

u/l

1.56

5020

23823

Acute pancreatitis

2142

5770

4.53

307.65

6.5

1.8

185.95

32.46

u/l

4.07

1939

4909

Tramadol

7405

17293

2.91

307.65

3.5

2.1

35.95

48.15

u/l

1.82

6351

14868

Explicit Sepsis

3377

14512

2.37

307.65

3.9

2.3

77.41

41.67

u/l

0.81

2913

12357

Any mental disorder

7877

22714

1.82

307.65

2.8

2.4

41.52

48.43

u/l

0.46

6690

19544

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

7527

28015

1.97

307.65

3.1

2.4

39.99

45.48

u/l

0.60

6508

23955

Pain in limb

6479

22114

2.10

307.65

2.9

2.4

42.31

41.09

u/l

0.09

5555

18975

Asthma, unspecified (mode), excluding more controls

3752

13777

2.18

307.65

2.7

2.3

35.10

45.12

u/l

1.55

3162

11833

Other diseases of urinary system

6970

23189

1.77

307.65

2.6

2.4

45.02

44.65

u/l

0.01

5933

19874

Acute renal failure

1857

7167

2.95

307.65

3.8

2.4

71.54

47.51

u/l

0.42

1614

6097

Artificial opening status

903

1641

8.76

307.65

3.2

2.3

29.64

66.39

u/l

0.68

860

1401

Depression medications

2067

3492

3.19

307.65

2.7

1.8

59.48

50.32

u/l

0.15

1765

3041

Mental and behavioural disorders due to alcohol, excluding acute intoxication

3388

16498

2.22

307.65

3.5

2.5

54.95

47.31

u/l

0.21

2871

14225

Oxycodone

3205

11128

2.90

307.65

3.8

2.1

56.02

52.72

u/l

0.07

2776

9527

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2073

8493

2.65

307.65

3.0

2.3

34.83

41.44

u/l

0.97

1773

7361

Renal tubulo-interstitial diseases

7080

26081

2.18

307.65

3.4

2.3

50.03

43.48

u/l

0.37

6135

22222

Mood disorders, excluding more controls

7298

22270

2.09

307.65

2.9

2.4

40.50

48.57

u/l

0.52

6176

19193

Implicit Sepsis

6310

23626

2.09

307.65

3.1

2.3

43.82

42.31

u/l

0.07

5415

20197

Cystitis

6145

20193

1.91

307.65

2.7

2.4

49.46

43.40

u/l

0.21

5258

17254

Human immunodeficiency virus [HIV] disease

503

524

29.72

307.65

2.5

3.0

27.70

129.60

u/l

0.61

498

466

Abnormalities of breathing

6126

20508

1.82

307.65

2.8

2.4

33.68

49.42

u/l

3.02

5259

17593

Pneumonias (Asthma/COPD co-morbidities)

7533

28167

1.90

307.65

3.0

2.4

50.68

43.02

u/l

0.32

6421

24163

Solid cancers, helper endpoint

5808

19465

1.86

307.65

2.9

2.4

37.48

41.93

u/l

0.80

5083

16569

Disorders of lipoprotein metabolism and other lipidaemias

6019

20095

1.97

307.65

2.8

2.4

37.49

47.02

u/l

1.35

5128

17232

Acute tubulo-interstitial nephritis

4550

20707

2.03

307.65

3.2

2.3

41.26

42.17

u/l

0.05

3891

17583

Renal failure

3629

14675

2.40

307.65

4.1

2.4

58.68

45.51

u/l

0.46

3202

12479

Influenza and pneumonia

7836

28118

1.87

307.65

3.0

2.4

45.15

43.05

u/l

0.08

6688

24120

6798

21832

2.00

307.65

3.0

2.3

46.80

44.86

u/l

0.07

5798

18731

ILD medications

8169

26376

1.76

307.65

3.2

2.3

38.06

45.28

u/l

1.13

7088

22481

Complications of surgical and medical care, not elsewhere classified

7209

28772

1.81

307.65

3.1

2.4

67.30

39.66

u/l

1.53

6178

24631

Malignant neoplasm

5986

19739

1.90

307.65

2.9

2.4

37.36

41.75

u/l

0.82

5232

16799

Alcohol use disorder, Swedish definition

4434

19011

2.33

307.65

3.7

2.4

80.48

39.55

u/l

1.37

3786

16376

Hernia of abdominal wall, postoperative

1565

3444

5.26

307.65

3.6

1.5

47.38

34.76

u/l

0.87

1383

2825

Diaphragmatic hernia

2899

12979

2.48

307.65

2.8

2.4

46.08

43.36

u/l

0.12

2494

11041

Constipation

6686

25030

1.97

307.65

2.9

2.4

33.16

47.95

u/l

3.57

5739

21364

Cholelithiasis

7467

21102

2.69

307.65

3.4

1.8

40.39

32.06

u/l

3.75

6558

17797

Certain infectious and parasitic diseases

7406

18620

2.11

307.65

2.9

2.1

44.58

41.33

u/l

0.19

6403

15844

Infections, IBD-co-morbidities

1417

3207

3.55

307.65

4.0

2.3

44.96

43.99

u/l

0.03

1230

2811

Other diseases of intestines

8746

23293

2.30

307.65

2.9

2.3

37.13

48.35

u/l

1.73

7628

19836

Nausea and vomiting

2510

6719

4.21

307.65

3.9

1.9

47.48

39.67

u/l

0.25

2206

5552

ILD medications: immunosuppressive drugs

4501

23418

1.89

306.65

3.8

2.3

40.71

46.00

u/l

0.53

3994

20003

Aplastic and other anaemias

3324

15810

2.12

305.32

3.4

2.4

38.32

48.67

u/l

0.96

2866

13425

Inflammatory bowel disease treatment related agents

7907

28105

1.64

303.21

2.9

2.4

44.48

44.86

u/l

0.02

6869

23959

Complications of medical and surgical care

5168

27798

1.81

302.95

3.1

2.4

71.50

40.62

u/l

1.15

4430

23786

Fall on same level

7864

27342

1.64

296.99

2.8

2.4

37.94

47.27

u/l

1.51

6685

23510

Oedema, not elsewhere classified

2301

10197

2.42

296.70

3.2

2.1

37.13

52.80

u/l

0.88

1986

8651

Viral hepatitis, IBD co-morbidity

640

1362

5.82

295.77

3.2

2.4

30.83

42.64

u/l

2.08

565

1200

Hypertensive diseases (excluding secondary)

3613

10768

2.07

291.81

3.5

2.2

50.24

40.26

u/l

0.34

3113

9279

Other anaemias

3098

14934

2.13

290.79

3.3

2.4

35.78

48.06

u/l

1.36

2667

12700

Other and unspecified anaemias

3073

14817

2.14

290.50

3.3

2.4

35.82

48.15

u/l

1.35

2649

12606

Dorsalgia

6908

22965

1.68

288.91

2.8

2.4

40.98

46.88

u/l

0.52

5909

19757

Kidney transplant status

661

1534

5.89

283.46

8.9

2.5

60.45

72.41

u/l

0.13

616

1335

Cholangitis (primary sclerosing, PSC), with reimbursement 202

370

512

14.17

283.17

6.4

2.5

46.52

125.77

u/l

0.40

361

435

Any death

4367

17646

1.90

281.51

3.4

2.4

42.36

49.63

u/l

0.58

3835

14971

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1327

4792

3.25

281.30

4.5

2.5

36.11

48.32

u/l

0.64

1175

4155

Care involving use of rehabilitation procedures

4326

22568

1.86

281.08

2.8

2.2

38.96

43.51

u/l

0.46

3681

19244

Need for other prophylactic measures

716

1776

5.37

280.79

3.5

2.5

37.65

67.36

u/l

0.58

609

1539

Erysipelas

4787

21183

1.82

279.38

3.0

2.3

51.86

41.77

u/l

0.29

4041

18148

Other diseases of intestine

1204

4113

3.37

278.53

3.1

2.3

39.96

53.42

u/l

0.57

1066

3502

Lower back pain or/and sciatica

7200

30075

1.63

277.89

2.8

2.5

46.25

43.41

u/l

0.17

6145

25783

Care involving dialysis

817

2218

4.57

277.89

6.9

2.3

52.10

61.23

u/l

0.15

741

1915

Dyspnoea

6131

28082

1.69

276.59

2.8

2.4

40.06

45.26

u/l

0.46

5268

23996

Benign neoplasm: Colon

3767

19884

1.94

272.21

2.8

2.5

48.15

47.35

u/l

0.03

3212

16965

Colitis, primary sclerosing

318

392

18.63

271.06

6.1

2.2

40.21

157.14

u/l

0.47

312

331

Adjustment and management of implanted device

1473

5676

2.93

270.82

2.6

2.2

35.07

47.25

u/l

0.79

1255

4815

1190

4113

3.32

269.43

3.5

2.2

34.04

49.55

u/l

0.72

1027

3515

Other pulmonary diagnosis

5357

15867

1.77

263.95

2.7

2.3

38.46

46.71

u/l

0.92

4559

13635

COPD/asthma/ILD related infections

6899

21835

1.65

263.32

2.8

2.3

44.78

44.86

u/l

0.00

5871

18734

COPD/asthma related infections

6899

21835

1.65

263.32

2.8

2.3

44.78

44.86

u/l

0.00

5871

18734

Excluding asthma or asthma-COPD overlap

5352

15867

1.76

262.80

2.7

2.3

38.76

46.71

u/l

0.86

4547

13635

Other disorders of fluid, electrolyte and acid-base balance

2236

9934

2.33

262.36

4.0

2.3

35.43

53.68

u/l

1.29

1897

8482

Hernia

6302

26573

1.66

262.26

2.8

2.5

51.83

44.55

u/l

0.26

5459

22700

COPD differential diagnosis

5334

15820

1.76

261.53

2.7

2.3

38.48

46.98

u/l

0.95

4536

13604

ILD differential diagnosis

5333

15819

1.76

261.34

2.7

2.3

38.48

46.98

u/l

0.95

4535

13603

Hypertensive diseases

5211

17531

1.76

257.98

3.3

2.3

47.17

43.57

u/l

0.14

4455

15136

Asthma-related infections

4071

22872

1.84

257.69

2.8

2.5

34.59

45.85

u/l

1.74

3457

19608

Asthma, hospital admission 2, infections

4071

22872

1.84

257.69

2.8

2.5

34.59

45.85

u/l

1.74

3457

19608

Hypertension

5208

17522

1.76

257.58

3.3

2.3

47.18

43.58

u/l

0.14

4452

15129

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1719

7198

2.61

256.34

3.6

2.3

50.30

44.59

u/l

0.23

1538

6091

Viral Sepsis

1589

6520

2.72

255.68

3.9

2.3

41.19

37.43

u/l

0.27

1372

5565

Asthma (only as main-diagnosis), excluding more controls

4506

14765

1.83

255.63

2.6

2.3

33.44

47.56

u/l

3.00

3812

12706

Implicit viral Sepsis

1587

6510

2.72

255.52

3.9

2.3

41.21

37.44

u/l

0.27

1371

5556

Cardiovascular diseases (excluding rheumatic etc)

4215

13691

1.86

251.60

3.2

2.1

47.13

41.88

u/l

0.19

3672

11776

Malignant neoplasm of pancreas

666

1690

4.86

247.60

7.1

2.1

111.12

38.83

u/l

0.80

587

1404

Asthma (only as main-diagnosis)

4643

15718

1.79

246.15

2.6

2.3

33.37

46.85

u/l

3.06

3923

13512

Convulsions, not elsewhere classified

1692

7129

2.54

245.21

3.2

2.1

33.35

58.61

u/l

1.39

1449

6090

Poisoning by drugs, medicaments and biological substances

1870

8397

2.45

244.57

3.3

2.5

34.32

45.03

u/l

0.97

1603

7223

Oral corticosteroids

7063

27347

1.59

244.13

2.8

2.4

38.64

44.97

u/l

0.76

6102

23326

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4170

24207

1.80

242.85

3.1

2.4

76.05

40.80

u/l

1.05

3555

20697

Chronic kidney disease

2163

10105

2.29

242.33

4.8

2.4

47.78

45.53

u/l

0.10

1934

8588

Other bacterial intestinal infections

1759

7728

2.51

242.30

3.4

2.3

41.74

43.88

u/l

0.08

1519

6598

Other reaction to severe stress, and adjustment disorders

2545

12868

2.12

240.96

2.9

2.4

50.25

40.61

u/l

0.22

2171

11110

Alcohol dependence

1990

9231

2.36

240.04

3.7

2.5

40.05

48.73

u/l

0.46

1694

7986

Malignant neoplasm of colon, including Hilmo

1372

5403

2.83

239.69

2.6

2.2

38.79

38.24

u/l

0.06

1219

4554

Other diseases of liver

1489

6143

2.74

239.20

3.3

2.4

34.80

36.66

u/l

0.50

1295

5252

Any reimbursement code in KELA

3825

10552

1.90

238.74

2.9

1.9

49.49

45.97

u/l

0.10

3300

9055

Functional dyspepsia

1984

9213

2.35

238.34

3.3

2.2

42.63

40.10

u/l

0.13

1717

7848

Asthma (diagnoses ohter than nonallergic)

5829

30863

1.64

236.71

2.6

2.5

33.97

46.59

u/l

3.04

4928

26448

Poisoning by medicine

1713

7538

2.51

235.40

3.3

2.5

33.90

45.62

u/l

0.97

1473

6498

Personality disorders

2032

9571

2.31

235.26

2.9

2.5

38.46

44.57

u/l

0.38

1717

8276

Other headache syndromes

3010

16269

1.97

233.41

2.8

2.5

37.86

47.20

u/l

0.72

2593

13961

Unspecified jaundice

496

1040

5.91

233.37

6.5

1.9

47.57

45.66

u/l

0.08

449

862

Gastro-oesophageal reflux disease

4407

22821

1.75

231.39

2.8

2.3

35.56

45.69

u/l

1.65

3737

19501

Irritable bowel syndrome

1898

8747

2.35

230.36

2.8

2.3

32.32

44.98

u/l

1.54

1617

7444

Other/unspecified dorsalgia

2671

13839

2.05

229.85

2.9

2.4

37.45

49.93

u/l

1.05

2243

11882

Hypothyroidism (congenital or acquired)

1510

3302

2.73

228.87

2.6

1.8

35.82

42.35

u/l

1.27

1292

2874

Diseases of arteries, arterioles and capillaries (FINNGEN)

1736

5178

2.52

228.69

3.4

2.2

43.80

44.88

u/l

0.06

1467

4468

Disorders of adult personality and behaviour

2107

10189

2.24

227.39

2.9

2.5

36.03

44.00

u/l

0.62

1775

8806

Erysipelas

3609

18262

1.85

226.96

3.0

2.3

57.99

42.48

u/l

0.36

3080

15584

Endocrine, nutritional and metabolic diseases

5275

16381

1.69

226.78

2.9

2.2

44.00

42.77

u/l

0.05

4483

14237

Other heart diseases

3109

10885

1.97

226.15

3.1

2.2

36.67

39.87

u/l

0.61

2677

9359

Hypothyroidism, levothyroxine purchases

1494

3284

2.72

224.63

2.5

1.8

35.60

42.42

u/l

1.34

1277

2856

Hypothyroidism and >3 levothyroxin purchases

1494

3284

2.72

224.63

2.5

1.8

35.60

42.42

u/l

1.34

1277

2856

Dysphagia

1505

6360

2.56

222.61

3.0

1.9

33.05

39.10

u/l

2.75

1291

5294

Asthma, hospital admissions 3, pneumonia

2543

13217

2.06

222.17

2.9

2.5

36.59

50.35

u/l

1.08

2154

11290

Asthma-related pneumonia or sepsis

2543

13217

2.06

222.17

2.9

2.5

36.59

50.35

u/l

1.08

2154

11290

Cardiovascular diseases

3924

12041

1.83

221.82

3.0

2.1

50.03

41.66

u/l

0.30

3415

10341

Need for immunization against other single viral diseases

340

556

10.66

221.66

3.3

2.6

30.20

127.21

u/l

0.60

322

480

Asthma-related pneumonia

2537

13198

2.06

221.07

2.9

2.5

36.60

50.37

u/l

1.07

2150

11274

Panic disorder

1172

4444

2.94

220.77

3.1

2.4

76.01

38.98

u/l

0.43

988

3860

Nonorganic sleeping disorders, excluding more controls

1382

5661

2.67

220.67

2.7

2.4

30.72

39.50

u/l

5.46

1184

4911

Autoimmune diseases related-to ILD

5627

31020

1.62

220.20

2.9

2.4

46.60

44.62

u/l

0.10

4873

26508

Other dorsopathies, not elsewhere classified

6706

23037

1.58

219.29

2.7

2.4

33.26

46.82

u/l

2.97

5729

19819

Follow-up examination after treatment for conditions other than malignant neoplasms

3047

10897

1.95

217.51

2.6

2.2

59.37

41.91

u/l

0.34

2568

9377

Other external causes of accidental injury

5367

16734

1.67

217.14

2.6

2.4

46.76

43.45

u/l

0.14

4612

14337

Injuries to the head

7294

30272

1.53

216.35

2.8

2.4

37.95

46.23

u/l

1.59

6199

25952

Dizziness and giddiness

4894

24238

1.67

216.22

2.7

2.4

36.54

47.91

u/l

1.63

4154

20774

Other noninfective gastroenteritis and colitis

1847

8671

2.33

215.85

3.2

2.4

37.78

42.29

u/l

0.35

1608

7374

Heart failure and antihypertensive medication

1739

5010

2.46

215.10

3.0

2.4

34.09

42.85

u/l

1.47

1479

4371

Mucosal proctocolitis

1115

4226

3.02

213.52

3.4

2.5

39.04

49.16

u/l

0.42

1010

3639

Bronchitis

7055

29918

1.54

213.02

2.9

2.4

38.31

46.13

u/l

0.73

6067

25574

Benign neoplasm of other and ill-defined parts of digestive system

1432

6150

2.63

211.13

3.4

2.4

80.51

45.61

u/l

0.99

1240

5236

Alcohol abuse, main dg, excluding more controls

1129

4320

2.91

209.06

3.8

2.5

32.41

44.53

u/l

1.82

969

3779

Heartburn

798

2536

3.54

206.28

3.1

1.9

35.44

39.60

u/l

0.53

696

2120

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3823

22970

1.76

205.21

3.2

2.4

73.57

42.52

u/l

0.79

3258

19627

Speech therapy

1947

9582

2.22

202.58

2.8

2.5

39.63

43.07

u/l

0.16

1678

8170

Cholecystitis

1042

3892

3.00

202.56

4.1

1.8

55.68

31.93

u/l

1.08

914

3282

Specific personality disorders

1735

8163

2.32

201.54

2.8

2.5

36.65

45.33

u/l

0.53

1474

7061

Falls/tendency to fall

7049

23789

1.53

201.34

2.8

2.4

43.74

46.49

u/l

0.14

6011

20465

Accidents

5288

16734

1.64

201.30

2.6

2.4

46.83

43.45

u/l

0.14

4541

14337

Obesity, other/unspecified

2407

12735

2.03

201.08

2.5

60.82

40.02

u/l

0.49

2011

11009

Preparatory care for dialysis

514

1283

5.41

201.02

6.9

2.5

57.40

74.69

u/l

0.17

465

1102

Alcohol-induced chronic pancreatitis

658

1936

4.24

200.15

7.5

2.4

301.55

39.05

u/l

1.33

571

1701

Symptoms and signs involving the urinary system

4945

24033

1.64

199.28

2.9

2.5

51.26

44.40

u/l

0.20

4284

20484

L04AA Selective immunosuppressants

1707

8053

2.34

198.97

5.4

2.4

41.55

46.00

u/l

0.29

1541

6906

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2073

10458

2.14

198.83

3.0

2.5

34.83

43.21

u/l

0.81

1773

9011

Haemorrhage from respiratory passages

2242

10406

2.07

197.61

2.8

2.4

38.78

56.97

u/l

1.28

1944

8880

Nutritional anaemias

3263

18290

1.82

197.37

3.0

2.4

38.16

45.48

u/l

0.70

2804

15561

Syncope and collapse

2780

13106

1.91

196.25

2.9

2.2

34.05

51.19

u/l

1.89

2376

11123

7373

26089

1.51

196.15

2.7

2.4

37.89

46.25

u/l

1.22

6304

22339

Infections of the skin and subcutaneous tissue

3842

23187

1.73

195.02

3.3

2.5

54.22

44.38

u/l

0.22

3279

19958

2981

16832

1.86

194.74

2.9

2.5

34.08

42.07

u/l

1.14

2547

14489

Substance use, excluding alcohol

1486

6670

2.45

194.52

3.4

2.5

62.59

40.63

u/l

0.31

1284

5761

Bacterial pneumonia, not elsewhere classified

2584

12355

1.96

193.64

2.9

2.3

35.09

46.54

u/l

1.31

2216

10581

Alcoholic liver disease

871

3065

3.33

193.50

4.5

2.5

38.62

39.26

u/l

0.05

768

2657

Mycoses

5528

31775

1.57

193.49

2.6

2.5

37.55

45.99

u/l

1.55

4723

27239

Bacterial pneumoniae

2689

13088

1.92

190.88

2.9

2.4

35.33

45.90

u/l

1.24

2299

11213

Ulcer of lower limb, not elsewhere classified

1150

4687

2.78

190.01

3.7

2.4

32.65

48.84

u/l

0.93

957

4014

Inflammatory bowel disease

2231

11747

2.04

189.29

3.3

2.5

39.88

43.09

u/l

0.30

1988

10084

Other viral hepatitis

640

1909

4.08

189.08

3.2

2.6

30.69

66.13

u/l

0.82

566

1669

Behavioural syndromes associated with physiological disturbances and physical factors

5965

28351

1.55

188.81

2.7

2.5

35.12

45.92

u/l

2.52

5117

24306

Other diseases of anus and rectum

1907

9474

2.15

188.27

2.8

2.3

33.46

55.97

u/l

1.76

1643

8023

Viral hepatitis

707

2248

3.77

187.99

3.1

2.7

31.07

61.75

u/l

0.84

624

1959

Suicide or other Intentional self-harm

1774

8655

2.23

187.51

3.1

2.5

36.03

44.92

u/l

0.68

1515

7455

Other symptoms and signs involving cognitive functions and awareness

2972

15532

1.85

186.50

2.6

2.4

31.55

49.85

u/l

2.73

2508

13256

Chronic apical periodontitis

7232

28514

1.49

186.24

2.8

2.4

41.47

45.77

u/l

0.25

6163

24444

Emotionally unstable personality disorder

1008

3885

2.92

185.32

2.8

2.3

39.90

49.81

u/l

0.29

850

3357

Venous thromboembolism

3512

20478

1.75

185.00

2.9

2.4

46.42

45.15

u/l

0.05

3026

17437

Soft tissue disorders

6595

23008

1.52

184.47

2.7

2.4

43.77

42.53

u/l

0.06

5682

19734

Total colectomy operation

485

1229

5.18

184.47

3.5

2.5

44.73

79.02

u/l

0.42

453

1054

Total colectomy

485

1229

5.18

184.47

3.5

2.5

44.73

79.02

u/l

0.42

453

1054

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

6268

27689

1.53

183.69

3.3

2.3

58.77

40.72

u/l

0.76

5456

23636

Autoimmune diseases excluding thyroid diseases

6808

25445

1.51

183.25

3.3

2.3

47.07

45.25

u/l

0.10

5882

21834

Antihypertensive medication - note that there are other indications

3844

12202

1.74

182.86

2.9

2.2

50.25

41.30

u/l

0.31

3294

10590

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

561

1561

4.29

181.95

6.1

2.2

42.53

38.00

u/l

0.37

508

1293

Iron deficiency anaemia

2808

15821

1.86

181.24

3.0

2.4

38.99

46.94

u/l

0.64

2411

13481

Benign neoplasms

6236

23222

1.53

179.68

2.7

2.5

39.62

46.27

u/l

0.71

5363

19883

Heart failure,strict

3315

13838

1.79

178.94

2.8

2.4

41.48

47.71

u/l

0.43

2803

11837

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1252

5425

2.55

178.22

3.5

2.2

39.57

46.70

u/l

0.31

1119

4586

Other and unspecified iron deficiency

2271

12259

1.98

177.96

2.9

2.4

40.06

47.05

u/l

0.41

1952

10415

Chronic viral hepatitis

552

1558

4.38

177.81

3.1

2.6

31.34

72.86

u/l

0.78

483

1370

Ulcerative colitis

1768

8785

2.18

177.81

3.4

2.5

41.02

45.81

u/l

0.35

1581

7539

Alcohol-induced acute pancreatitis

432

1036

5.62

177.61

8.9

2.5

93.59

85.56

u/l

0.06

387

910

Autoimmune diseases excluding thyroid diseases, strict definition

6591

24750

1.51

176.46

3.3

2.3

47.59

45.41

u/l

0.12

5698

21245

Other bacterial intestinal infections

1317

5867

2.47

175.70

3.8

2.3

45.75

45.62

u/l

0.00

1149

4973

Malignant neoplasm of colon

1029

4103

2.79

175.51

2.7

2.2

39.00

37.54

u/l

0.14

922

3448

Generalized anxiety disorder

1142

4765

2.62

175.48

2.7

2.3

41.56

39.29

u/l

0.10

972

4126

Budesonide

1118

4670

2.68

173.89

2.8

2.4

37.36

47.46

u/l

0.47

980

4003

Genitourinary diseases

3639

10889

1.74

172.69

2.9

2.4

48.03

47.00

u/l

0.03

3165

9345

Other specific joint derangements/joint disorders

4834

20346

1.60

171.91

2.6

2.5

40.90

43.61

u/l

0.20

4090

17520

Diseases of the skin and subcutaneous tissue

6463

22181

1.51

171.23

2.8

2.4

45.75

47.73

u/l

0.06

5513

19022

Bipolar affective disorders

1331

6008

2.41

170.86

2.8

2.4

33.58

41.42

u/l

1.22

1130

5239

774

2715

3.25

170.54

2.3

2.2

30.05

34.64

u/l

1.91

660

2317

Other gastritis (incl. Duodenitis)

1559

7514

2.25

170.22

3.5

2.3

36.26

47.97

u/l

0.64

1352

6385

Schizophrenia or delusion, excluding more controls

1884

9568

2.07

170.03

2.6

2.4

29.56

43.55

u/l

3.47

1601

8307

Appendectomy

4172

25600

1.63

169.59

2.5

37.60

46.15

u/l

1.21

3623

21961

Sleep disorders

5648

27673

1.53

169.42

2.6

2.5

35.08

46.25

u/l

2.55

4849

23720

Fibrosis and cirrhosis of liver

694

2359

3.51

165.33

3.9

2.4

32.27

38.82

u/l

1.77

623

2048

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1256

5646

2.45

164.52

3.3

2.5

33.40

46.02

u/l

0.79

1084

4885

External causes of morbidity and mortality

4181

13126

1.65

164.46

2.6

2.3

48.32

39.02

u/l

0.38

3575

11251

Gingivitis and periodontal diseases

6462

23037

1.49

164.42

2.7

2.4

36.73

47.63

u/l

1.85

5466

19814

Other heart diseases, wide

5756

24012

1.52

161.94

2.9

2.5

36.11

45.90

u/l

1.73

4934

20657

Factors influencing health status and contact with health services

1858

4564

2.13

161.43

2.6

2.0

64.79

41.04

u/l

0.46

1613

3901

Any operation in hilmo

261

130

10.95

161.09

2.4

1.2

30.57

30.90

u/l

0.06

215

105

Type 2 diabetes, wide definition

4898

20781

1.57

160.74

2.9

2.2

30.32

36.63

u/l

2.45

4023

17914

Unspecified kidney failure

805

2998

3.06

159.30

3.8

2.3

41.00

38.16

u/l

0.37

705

2533

Asthma, including avohilmo

7455

29990

1.44

158.29

2.5

34.76

46.80

u/l

2.61

6300

25762

Insomnia

5498

27406

1.51

157.89

2.6

2.5

35.12

45.81

u/l

2.36

4721

23496

IBD patients in KELA-register

1617

8121

2.15

157.72

3.4

2.5

40.44

45.43

u/l

0.34

1449

6960

Superficial injury of head

1655

8378

2.13

157.62

3.0

2.4

35.80

45.01

u/l

0.73

1394

7187

Cerebrovascular diseases (FINNGEN)

1960

7264

2.02

156.32

3.1

2.2

41.49

42.82

u/l

0.11

1682

6256

Noninfectious colitis NAS

1055

4510

2.61

156.02

3.4

2.4

37.19

47.68

u/l

0.47

917

3837

Bacterial pneumonia (organism specified)

2826

15242

1.77

155.54

2.9

2.4

35.30

48.62

u/l

1.33

2420

13013

Cardiac arrhythmias

3721

15170

1.66

155.10

2.7

2.2

35.43

43.07

u/l

1.69

3204

13213

Other nutritional deficiencies

4151

25570

1.59

154.60

2.7

2.5

50.07

45.47

u/l

0.14

3461

21987

Conjunctivitis

4759

26661

1.55

154.26

2.5

45.80

45.15

u/l

0.03

4079

22831

Dorsopathies

6493

23122

1.47

152.42

2.7

2.4

34.31

46.75

u/l

2.57

5548

19891

Cutaneous abscess, furuncle and carbuncle

1767

9270

2.05

151.77

3.6

2.4

34.52

44.85

u/l

1.13

1510

7998

5-aminosalicylic acid

1505

7467

2.18

151.60

3.2

2.4

38.70

47.25

u/l

0.64

1338

6410

Disorders of conjunctiva

5193

28521

1.51

151.46

2.5

47.66

44.77

u/l

0.14

4453

24424

Myalgia

1615

8215

2.11

151.38

3.0

2.4

62.73

39.13

u/l

0.38

1403

7048

Other acute lower respiratory infections

3344

19942

1.67

151.24

3.0

2.5

43.19

45.34

u/l

0.07

2860

17081

Abnormal findings on examination of blood, without diagnosis

2911

16173

1.74

151.02

3.2

2.5

62.93

44.94

u/l

0.42

2516

13797

COPD (mode)

1893

7867

2.01

150.42

2.8

2.4

32.43

46.80

u/l

1.67

1584

6758

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

611

2021

3.51

150.34

3.3

2.7

25.97

40.63

u/l

4.37

527

1769

Gout, idiopatic and unspecified

1617

8278

2.12

150.00

3.1

2.5

50.19

53.11

u/l

0.08

1414

7058

Persons encountering health services for examination and investigation

4083

13041

1.62

149.99

2.7

2.3

46.14

43.58

u/l

0.08

3512

11232

Gout

1826

8503

2.02

149.24

3.1

2.5

48.45

50.94

u/l

0.08

1601

7281

Other CVD (FINNGEN)

830

2430

2.94

148.88

3.4

2.2

38.40

39.77

u/l

0.14

719

2100

ILD medications: azathioprine

1091

4823

2.49

148.30

3.6

2.2

51.14

47.18

u/l

0.10

986

4129

Inflammatory bowel disease, strict (require KELA)

1617

8303

2.10

148.21

3.4

2.5

40.44

45.18

u/l

0.33

1449

7137

Acute bronchitis

2601

15074

1.78

148.19

3.0

2.4

33.05

47.02

u/l

1.69

2226

12866

Hernia of abdominal wall

2883

17557

1.73

148.06

3.0

2.5

40.90

49.44

u/l

0.63

2513

15038

Sciatica+with lumbago

3218

18433

1.68

148.03

2.8

2.4

42.92

47.34

u/l

0.23

2752

15876

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2691

9897

1.79

147.94

3.2

2.2

32.48

40.68

u/l

3.38

2336

8523

Migraine

3165

15834

1.69

147.69

2.6

2.4

39.11

43.34

u/l

0.24

2748

13571

Chronic rhinitis, nasopharyngitis and pharyngitis

2138

12004

1.90

147.53

2.6

2.5

32.69

39.37

u/l

4.76

1817

10316

Heart failure, strict

3545

15842

1.66

146.13

2.8

2.5

41.05

50.91

u/l

0.70

2994

13546

Injuries to the thorax

2857

17402

1.73

145.83

3.1

2.5

37.23

46.50

u/l

1.00

2448

14909

Symptoms and signs involving the skin and subcutaneous tissue

4373

28693

1.55

145.70

2.7

2.5

49.23

43.42

u/l

0.25

3770

24530

Acute upper respiratory infections of multiple and unspecified sites

4733

23697

1.53

144.98

3.0

2.4

33.05

46.32

u/l

3.06

4110

20307

Chronic lower respiratory diseases

7524

29126

1.41

144.79

2.6

2.5

33.59

47.47

u/l

3.80

6359

25027

Extracorporeal dialysis

556

1809

3.72

143.32

6.4

2.5

57.40

65.33

u/l

0.10

505

1566

Other and unspecified mood [affective] disorders

592

1969

3.43

143.21

2.8

2.3

27.01

37.46

u/l

3.87

514

1697

Continuous positive airway pressure

1216

4718

2.33

142.71

3.1

2.3

36.32

55.98

u/l

1.56

1030

4150

Gastroduodenal ulcer

1628

8453

2.05

141.87

3.5

2.3

69.30

46.89

u/l

0.34

1413

7172

Episodal and paroxysmal disorders

6893

25174

1.43

141.62

2.6

2.5

35.61

45.96

u/l

2.04

5913

21575

Intracranial trauma

3607

16204

1.62

141.01

2.8

2.4

50.47

47.29

u/l

0.08

3065

13993

Persistent mood disorders

1323

6434

2.23

140.87

2.8

2.3

34.73

41.24

u/l

1.03

1115

5510

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

420

1147

4.38

140.20

6.4

2.2

39.90

37.42

u/l

0.17

383

947

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

3447

21527

1.63

139.92

2.4

2.5

35.72

43.91

u/l

1.81

2947

18452

Atrial fibrillation and flutter

1918

6676

1.97

139.49

2.8

2.2

36.94

43.22

u/l

0.87

1654

5761

Assault

994

4339

2.53

139.47

3.3

2.7

34.60

50.21

u/l

0.81

850

3787

Hypothyroidism, drug reimbursement

783

2041

2.88

139.24

2.4

1.8

36.03

44.73

u/l

1.18

666

1767

Exposure to other specified factors

4665

29289

1.52

139.11

2.8

2.5

43.16

45.15

u/l

0.13

4022

25099

Ventral hernia

1589

8291

2.06

139.02

3.2

2.4

47.83

46.98

u/l

0.03

1406

7094

Oesophageal varices

428

1211

4.48

138.80

5.1

2.4

28.81

81.13

u/l

0.74

387

1039

Abnormalities of heart beat

2145

11988

1.84

138.35

2.9

2.3

33.17

51.68

u/l

1.89

1825

10233

Disturbances of skin sensation

1844

10105

1.95

138.27

2.8

2.5

31.03

44.86

u/l

2.07

1605

8668

Injuries to the abdomen, lower back, lumbar spine and pelvis

2522

14929

1.76

137.97

3.0

2.5

69.41

41.95

u/l

0.47

2160

12759

Unspecified haematuria

2587

12828

1.76

137.70

2.7

2.5

40.41

47.67

u/l

0.51

2256

10970

Bacterial intestinal infections, IBD co-morbidities

1291

6303

2.23

136.98

3.8

2.4

46.92

45.07

u/l

0.05

1127

5378

Azathioprine

1091

4992

2.40

136.69

3.6

2.4

51.14

47.36

u/l

0.09

986

4285

DVT of lower extremities and pulmonary embolism

2613

15778

1.74

136.32

2.9

2.4

48.30

47.15

u/l

0.04

2242

13432

All-cause Heart Failure

3449

15580

1.64

136.26

2.8

2.5

41.30

51.13

u/l

0.67

2913

13325

Diseases of the respiratory system

4029

13125

1.59

135.85

2.5

2.3

46.10

43.96

u/l

0.06

3413

11262

Obesity and other hyperalimentation

3882

24820

1.57

135.77

2.6

2.5

51.77

44.12

u/l

0.24

3221

21375

Obesity

3865

24730

1.57

135.64

2.6

2.5

51.86

44.15

u/l

0.24

3208

21303

Diseases of arteries, arterioles and capillaries

4025

19732

1.57

135.46

3.1

2.5

60.73

44.49

u/l

0.43

3421

16846

Cirrhosis of liver, NAS

500

1583

3.87

135.34

4.1

2.4

28.97

68.91

u/l

0.74

446

1361

Invasive ventilation

615

2178

3.30

135.34

3.2

2.4

41.79

61.61

u/l

0.42

526

1858

Other diseases of hard tissues of teeth

3633

11976

1.63

135.15

2.5

2.3

35.65

49.96

u/l

1.55

3053

10316

Gout, FINNGEN

1826

10018

1.94

135.09

3.1

2.5

48.45

52.33

u/l

0.12

1601

8564

Memory loss

729

2830

2.97

134.34

2.5

2.4

30.99

40.10

u/l

2.87

598

2415

Alcohol abuse, main dg

1129

5280

2.35

134.32

3.8

2.6

32.41

50.60

u/l

1.19

969

4569

Neurological diseases, wide definition

1887

4999

1.98

133.84

2.6

2.3

60.66

46.79

u/l

0.22

1613

4376

Chronic periodontitis, complicated

3342

21458

1.62

132.14

2.9

2.5

38.88

48.82

u/l

1.32

2853

18388

Mental and behavioural disorders due to sedatives or hypnotics

592

2079

3.32

131.91

3.8

2.5

28.87

39.06

u/l

2.86

501

1805

Other and unspecified nonorganic psychotic disorders

1337

6689

2.16

131.86

2.6

29.69

47.95

u/l

1.75

1151

5805

Adenocarcinoma and ductal carcinoma of pancreas

328

792

5.22

131.25

8.9

2.1

168.13

34.22

u/l

0.72

294

655

Diseases of pulp and periapical tissues, including avohilmo

6531

24398

1.43

131.03

2.7

2.4

41.90

46.93

u/l

0.27

5583

20917

Hypokalaemia

860

3640

2.62

129.67

3.8

2.3

39.27

50.98

u/l

0.38

731

3104

Polyarthropathies

4202

18459

1.54

128.87

2.9

2.5

39.87

44.08

u/l

0.42

3608

15868

Unspecified fall

3111

19628

1.63

128.76

2.9

2.5

38.17

45.41

u/l

0.81

2646

16789

Allergic conjunctivitis

3542

22724

1.58

128.72

2.4

2.5

35.83

43.56

u/l

1.77

3032

19477

Gout, unspecified

1329

6712

2.15

128.51

3.1

2.5

43.17

57.22

u/l

0.48

1170

5730

Neurological diseases

5402

18968

1.47

128.21

2.6

2.4

44.55

46.64

u/l

0.08

4626

16332

Used for control exclusion in common control thyroid runs

6537

23886

1.42

128.09

3.0

2.3

37.69

45.50

u/l

1.21

5589

20509

Nonorganic sleeping disorders

1382

7076

2.11

127.84

2.7

2.5

30.72

43.98

u/l

1.28

1184

6092

Atrial fibrillation and flutter with reimbursement

1562

5127

2.06

127.52

2.7

2.2

37.68

43.46

u/l

0.58

1337

4427

Problems related to lifestyle

757

3042

2.76

127.10

3.7

2.3

28.95

54.23

u/l

0.97

633

2614

Periodontitis

5882

28282

1.44

127.01

2.9

2.5

47.46

45.10

u/l

0.13

5017

24289

Sleep disorders (combined)

6975

26849

1.40

126.86

2.5

39.32

45.41

u/l

0.63

5921

23055

Chronic periodontitis, including avohilmo

5865

28264

1.43

126.64

2.9

2.5

47.49

44.96

u/l

0.14

5004

24270

Cough

2406

13710

1.74

126.35

2.6

2.3

41.27

50.13

u/l

0.50

2052

11723

Pulmonary heart disease, diseases of pulmonary circulation

2010

11608

1.84

126.09

2.8

2.4

48.12

48.50

u/l

0.01

1723

9886

Acute alcohol intoxication

1624

8802

1.97

125.59

3.6

2.5

32.29

48.89

u/l

1.32

1398

7586

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3944

23859

1.54

124.95

2.9

2.5

46.77

45.88

u/l

0.03

3425

20305

Diseases of oral cavity, salivary glands and jaws

3627

12102

1.59

124.37

2.5

2.3

50.90

49.76

u/l

0.03

3078

10413

Early onset COPD, excluding more controls

1235

6118

2.16

123.82

3.2

2.4

32.18

49.63

u/l

1.57

1041

5309

Injury, poisoning and certain other consequences of external causes

3325

10588

1.63

123.53

2.5

2.3

51.07

38.87

u/l

0.40

2856

9124

Acute alcohol intoxication, ICD10

1358

6997

2.09

123.51

3.7

2.5

32.71

47.97

u/l

1.38

1175

6055

Pulmonary embolism

1866

10633

1.87

122.86

2.9

2.4

47.03

49.60

u/l

0.07

1600

9053

Disorders of eyelid, lacrimal system and orbit

5155

27770

1.46

122.73

2.6

2.5

40.14

45.61

u/l

0.59

4408

23755

Other specified and unspecified personality disorders

709

2824

2.83

122.69

3.1

2.4

29.40

55.89

u/l

0.94

607

2447

Ulcerative colitis, NAS

1005

4653

2.37

122.62

3.5

2.4

42.33

47.74

u/l

0.21

903

3993

Pulmonary heart disease

1866

10652

1.87

122.11

2.9

2.4

47.03

49.55

u/l

0.07

1600

9074

Nonalcoholic fatty liver disease

774

3240

2.71

121.41

2.9

2.5

31.37

52.92

u/l

0.85

676

2811

Other inflammatory liver diseases

562

2017

3.26

120.82

4.5

2.3

117.18

39.12

u/l

0.47

498

1747

Colon adenocarcinoma

756

3111

2.68

120.60

2.7

2.1

41.24

37.22

u/l

0.33

669

2611

Retention of urine

2035

9698

1.82

120.46

3.0

2.5

67.59

44.68

u/l

0.29

1754

8270

Calculus of kidney and ureter

1862

10716

1.85

118.45

2.5

2.6

34.18

52.82

u/l

1.55

1623

9162

Autoimmune diseases

6816

25580

1.39

118.26

3.1

2.3

42.68

45.24

u/l

0.16

5825

21949

Injuries to the knee and lower leg

7254

30087

1.37

118.23

2.7

2.5

40.74

45.54

u/l

0.48

6162

25814

Other and unspecified effects of external causes

1766

10020

1.87

117.68

2.6

2.5

72.87

42.84

u/l

0.34

1499

8599

Candidiasis

1830

10517

1.85

117.04

2.8

2.4

39.59

41.93

u/l

0.13

1549

8992

Injuries to the ankle and foot

4240

26197

1.49

115.55

2.9

2.5

50.07

44.22

u/l

0.20

3586

22571

Phobic anxiety disorders

870

3860

2.43

115.54

2.9

2.4

48.89

40.48

u/l

0.32

734

3374

Concussion

3024

15958

1.60

115.16

2.9

2.4

37.01

47.52

u/l

1.27

2572

13782

Benign neoplasm: Colon, unspecified

1604

8937

1.93

114.87

2.9

2.4

47.64

51.91

u/l

0.13

1338

7650

Viral infections characterized by skin and mucous membrane lesions

5183

31943

1.43

114.19

2.6

2.5

46.00

44.47

u/l

0.07

4466

27317

Progressive vascular leukoencephalopathy

360

1031

4.35

114.17

2.3

30.90

38.68

u/l

1.56

302

851

Visual disturbances and blindness

3129

20625

1.58

113.87

2.8

2.5

43.19

46.49

u/l

0.11

2672

17636

Mental and behavioural disorders due to use of other stimulants, including caffeine

315

824

4.83

113.84

2.9

2.6

25.37

35.02

u/l

3.89

272

716

Urolithiasis

1969

11636

1.79

113.68

2.6

34.03

52.09

u/l

1.67

1717

9952

Liquid cancers, helper endpoint

2091

10860

1.76

113.59

2.7

2.3

35.71

43.31

u/l

0.88

1785

9183

Visual disturbances

2934

19098

1.61

113.59

2.8

2.5

44.07

47.32

u/l

0.10

2512

16343

Other disorders of skin and subcutaneous tissue

4114

25380

1.49

113.26

3.0

2.4

33.16

46.92

u/l

3.32

3472

21724

Non-selective monoamine reuptake inhibitors

2224

13045

1.72

113.04

2.8

2.4

33.10

46.90

u/l

1.66

1854

11193

Dialysis

373

1099

4.16

112.85

8.3

2.4

40.30

39.81

u/l

0.04

334

945

Hypo-osmolality and hyponatraemia

1109

5459

2.18

112.55

3.9

2.4

33.06

47.68

u/l

0.99

932

4665

Overexertion and strenuous or repetitive movements

756

3241

2.62

111.88

2.5

30.54

52.33

u/l

0.87

626

2812

Spondylopathies

4658

19557

1.47

111.74

2.7

2.4

46.27

47.16

u/l

0.03

3952

16820

Hypertensive heart and/or renal disease

1519

6149

1.95

110.69

3.0

2.3

43.61

50.79

u/l

0.21

1280

5286

Hyperkinetic disorders, excluding more controls

661

2510

2.70

110.64

2.4

2.3

30.53

40.69

u/l

2.23

566

2204

Disorders of thyroid, IBD co-morbidities

1101

3720

2.20

110.50

2.4

2.3

40.62

43.35

u/l

0.21

942

3260

Obesity related asthma

2109

12793

1.74

110.21

2.7

2.5

35.44

50.04

u/l

1.12

1760

11012

Migraine with aura

1542

8556

1.91

110.10

2.7

2.4

31.19

43.89

u/l

1.56

1339

7334

Alcohol withdrawal state with delirium

554

2072

3.09

109.96

4.8

2.5

31.26

62.49

u/l

0.77

478

1810

All influenza

1549

8620

1.91

109.72

3.2

2.4

32.96

47.01

u/l

1.56

1332

7438

Acute upper respiratory infections

6290

28747

1.38

109.66

2.7

2.4

46.75

44.55

u/l

0.10

5418

24554

Asthma, hospital admissions , main diagnosis only

4914

31202

1.43

109.65

2.6

2.5

33.07

46.49

u/l

3.79

4159

26728

Secondary hypertension

557

2040

3.00

109.54

6.0

2.2

38.50

39.88

u/l

0.22

509

1772

Spondylosis

3197

17282

1.57

109.50

2.6

2.4

40.01

48.75

u/l

0.69

2682

14872

STROKE

3308

14948

1.56

108.69

2.8

2.3

42.24

47.32

u/l

0.47

2816

12892

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1108

5570

2.16

108.43

3.5

2.5

40.76

46.02

u/l

0.26

996

4819

Heart failure and bmi 25plus

1971

7824

1.79

108.12

2.8

2.6

37.93

50.88

u/l

0.63

1670

6671

Infections with a predominantly sexual mode of transmission

2353

13676

1.67

107.53

2.6

2.5

37.16

44.36

u/l

0.76

2038

11787

Osteopathies and chondropathies

3352

21091

1.54

107.45

3.2

2.4

36.10

45.88

u/l

1.44

2858

18038

Gout, strict definition

1143

5837

2.12

107.24

3.1

2.5

44.97

60.86

u/l

0.47

992

4972

Subjective visual disturbances

1621

9240

1.87

107.08

2.8

2.4

32.15

43.55

u/l

1.41

1389

7885

Implicit fungal Sepsis

532

1974

3.10

106.84

3.4

2.2

35.07

39.36

u/l

0.49

446

1692

Viral haemorrhagic fevers, not elsewhere classified/unspecified

1088

5494

2.16

105.62

2.7

2.4

82.82

38.48

u/l

0.52

959

4713

Diseases of the eye and adnexa

4940

17641

1.44

104.91

2.8

2.4

34.74

44.72

u/l

2.23

4223

15258

Mental and behavioural disorders due to opioids

361

1088

3.99

104.83

3.2

2.6

26.89

34.76

u/l

2.98

313

935

Ulcerative colitis (strict definition, require KELA)

1129

5788

2.11

104.41

3.4

2.5

40.52

48.57

u/l

0.42

1012

5001

Other disorders of eye and adnexa

975

4755

2.24

104.13

3.4

2.3

30.62

47.73

u/l

1.04

836

4075

Migraine without aura

1253

6633

2.01

103.87

2.6

2.3

50.79

44.67

u/l

0.13

1086

5694

Infections with a predominantly sexual mode of transmission

1850

10991

1.77

103.53

2.7

2.5

36.92

41.75

u/l

0.44

1607

9486

Polyuria

1376

7544

1.95

103.29

2.8

2.4

33.10

45.75

u/l

1.24

1169

6416

Viral pneumonia

861

4014

2.34

102.79

3.1

2.4

33.05

52.35

u/l

0.97

743

3472

Other maltreatment syndromes

312

869

4.43

102.66

3.7

2.6

40.09

93.86

u/l

0.50

266

759

Glomerular disorders in diseases classified elsewhere

817

3752

2.41

102.49

7.0

2.4

52.48

50.75

u/l

0.04

710

3222

Intracranial injury

3398

21973

1.51

101.87

2.8

2.5

37.41

48.35

u/l

1.51

2864

18845

Other disorders of veins

2468

15760

1.63

101.77

2.4

34.09

42.19

u/l

1.75

2103

13431

Other intervertebral disc disorders

4866

21092

1.43

101.75

2.7

2.4

41.72

46.70

u/l

0.43

4135

18180

KRA_PSY_EATING, excluding more controls

519

1908

2.95

101.71

2.7

2.1

31.46

40.21

u/l

1.56

439

1647

Vascular disorders of the intestines

468

1651

3.19

101.67

3.5

2.2

42.74

39.05

u/l

0.21

415

1399

Acetic acid derivatives and related substances

1687

4900

1.87

101.45

2.5

2.7

33.99

38.85

u/l

0.90

1432

4237

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1190

6281

2.04

100.86

3.4

2.5

40.28

48.05

u/l

0.45

1064

5418

Abnormal serum enzyme levels

1759

10146

1.79

100.76

2.9

2.5

56.73

49.23

u/l

0.15

1551

8701

Diseases of pulp and periapical tissues and dental caries

4046

14389

1.48

100.28

2.6

2.3

47.81

50.13

u/l

0.06

3417

12381

Undetermined asthma, excluding more controls

809

3701

2.36

100.10

2.5

2.3

29.41

53.11

u/l

1.18

680

3192

Hyperlipidaemia, other/unspecified

2174

12472

1.68

100.00

2.7

2.4

52.76

51.65

u/l

0.02

1835

10655

Mental disorders, not otherwise specified

624

2579

2.71

99.75

2.8

2.4

29.31

56.06

u/l

0.83

541

2222

Arthropod-borne viral fevers and viral haemorrhagic fevers

1183

6271

2.04

99.36

2.8

2.5

89.41

38.04

u/l

0.67

1044

5380

Dental caries, including avohilmo

4465

16186

1.45

98.97

2.6

2.3

46.00

48.76

u/l

0.09

3767

13920

Fracture of rib(s), sternum and thoracic spine

1827

10987

1.76

98.90

3.2

2.5

38.47

51.13

u/l

0.86

1576

9433

Adverse effects, not elsewhere classified

1263

6837

1.98

98.80

2.6

2.4

33.16

43.64

u/l

0.84

1071

5850

Soft tissue disorders related to use, overuse and pressure

1654

9693

1.80

98.32

2.7

2.4

48.14

40.34

u/l

0.35

1392

8291

Other disorders of kidney and ureter

885

4267

2.28

98.00

3.6

2.4

60.13

49.56

u/l

0.21

788

3645

Open wound of head

3129

20467

1.53

97.84

2.9

2.5

36.24

49.85

u/l

2.06

2656

17596

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

5655

26940

1.38

97.79

2.8

2.5

48.83

42.89

u/l

0.19

4887

23033

Mixed and other personality disorders

601

2473

2.72

97.10

3.5

2.4

33.67

59.43

u/l

0.74

507

2156

Diseases of the musculoskeletal system and connective tissue

3328

11194

1.53

96.97

2.6

2.3

50.89

42.52

u/l

0.25

2861

9661

Cardiomyopathy

1083

5608

2.07

96.76

2.6

2.5

57.37

63.57

u/l

0.10

931

4867

Fenamates

970

3178

2.21

96.59

2.5

2.7

69.40

41.06

u/l

0.37

820

2761

Unspecified mental disorder

2415

15600

1.62

96.39

2.6

31.11

44.37

u/l

2.93

2042

13452

Collagenous colitis

671

2922

2.58

96.06

3.0

2.3

36.85

54.10

u/l

0.52

585

2485

Sequelae of external causes of morbidity and mortality

1590

9297

1.82

95.97

3.3

2.4

66.56

42.05

u/l

0.61

1353

7939

Faecal incontinence

547

2150

2.79

95.70

2.5

1.8

32.29

38.40

u/l

1.35

466

1767

Dermatitis and eczema

6582

31116

1.34

95.18

2.7

2.5

35.24

46.60

u/l

2.92

5624

26648

Undetermined asthma

809

3785

2.30

94.72

2.5

2.2

29.41

52.97

u/l

1.21

680

3258

Caries of dentine, including avohilmo

4761

17572

1.42

94.50

2.6

2.4

44.66

49.52

u/l

0.17

3998

15129

Hypertensive Heart Disease

1334

5744

1.92

94.03

2.8

2.3

43.02

51.00

u/l

0.21

1119

4942

COPD

2571

13769

1.59

93.86

2.9

2.5

32.86

54.06

u/l

2.52

2163

11815

Benign neoplasm: Rectum

1151

6173

2.02

93.69

2.7

2.4

33.77

45.78

u/l

0.83

993

5267

Crohn disease

876

4268

2.23

93.54

3.4

2.5

41.41

48.71

u/l

0.28

785

3668

Abnormalities of gait and mobility

821

3920

2.31

93.38

2.7

2.4

53.64

38.97

u/l

0.57

677

3342

Acute appendicitis

4091

27477

1.43

93.24

2.6

2.5

37.50

47.71

u/l

1.59

3536

23564

Outcome of delivery

1065

3321

2.12

93.02

2.1

2.5

37.50

36.67

u/l

0.06

899

2815

Other Crohn's disease

526

2075

2.86

93.00

3.4

2.4

39.18

60.30

u/l

0.44

477

1790

Diseases of appendix

4366

28588

1.42

92.71

2.6

2.5

37.19

47.23

u/l

1.67

3773

24504

Gastric ulcer

1068

5579

2.05

92.69

3.5

2.2

82.35

39.39

u/l

0.48

921

4742

Malignant neoplasm of stomach, including Hilmo

410

1420

3.25

92.17

4.5

2.1

38.52

38.91

u/l

0.03

369

1177

Appendicitis, broad definition

4328

28445

1.42

91.82

2.6

2.5

37.16

47.31

u/l

1.68

3739

24375

Statin medication

3998

15887

1.46

91.72

3.0

2.5

35.09

44.15

u/l

1.79

3400

13795

Benign neoplasm: Rectum, anus and anal canal

1264

7024

1.93

91.56

2.6

2.4

35.10

45.36

u/l

0.77

1083

5978

Non-allergic asthma (mode), excluding more controls

1085

5665

2.00

90.48

2.6

2.3

30.61

48.58

u/l

1.45

928

4865

Malignant neoplasm of stomach

364

1192

3.47

90.45

4.6

2.2

37.41

38.56

u/l

0.09

328

983

Other dialysis

296

872

4.25

90.44

8.4

2.5

41.15

94.57

u/l

0.49

264

757

Glomerular diseases

1145

6207

1.98

89.70

5.9

2.5

59.31

45.86

u/l

0.40

1006

5337

Diabetes, varying definitions

6031

26829

1.35

89.63

3.4

2.3

44.60

40.98

u/l

0.17

4977

23253

Diabetes mellitus

6048

26867

1.35

88.82

3.4

2.3

44.56

40.99

u/l

0.17

4986

23290

Schizophrenia or delusion

1884

11718

1.69

88.79

2.6

29.56

46.05

u/l

2.83

1601

10093

Coagulation defects, purpura and other haemorrhagic conditions

1216

6759

1.92

87.59

2.9

2.4

48.19

44.78

u/l

0.07

1059

5754

Other specified and unspecified disorders of eye and adnexa

341

1113

3.67

87.35

3.5

2.4

31.76

38.50

u/l

0.77

290

939

Other chronic obstructive pulmonary disease

2442

13259

1.58

86.98

2.9

2.5

33.00

54.77

u/l

2.47

2050

11375

Polyneuropathies and other disorders of the peripheral nervous system

1327

7591

1.87

86.90

3.5

2.5

52.71

54.03

u/l

0.02

1114

6532

Schizophrenia, schizotypal and delusional disorders

1884

11781

1.68

86.85

2.6

29.62

45.95

u/l

2.81

1599

10153

Disorders resulting from impaired renal tubular function

326

1044

3.80

86.70

5.1

2.4

66.86

85.59

u/l

0.14

290

886

Hepatocellular carcinoma, including Hilmo

243

636

4.61

86.55

4.3

2.1

31.44

32.59

u/l

0.22

216

511

Insulin, intermediate and long-acting

3150

21328

1.49

86.43

4.4

2.4

77.58

42.51

u/l

0.63

2486

18433

Somatoform disorder

1007

5294

2.04

86.08

3.0

2.3

35.14

37.98

u/l

0.37

855

4537

Lung cancer and mesothelioma

1080

4927

1.99

85.61

2.7

2.3

33.55

41.17

u/l

3.26

948

4218

Chronic sinusitis

2509

16767

1.55

85.22

2.5

44.04

43.86

u/l

0.01

2106

14428

Trochanteric bursitis

912

4662

2.11

85.17

2.5

2.2

46.61

38.61

u/l

0.22

758

3948

Hypotension

1044

5583

2.01

85.04

3.1

2.4

37.14

37.33

u/l

0.02

898

4724

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1597

9508

1.74

84.92

2.8

2.4

31.91

41.51

u/l

1.15

1336

8192

Caries of enamel

5161

28007

1.36

84.69

2.7

2.5

47.11

45.74

u/l

0.07

4430

24034

Volume depletion

601

2616

2.51

84.49

4.2

2.4

44.76

57.93

u/l

0.29

515

2229

Fracture of skull and facial bones

1313

7534

1.85

84.30

2.9

2.5

36.95

46.65

u/l

0.72

1130

6508

Non-allergic asthma (mode)

1085

5805

1.95

84.01

2.6

2.3

30.61

47.97

u/l

1.42

928

4985

Dermatophytosis

3515

25087

1.45

83.98

2.5

37.31

47.89

u/l

1.74

3009

21531

Mental and behavioural disorders due to cannabinoids

280

827

4.03

83.64

2.9

2.6

194.00

40.67

u/l

0.46

248

724

Other arrhythmias

3645

19653

1.44

83.10

2.5

2.4

33.71

47.73

u/l

2.31

3102

16867

Carcinoma in situ of other and unspecified digestive organs

305

966

3.88

82.97

2.4

2.3

37.29

43.02

u/l

0.45

260

814

Transport accidents

2536

14607

1.54

82.79

2.7

2.4

62.32

43.48

u/l

0.31

2186

12522

Heart failure and coronary heart disease

2407

11267

1.58

82.72

2.7

2.5

39.00

50.69

u/l

0.98

2053

9627

Type 2 diabetes

5755

25641

1.34

82.55

3.1

2.3

45.43

41.39

u/l

0.19

4761

22229

Paroxysmal tachycardia

1262

5963

1.86

82.22

2.5

2.2

37.73

42.33

u/l

0.54

1063

5113

Paracetamol or NSAID medication

966

2404

2.10

82.03

2.4

84.93

38.77

u/l

0.45

811

2104

Other special examinations and investigations of persons without complaint or reported diagnosis

3649

13040

1.45

81.91

2.9

2.3

49.06

43.58

u/l

0.17

3112

11232

Agoraphobia

274

806

3.97

81.72

2.7

2.3

42.80

43.00

u/l

0.01

243

687

Ischaemic heart disease, wide definition

4374

19924

1.40

81.72

2.9

2.5

38.84

46.88

u/l

1.40

3731

17084

Coxibs

1603

4964

1.77

81.64

2.4

2.7

36.40

38.75

u/l

0.29

1367

4294

Vocal cord dysfunction

786

3421

2.19

81.49

2.7

2.2

37.41

45.75

u/l

0.62

661

2976

Later onset COPD, excluding more controls

1146

4862

1.93

81.27

2.6

2.2

34.26

40.90

u/l

1.66

957

4140

Non-ischemic cardiomyopathy

1763

8818

1.69

81.06

2.8

2.4

46.04

47.10

u/l

0.03

1494

7578

Other CVD

1179

6646

1.89

80.86

3.1

2.4

36.33

44.42

u/l

0.54

1013

5638

Pain and other conditions associated with female genital organs and menstrual cycle

1174

6027

1.89

80.82

2.4

2.3

40.38

35.55

u/l

0.27

1005

5130

Cerebrovascular diseases

4157

21425

1.40

80.62

2.8

2.5

41.96

48.01

u/l

0.51

3529

18323

Inflammatory diseases of female pelvic organs

3448

18042

1.45

80.58

2.5

2.3

34.61

39.14

u/l

1.24

2923

15316

Viral and other specified intestinal infections

1560

9115

1.72

80.43

3.2

2.3

66.17

40.38

u/l

0.40

1341

7796

Other chronic obstructive pulmonary disease, including avohilmo

2978

17151

1.49

80.03

2.8

2.5

33.80

50.34

u/l

2.37

2498

14687

Second line medication for Crohn's disease

3308

23603

1.45

79.69

2.9

2.5

40.03

45.31

u/l

0.46

2905

20205

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

497

2054

2.71

79.66

3.3

2.4

29.41

61.93

u/l

0.79

419

1753

Acute appendicitis, no complications

3192

22528

1.46

79.53

2.6

38.52

45.65

u/l

0.78

2754

19373

Insulin medication

3427

20625

1.44

79.15

4.4

2.4

73.86

42.82

u/l

0.61

2720

17833

Ulcerative ileocolitis

339

1165

3.40

78.91

3.7

2.4

37.95

80.78

u/l

0.53

312

1001

Shoulder lesions

4295

19156

1.39

78.71

2.8

2.4

37.51

41.98

u/l

0.59

3652

16461

Fracture of lumbar spine and pelvis

1311

7663

1.81

78.65

3.1

2.3

36.13

44.23

u/l

0.55

1121

6529

Post-traumatic stress disorder

525

2220

2.57

78.45

2.9

2.2

115.60

38.70

u/l

0.42

462

1908

Migraine with aura and triptan purchases

952

5066

2.00

78.21

2.7

2.4

31.02

46.29

u/l

0.97

822

4364

Pain in thoracic spine

954

5087

2.00

78.12

3.1

2.3

30.64

52.30

u/l

1.49

809

4385

Other diseases of upper respiratory tract

6502

26386

1.31

77.98

2.5

47.74

45.07

u/l

0.11

5541

22621

Other and unspecified polyneuropathies, also in other diseases

1148

6502

1.89

77.92

3.5

2.5

56.93

46.18

u/l

0.22

957

5587

Hard cardiovascular diseases

4745

21190

1.37

77.90

3.1

2.5

39.08

44.88

u/l

0.95

4091

18180

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

650

2072

2.38

77.77

2.8

2.3

35.57

40.09

u/l

1.11

584

1823

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1169

5861

1.87

77.63

2.4

2.5

36.34

49.47

u/l

0.54

994

5070

Adenocarcinoma of pancreas

230

627

4.43

77.57

8.8

2.1

62.35

35.48

u/l

0.65

205

514

Right hemicolectomy

436

1723

2.89

77.51

3.6

2.4

42.04

40.50

u/l

0.08

397

1458

Syphilis

250

729

4.25

77.33

3.1

2.6

34.59

103.10

u/l

0.55

227

641

Syphilis

250

729

4.25

77.33

3.1

2.6

34.59

103.10

u/l

0.55

227

641

Symptoms and signs involving speech and voice

1918

12392

1.62

77.29

2.6

2.4

52.51

43.66

u/l

0.20

1637

10562

Malignant neoplasm of liver and intrahepatic bile ducts

230

626

4.37

77.29

4.8

2.2

31.44

39.44

u/l

0.54

205

510

Allergic asthma (mode), excluding more controls

1294

7379

1.79

77.03

2.3

2.2

33.89

50.54

u/l

1.43

1104

6378

Abnormal findings on diagnostic imaging of lung

2683

17786

1.50

76.73

2.8

2.5

47.56

47.96

u/l

0.01

2345

15128

Benign neoplasm: Pancreas

262

797

4.13

76.56

4.8

2.3

244.35

35.70

u/l

1.47

237

670

Explicit bacterial Sepsis

660

3112

2.30

76.52

3.2

2.2

36.40

38.13

u/l

0.21

555

2670

Cellulitis

1316

7770

1.79

76.51

3.6

2.5

92.89

46.40

u/l

0.41

1115

6684

Migraine without aura and triptan purchases

976

5283

1.96

75.93

2.6

2.4

35.54

46.26

u/l

0.56

850

4557

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3119

17719

1.46

75.73

2.8

2.5

40.89

47.79

u/l

0.59

2588

15253

Superficial injury of lower leg

1473

8975

1.73

75.63

2.6

2.5

55.44

44.30

u/l

0.27

1252

7700

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5455

25232

1.33

75.00

3.5

2.3

59.29

41.44

u/l

0.56

4468

21879

Chronic hepatitis, not elsewhere classified

297

981

3.61

74.63

3.8

2.2

33.80

35.48

u/l

0.29

268

840

Other diseases of gallbladder

333

1167

3.27

74.22

3.1

1.7

43.60

32.55

u/l

0.42

295

990

Enterocolitis due to Clostridium difficile

688

3343

2.24

74.17

4.6

2.4

38.00

51.63

u/l

0.45

604

2856

Major coronary heart disease event excluding revascularizations

3414

16369

1.44

74.01

2.8

2.5

57.16

47.49

u/l

0.19

2920

13974

Disorder of lipoprotein metabolism, unspecified

781

3979

2.11

73.38

2.8

2.4

39.96

69.48

u/l

0.74

658

3400

Ulcerative colitis (strict definition, all Crohn cases excluded)

902

4839

2.00

72.85

3.3

2.5

39.48

47.30

u/l

0.36

804

4175

Cerebral palsy and other paralytic syndromes

726

3625

2.17

72.70

3.0

2.5

30.13

51.87

u/l

1.00

626

3108

Allergic asthma (mode)

1294

7500

1.76

72.70

2.3

2.2

33.89

50.45

u/l

1.45

1104

6476

Streptococcal septicaemia

552

2477

2.44

72.67

3.3

2.2

35.33

37.55

u/l

0.26

469

2127

Hepatic failure, not elsewhere classified

307

1049

3.45

72.50

4.9

2.3

35.56

39.22

u/l

0.32

273

903

Voice disturbances

1558

9747

1.68

72.42

2.6

2.4

56.91

42.74

u/l

0.27

1323

8318

Assault by bodily force

528

2332

2.49

72.33

3.3

2.6

31.41

58.04

u/l

0.73

460

2038

Other diseases of blood and blood-forming organs, wide

1322

7947

1.76

72.30

3.2

2.4

33.45

44.26

u/l

1.09

1172

6789

Other inflammation of eyelid

852

4505

2.04

72.28

2.6

2.4

37.47

49.70

u/l

0.57

731

3823

Other diseases of stomach and duodenum

449

1854

2.71

72.12

4.2

2.2

40.95

39.68

u/l

0.12

402

1577

Other viral diseases

2112

14026

1.55

71.42

3.1

2.5

41.54

41.93

u/l

0.02

1814

12092

Myocardial infarction, without ST-elevation

2180

13375

1.54

71.09

2.7

2.5

35.60

49.67

u/l

1.38

1818

11448

Paralytic ileus

280

911

3.53

70.86

4.2

2.3

30.89

40.64

u/l

1.12

245

772

Vascular diseases of the intestine

311

1081

3.35

70.82

3.6

2.3

43.64

37.10

u/l

0.29

283

900

Other complications of surgical and medical care, not elsewhere classified

644

3110

2.26

70.77

3.0

2.2

36.27

53.32

u/l

0.57

573

2658

Spinal stenosis

2796

14916

1.47

70.73

2.7

2.4

43.12

49.96

u/l

0.38

2376

12795

COPD, early/later onset

2457

14279

1.50

70.17

2.9

2.5

32.93

51.68

u/l

2.24

2062

12205

Umbilical hernia

1525

9561

1.67

69.86

2.7

2.6

40.63

47.26

u/l

0.36

1320

8234

Insulin, combination of fast acting with intermediate-acting or long-acting

3428

22936

1.41

69.76

4.4

2.4

73.86

42.09

u/l

0.63

2721

19798

COPD, hospital admissions

2433

14177

1.51

69.68

2.9

2.5

33.05

51.62

u/l

2.19

2039

12125

Diabetes medication

5980

27817

1.30

69.42

3.4

2.3

57.78

41.27

u/l

0.57

4922

24097

Other disorders of lacrimal gland

1977

13166

1.57

69.21

2.8

2.4

43.53

43.96

u/l

0.02

1704

11214

Type 2 diabetes, definitions combined

5416

24639

1.32

69.19

2.7

2.3

58.02

41.78

u/l

0.50

4526

21359

Benign neoplasm: Sigmoid colon

1119

6513

1.83

69.19

2.5

2.4

31.56

45.49

u/l

1.20

964

5568

Sequelae with surgical and medical care as external cause

1214

7228

1.78

68.97

3.3

2.4

51.63

44.26

u/l

0.27

1032

6167

Asthma and allergy, excluding more controls

739

3702

2.08

68.84

2.3

2.2

32.35

51.77

u/l

0.88

627

3210

Asthma and allergy

739

3704

2.08

68.73

2.3

2.2

32.35

52.03

u/l

0.90

627

3214

Peripheral artery disease

2346

12798

1.51

68.52

3.3

2.5

69.76

43.34

u/l

0.40

1950

10916

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

184

469

4.83

68.49

9.6

2.1

53.95

35.38

u/l

1.34

178

382

Persons with potential health hazards related to communicable diseases

2116

14167

1.53

68.35

3.0

2.5

32.82

41.22

u/l

1.55

1862

12180

Exclusions for E4_PCOS_CONSORTIUM

4102

19230

1.37

68.21

2.5

2.4

35.06

41.14

u/l

1.24

3524

16446

Fracture of lower leg, including ankle

3108

22303

1.42

68.06

2.8

2.5

37.39

45.24

u/l

1.05

2593

19092

Cardiomyopathy, other and unspecified

515

2315

2.45

67.93

2.4

2.5

41.02

60.31

u/l

0.46

442

2017

Type 2 diabetes, strict (exclude DM1)

5437

24811

1.32

67.90

2.7

2.3

57.95

41.75

u/l

0.50

4544

21505

Diabetes, insulin treatment (Kela reimbursement)

5761

27284

1.30

67.53

3.5

2.3

58.38

41.05

u/l

0.58

4715

23627

Malignant neoplasm of skin

2507

11889

1.49

67.38

2.5

2.3

43.10

43.21

u/l

0.00

2157

10036

Symptoms and signs concerning food and fluid intake

611

2928

2.24

67.32

3.0

2.1

34.61

56.02

u/l

0.70

506

2468

Obsessive-compulsive disorder

416

1706

2.65

66.64

2.5

2.4

29.28

39.38

u/l

2.59

361

1472

COPD, hospital admission 2, with asthma infections

1743

9714

1.61

66.58

3.0

2.4

32.20

52.75

u/l

1.63

1466

8302

Acute peritonitis

443

1889

2.62

66.50

5.0

2.4

42.77

64.10

u/l

0.39

382

1615

Injuries to unspecified part of trunk, limb or body region

664

3327

2.17

66.15

3.0

2.4

28.88

52.63

u/l

1.01

584

2853

Crohn's disease NAS

451

1941

2.58

66.07

3.6

2.3

36.63

61.26

u/l

0.50

403

1671

Myocardial infarction

2714

13505

1.46

65.62

2.8

2.5

63.17

49.61

u/l

0.22

2316

11538

Non-small cell lung cancer, including Hilmo

786

3901

2.01

65.55

2.8

2.1

32.91

39.55

u/l

1.71

688

3269

Speech and linguistic disorders, excluding more controls

450

1796

2.53

65.51

2.4

28.18

37.76

u/l

2.21

396

1555

Ischemic heart diseases

4629

21298

1.34

65.05

3.0

2.5

39.51

45.62

u/l

0.99

3973

18230

Ovarian cyst

2013

7699

1.56

65.00

2.5

2.3

33.91

37.00

u/l

0.86

1695

6549

Coronary atherosclerosis

3590

16805

1.39

64.98

2.8

2.5

38.66

47.58

u/l

1.36

3044

14374

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

234

731

3.89

64.85

2.2

2.0

31.82

34.41

u/l

0.39

197

613

Lumbar disc prolapse

3523

20021

1.39

64.62

2.7

2.5

41.52

46.99

u/l

0.43

2990

17273

L04AX Other immunosuppressants

3130

22929

1.41

64.41

2.8

2.5

40.56

45.68

u/l

0.42

2741

19621

Social phobias

501

2260

2.38

64.35

2.9

2.4

59.74

37.91

u/l

0.54

420

1960

Anogenital herpesviral [herpes simplex] infection

663

3342

2.13

64.29

2.6

2.3

32.58

51.44

u/l

0.71

582

2877

Benign neoplasm: Stomach

638

3195

2.19

64.20

3.0

2.4

47.60

53.27

u/l

0.10

542

2725

Fissure and fistula of anal and rectal regions

1260

7679

1.71

64.17

2.5

2.4

40.68

59.01

u/l

0.76

1096

6540

Other joint disorders

5123

20926

1.32

64.14

2.5

2.4

49.49

44.77

u/l

0.13

4382

17992

Other arthrosis

3008

15047

1.43

64.06

2.6

2.5

43.63

46.16

u/l

0.15

2589

12928

Hydronephrosis

677

3453

2.11

63.56

2.9

2.3

37.44

39.01

u/l

0.24

606

2932

Fracture of shoulder and upper arm

2031

13811

1.53

63.54

2.8

2.5

42.54

44.02

u/l

0.07

1743

11835

Other sexually transmitted chlamydial diseases

597

2901

2.20

63.54

2.4

29.72

52.58

u/l

0.78

534

2504

Inflammatory disease of uterus

836

4571

1.95

63.49

2.5

2.2

32.14

35.50

u/l

0.89

701

3862

Other diseases of pleura

2427

14927

1.48

63.48

2.9

2.5

44.69

46.86

u/l

0.08

2086

12719

Viral pneumonia (unknown virus, not influenza)

467

2082

2.48

63.02

3.2

2.5

37.26

61.28

u/l

0.53

402

1780

Delirium, not induced by alcohol and other psychoactive substances

710

3695

2.06

62.58

3.3

2.4

38.34

51.85

u/l

0.51

596

3156

Injuries to the wrist and hand

5680

31206

1.29

61.95

2.6

2.5

51.19

43.71

u/l

0.25

4893

26722

Acute sinusitis

2856

19164

1.42

61.83

2.8

2.4

45.71

40.17

u/l

0.49

2414

16462

Dental pulpitis, including avohilmo

5162

26242

1.30

61.81

2.8

2.5

35.11

47.43

u/l

2.52

4429

22543

Fall on and from stairs and steps

1480

9502

1.63

61.51

2.8

2.5

33.18

42.97

u/l

1.19

1275

8123

Attention to artificial openings

294

1069

3.14

61.39

2.6

2.2

30.80

40.30

u/l

1.18

262

916

Cervicalgia

1169

7085

1.73

61.34

2.7

2.4

34.19

49.38

u/l

1.28

998

6106

Personal history of other diseases and conditions

684

3528

2.07

61.19

2.9

2.1

43.26

49.98

u/l

0.14

578

2968

Injuries to the shoulder and upper arm

4713

29573

1.31

61.06

2.7

2.5

41.98

45.77

u/l

0.33

4007

25369

COPD related to multimorbidity

2082

12069

1.51

61.05

2.9

2.4

32.81

50.05

u/l

1.73

1737

10325

Polycystic kidney disease

234

760

3.72

60.90

4.2

2.5

42.73

96.64

u/l

0.41

222

653

Asthma/COPD (KELA code 203)

5373

29067

1.29

60.89

2.5

36.25

47.50

u/l

2.18

4533

24981

Emotional disorders starting during childhood or adolecense, excluding more controls

261

854

3.25

60.87

2.5

2.2

27.59

35.17

u/l

2.42

215

730

Kela-code for severe mental illness

2021

13861

1.51

60.76

2.6

31.11

44.93

u/l

2.58

1702

11964

Disorders of lacrimal system

2350

16543

1.47

60.71

2.7

2.4

43.80

43.68

u/l

0.01

2010

14092

Malignant neoplasm of small intestine, including Hilmo

229

731

3.67

60.45

3.4

2.1

39.96

42.60

u/l

0.11

212

609

Emergency coronary revascularization (for ACS)

4730

22324

1.32

60.29

2.9

2.5

38.24

48.48

u/l

1.53

4082

19068

Type 2 diabetes, definitions combined, including avohilmo

5381

24701

1.29

60.00

2.8

2.3

45.09

41.77

u/l

0.14

4490

21422

Atherosclerosis, excluding cerebral and coronary sclerosis

2160

11839

1.50

59.86

3.1

2.4

73.28

38.37

u/l

0.52

1796

10097

Rash and other nonspecific skin eruption

620

3144

2.14

59.82

2.5

2.3

36.53

54.35

u/l

0.60

531

2677

Anogenital herpesviral [herpes simplex] infection

426

1867

2.52

59.74

2.7

2.4

34.13

61.51

u/l

0.54

373

1601

Early syphilis

140

328

5.77

59.67

2.1

3.0

31.92

45.85

u/l

0.51

135

284

Malignant neoplasm of bronchus and lung, including Hilmo

1050

5169

1.78

59.57

2.8

2.2

33.96

39.02

u/l

1.49

916

4336

Injuries to the hip and thigh

2599

16910

1.44

59.49

2.7

2.5

37.90

47.50

u/l

0.94

2162

14443

Other and unspecified injuries of head

461

2095

2.42

59.36

3.1

2.3

43.91

62.44

u/l

0.34

396

1804

Percutaneous Coronary Intervention

4350

20535

1.33

59.11

3.0

2.5

38.33

45.87

u/l

1.35

3772

17582

Other viral diseases

1614

10605

1.58

59.04

3.3

2.5

45.16

43.40

u/l

0.06

1395

9140

Other embolism and thrombosis

781

4286

1.95

58.95

3.0

2.4

43.30

52.00

u/l

0.23

659

3656

Carcinoma in situ of rectum

138

327

6.01

58.85

1.8

2.5

36.14

35.29

u/l

0.09

121

279

Abnormal involuntary movements

816

4545

1.92

58.82

2.9

2.4

33.97

49.48

u/l

0.81

692

3881

Portal vein thrombosis

163

430

4.85

58.78

6.5

2.3

431.22

43.72

u/l

0.48

152

365

Abscess of anal and rectal regions

512

2428

2.28

58.53

3.2

2.4

34.71

58.69

u/l

0.66

453

2119

Stomatitis and related lesions

1134

6917

1.73

58.51

2.8

2.4

32.10

43.70

u/l

1.00

957

5900

Amiodarone users

612

3119

2.14

58.42

2.6

2.5

40.39

38.36

u/l

0.19

532

2664

COPD, hospital admissions 3, with asthma pneumonia sepsis

1442

7909

1.63

58.25

3.1

2.4

31.73

49.37

u/l

1.24

1212

6748

Enlarged lymph nodes

844

4748

1.87

57.71

3.0

2.1

34.40

48.89

u/l

0.79

726

4037

Non-small cell lung cancer, adenocarcinoma

358

1473

2.68

57.54

2.7

2.2

32.54

36.66

u/l

0.52

315

1230

Diseases of peritoneum

629

3249

2.09

57.47

4.5

2.4

42.02

52.84

u/l

0.32

545

2781

Fibromyalgia

565

2806

2.17

57.33

2.8

2.1

35.89

40.17

u/l

0.29

471

2365

Finngen Rheumatological endpoints

5519

24938

1.28

57.33

2.7

2.5

37.55

41.18

u/l

0.76

4697

21464

Cardiodefibrillation

1888

12922

1.52

57.22

2.4

2.5

36.02

51.67

u/l

1.52

1632

11064

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2045

14148

1.49

57.07

2.7

2.5

34.54

40.66

u/l

1.12

1722

12199

Phlebitis and thrombophlebitis (not including DVT)

1296

8218

1.66

57.00

3.1

2.4

36.30

45.23

u/l

0.48

1118

7059

Fentanyl

555

2726

2.16

56.98

4.0

2.0

36.86

38.05

u/l

0.06

491

2320

Ductal carcinoma of pancreas

181

8.34

56.97

9.3

2.0

407.26

32.19

u/l

0.59

150

Duodenal ulcer

615

3148

2.09

56.93

3.3

2.3

44.54

39.23

u/l

0.27

539

2686

Monoamine oxidase A inhibitors

688

3665

2.01

56.81

2.5

2.4

38.16

36.61

u/l

0.12

578

3163

Congenital malformations, deformations and chromosomal abnormalities

3529

24661

1.35

56.74

2.7

2.5

35.68

46.40

u/l

2.03

3059

21175

Hepatocellular carcinoma

168

457

4.37

56.66

3.8

2.2

30.68

33.46

u/l

0.56

151

370

Early onset COPD

1235

7756

1.67

56.63

3.2

2.5

32.18

56.87

u/l

1.55

1041

6680

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

544

2672

2.19

56.60

2.8

2.2

63.02

57.25

u/l

0.07

482

2246

Postprocedural disorders of digestive system, not elsewhere classified

258

919

3.27

56.52

4.0

2.2

33.43

33.31

u/l

0.02

230

775

Rotator cuff syndrome

3289

17638

1.37

56.49

2.7

2.4

35.51

42.29

u/l

1.92

2794

15159

Malignant neoplasm of respiratory system and intrathoracic organs

1019

5019

1.77

56.47

2.7

2.2

33.91

38.48

u/l

1.27

890

4222

6-mercaptopurine

262

937

3.19

56.38

4.0

2.3

31.24

89.18

u/l

0.60

239

809

Haemorrhage, not elsewhere classified

264

947

3.15

56.18

3.6

2.1

109.99

94.72

u/l

0.06

236

796

In situ neoplasms

2058

14402

1.48

55.90

2.6

2.4

67.46

38.94

u/l

0.39

1760

12178

Abnormal spermatozoa

3866

0.20

55.90

2.3

2.6

47.32

58.02

u/l

0.20

3345

Volvulus

200

617

3.74

55.41

3.6

2.2

34.72

38.05

u/l

0.32

170

530

Cystic kidney disease

258

931

3.24

55.41

4.0

2.5

42.57

84.88

u/l

0.39

244

798

Coronary revascularization (ANGIO or CABG)

4324

20548

1.32

55.40

2.9

2.5

38.42

45.89

u/l

1.33

3742

17593

Early syphilis

146

372

5.08

55.35

2.1

2.9

31.59

43.96

u/l

0.51

138

323

Disease of hard tissues of teeth, NOS

3009

11535

1.40

55.28

2.5

2.3

35.60

50.67

u/l

1.56

2540

9955

Other sexually transmitted chlamydial diseases

414

1850

2.43

54.98

2.4

2.5

27.73

59.95

u/l

0.68

371

1596

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2354

11342

1.45

54.85

2.5

2.3

44.17

41.94

u/l

0.08

2011

9581

Atopic dermatitis

3217

19784

1.37

54.83

2.5

34.62

43.21

u/l

1.92

2744

17029

Other viral diseases, not elsewhere classified

1445

9409

1.59

54.55

3.0

2.5

45.48

44.11

u/l

0.04

1227

8101

Fungal Sepsis

288

1104

2.97

54.43

3.9

2.2

33.30

37.97

u/l

0.83

247

954

Viral infections characterized by skin and mucous membrane lesions

2284

16332

1.44

54.43

2.9

2.5

62.09

45.70

u/l

0.44

1995

14005

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

279

1059

3.02

53.99

2.6

2.4

34.81

84.93

u/l

0.57

236

898

Adenomyosis (Endometriosis of uterus)

792

4482

1.88

53.92

2.5

2.4

37.27

37.62

u/l

0.02

680

3805

Arthropathies

5218

20963

1.28

53.78

2.7

2.4

35.55

44.74

u/l

1.93

4485

18022

Elevated blood glucose level

524

2604

2.19

53.56

4.5

2.3

127.44

38.94

u/l

0.45

424

2236

Zoster [herpes zoster]

2666

19314

1.40

53.48

2.5

49.00

46.65

u/l

0.06

2299

16425

Cystic kidney disease

270

1016

3.08

53.47

3.9

2.5

42.31

86.83

u/l

0.47

255

872

Systemic connective tissue disorders

1921

13389

1.49

53.43

2.4

48.18

40.87

u/l

0.27

1624

11349

Use of disulfiram, acamprosate or naltrexone

558

2840

2.14

53.40

3.5

2.8

33.69

56.40

u/l

0.76

472

2488

Myocardial infarction, strict

2474

12718

1.43

53.39

2.7

2.5

37.26

50.46

u/l

1.68

2111

10872

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

557

2832

2.13

53.23

3.0

2.3

69.29

54.60

u/l

0.14

489

2429

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

153

413

4.59

52.98

2.7

1.9

47.68

33.39

u/l

0.43

130

342

Malignant neoplasm of other and unspecified parts of biliary tract

132

319

5.16

52.94

10.1

2.0

56.41

30.87

u/l

1.47

127

261

Fracture of foot, except ankle

1348

8767

1.60

52.73

3.1

2.5

73.67

38.67

u/l

0.49

1153

7544

Other and unspecified coagulation defects

348

1482

2.63

52.60

3.2

2.4

29.56

70.37

u/l

0.68

300

1254

Benign neoplasm: Ascending colon

811

4672

1.86

52.45

2.8

2.4

48.20

48.22

u/l

0.00

698

3992

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

17.96

52.40

2.5

2.6

30.20

26.42

u/l

0.61

Open wound of lower leg

860

5027

1.81

52.10

3.0

2.5

31.48

47.14

u/l

0.99

749

4321

Other and unspecified dermatitis

2781

20682

1.38

52.05

2.8

2.4

36.64

47.18

u/l

1.56

2394

17731

Non-Hodgkin lymphoma, all, including Hilmo

676

3680

1.95

51.91

2.5

2.2

35.88

51.01

u/l

0.59

581

3105

Epilepsy

1668

11328

1.52

51.82

2.9

2.5

36.66

49.74

u/l

0.93

1441

9706

Ocular pain

532

2692

2.15

51.77

3.5

2.3

29.54

56.78

u/l

0.90

462

2308

Idiopathic gout

549

2809

2.12

51.69

2.9

2.5

59.89

55.32

u/l

0.06

474

2382

Obesity due to excess calories

2515

18448

1.40

51.54

2.7

2.5

34.76

43.63

u/l

1.25

2084

15929

Purpura and other haemorrhagic conditions

780

4457

1.86

51.51

2.9

2.4

32.07

48.73

u/l

0.90

678

3795

Implicit fungal Sepsis

267

1014

3.00

51.48

3.7

2.3

33.52

38.60

u/l

0.84

227

875

Benign neoplasm: Small intestine

298

1203

2.85

51.33

3.7

2.4

52.40

40.73

u/l

0.48

273

1019

Cardiomyopathy (excluding other)

704

3902

1.92

51.21

2.4

2.6

38.76

70.19

u/l

0.84

605

3389

Other (not insulin) diabetes medications

5415

25834

1.27

51.17

2.7

2.3

46.77

42.01

u/l

0.21

4499

22379

Cardiomyopathies, Primary/intrinsic

677

3708

1.94

51.16

2.4

2.5

38.39

72.60

u/l

0.88

583

3223

Eating disorder

520

2602

2.13

51.15

2.7

2.2

31.46

54.19

u/l

0.65

439

2203

Congenital malformations of the urinary system

386

1742

2.45

50.88

3.6

2.4

43.66

64.37

u/l

0.34

354

1482

Congenital malformations of the urinary system

407

1877

2.39

50.86

3.5

2.4

43.29

64.29

u/l

0.39

373

1606

Disorders of tooth development and eruption

885

4201

1.78

50.42

2.8

2.3

40.40

47.80

u/l

0.57

770

3668

Pleural effusion

849

4996

1.80

50.29

2.9

2.4

32.56

38.11

u/l

2.47

732

4258

Other infectious diseases

549

2833

2.09

50.27

3.6

2.4

37.18

54.91

u/l

0.51

473

2418

Chondrocostal junction syndrome [Tietze]

283

1124

2.88

50.15

3.7

2.3

28.86

39.08

u/l

2.84

249

951

Major coronary heart disease event

4579

21875

1.29

50.04

3.0

2.5

38.85

45.34

u/l

1.14

3957

18701

Insulin, fast-acting

1935

13659

1.46

49.82

5.2

2.4

74.48

39.48

u/l

0.42

1502

11814

Other infectious diseases

480

2375

2.20

49.66

3.6

2.4

38.26

58.76

u/l

0.49

416

2026

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

443

2136

2.26

49.20

3.2

2.5

40.28

61.41

u/l

0.45

400

1838

Hyperkalaemia

342

1482

2.53

49.05

5.2

2.4

32.01

71.39

u/l

0.65

296

1258

Other eating disorders

315

1312

2.62

49.04

2.9

2.2

32.30

32.87

u/l

0.07

267

1101

Non-small cell lung cancer

503

2506

2.11

48.81

2.8

2.1

33.31

37.05

u/l

0.61

443

2072

Endometriosis

1849

7498

1.49

48.80

2.4

2.3

42.99

37.16

u/l

0.46

1591

6380

Other diseases of lip and oral mucosa

2151

15540

1.43

48.74

2.8

2.5

37.82

43.80

u/l

0.69

1800

13326

Crohn's disease of small intestine

435

2089

2.27

48.70

3.2

2.4

42.70

61.06

u/l

0.36

391

1792

Disturbance of activity and attention

627

3325

1.95

48.59

2.4

2.5

30.63

52.14

u/l

0.87

534

2886

Covid-19 suspected case

1189

7665

1.62

48.36

2.8

2.4

31.70

43.03

u/l

1.11

1048

6580

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2162

10614

1.44

48.27

2.4

2.2

44.55

37.98

u/l

0.30

1851

8945

Superficial injury of wrist and hand

1115

7092

1.64

48.18

2.7

2.5

32.39

45.49

u/l

1.11

962

6089

Disorders of skin appendages

2563

19039

1.38

47.99

2.9

2.5

38.17

45.77

u/l

0.84

2189

16355

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

19.21

47.88

2.5

30.83

27.32

u/l

0.46

Hyperkinetic disorders

666

3613

1.90

47.87

2.4

2.5

30.47

50.12

u/l

0.86

569

3137

Cervicocranial syndrome

618

3366

1.96

47.67

2.9

2.2

31.79

53.70

u/l

0.90

534

2894

Congenital malformations, deformations and chromosomal abnormalities

3146

22960

1.34

47.22

2.7

2.5

36.06

46.17

u/l

1.67

2742

19715

Crohn disease (strict definition, require KELA, min 2 HDR)

413

1976

2.29

46.89

3.3

2.5

40.94

63.32

u/l

0.44

372

1700

Other local infections of skin and subcutaneous tissue

609

3329

1.96

46.78

3.4

2.4

33.30

50.83

u/l

0.66

532

2869

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2776

20360

1.36

46.70

2.6

43.28

46.01

u/l

0.12

2394

17522

Hemiplegia

330

1444

2.52

46.58

3.0

2.4

30.06

41.15

u/l

1.99

289

1226

Injuries to the elbow and forearm

3851

26652

1.30

46.50

2.7

2.5

36.93

44.86

u/l

1.33

3288

22814

Recurrent aphthous stomatitis , including avohilmo

809

4807

1.78

46.42

2.8

2.4

30.88

47.87

u/l

1.04

677

4100

Crohn disease (strict definition, require KELA)

416

2005

2.27

46.32

3.3

2.5

40.82

62.90

u/l

0.44

375

1724

Other obstetric conditions, not elsewhere classified

1592

6888

1.52

46.29

2.3

34.05

37.31

u/l

0.63

1366

5896

Conjunctivitis (acute, non atopic)

1478

10028

1.52

46.28

2.8

2.5

57.90

45.05

u/l

0.23

1278

8582

Other metabolic disorders

735

4251

1.83

46.23

2.7

2.2

41.95

48.72

u/l

0.23

640

3611

Crohn's disease of large intestine

339

1507

2.48

46.22

3.5

2.4

38.89

70.13

u/l

0.49

306

1299

Basal cell carcinoma, including avohilmo

2155

10708

1.42

46.17

2.4

2.2

44.85

42.20

u/l

0.09

1851

9022

Nerve, nerve root and plexus disorders

5887

29602

1.24

46.05

2.8

2.5

47.67

43.40

u/l

0.20

4986

25422

Malignant neoplasm of urinary organs

490

2501

2.09

45.84

3.0

2.2

62.61

58.12

u/l

0.05

437

2092

ILD, hospital admission 2, with pulmonary infections

527

2763

2.04

45.68

3.1

2.3

36.60

57.38

u/l

0.64

480

2376

Decubitus ulcer and pressure area

375

1745

2.35

45.59

3.3

2.4

33.82

38.51

u/l

0.58

288

1487

Eating disorders

596

3246

1.94

45.55

2.8

2.3

31.30

51.62

u/l

0.76

505

2772

Injury of unspecified body region

481

2460

2.12

45.50

2.9

2.4

29.47

58.07

u/l

0.85

425

2101

Gonococcal infection

252

993

2.91

45.49

2.2

2.4

30.01

88.55

u/l

0.66

220

856

Gonococcal infection

263

1057

2.83

45.45

2.2

2.5

29.97

85.11

u/l

0.66

231

911

Dermatitis

3259

25172

1.32

45.31

2.8

2.5

36.40

46.65

u/l

1.83

2790

21560

Other coagulation defects

461

2328

2.15

45.13

3.0

2.4

74.10

57.40

u/l

0.13

402

1984

Basal cell carcinoma

2061

10253

1.43

45.07

2.5

2.2

44.76

37.96

u/l

0.29

1761

8646

Malignant neoplasm of bronchus and lung

861

4298

1.73

45.02

2.7

2.2

34.13

39.16

u/l

1.19

752

3599

Primary_lymphoid and hematopoietic malignant neoplasms

1278

8526

1.56

44.74

2.7

2.5

37.33

51.92

u/l

0.81

1098

7259

Diabetic nephropathy, excluding more controls

826

4078

1.77

44.58

7.0

2.8

48.90

50.87

u/l

0.04

699

3407

Other and unspecified local infections of skin and subcutaneous tissue

570

3104

1.97

44.36

3.5

2.4

32.61

52.15

u/l

0.69

497

2671

Other disorders of bone

1088

7024

1.62

44.26

3.0

2.4

33.92

46.69

u/l

1.05

929

6044

Other diseases of oesophagus

530

2815

2.01

44.24

3.4

2.3

44.44

40.75

u/l

0.19

459

2402

Dental operations

3566

14219

1.32

44.08

2.6

2.4

39.34

50.88

u/l

1.07

3057

12182

Misadventures to patients during surgical and medical care

794

4768

1.76

43.76

3.5

2.3

87.98

47.50

u/l

0.48

703

4058

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1542

6694

1.51

43.73

2.3

34.29

37.39

u/l

0.56

1319

5739

Laparoscopic left hemicolectomy

156

488

3.95

43.67

3.1

2.3

33.18

43.68

u/l

0.58

137

423

Urticaria and erythema

1926

13909

1.43

43.60

2.6

2.5

34.89

42.12

u/l

1.14

1637

11937

Oter anti-inflammatory and antirheumatic agents, non-steroids

1117

3905

1.63

43.57

2.6

36.67

39.01

u/l

0.39

951

3376

Oesophagitis

340

1551

2.40

43.50

4.6

2.2

48.03

41.28

u/l

0.18

293

1320

Procreative management

1754

10352

1.46

43.46

2.6

2.7

34.72

44.37

u/l

1.17

1533

8929

Insulin, fast-acting or short human

1949

14107

1.42

43.42

5.2

2.4

74.33

42.52

u/l

0.37

1513

12166

Disorders of other endocrine glands

2325

17017

1.38

43.42

2.9

2.5

39.32

42.22

u/l

0.23

2009

14587

Autoimmune hepatitis

100

231

5.82

43.40

3.9

2.2

39.84

30.52

u/l

1.45

191

Sequelae of injuries, of poisoning and of other consequences of external causes

1269

8503

1.55

43.39

3.0

2.5

73.79

40.92

u/l

0.41

1071

7340

Follow-up examination after treatment for malignant neoplasms

563

3070

1.95

43.14

2.6

2.2

38.36

40.11

u/l

0.17

470

2613

Disorders of vitreous body and globe

2662

19433

1.35

43.08

3.1

2.5

42.26

46.76

u/l

0.33

2231

16579

Herpesviral [herpes simplex] infections

1323

8949

1.54

43.07

2.7

2.4

33.48

42.61

u/l

0.99

1140

7650

Medical abortion

3388

14256

1.32

42.87

2.4

2.3

33.42

39.62

u/l

2.28

2878

12079

Maternal care for other conditions predominantly related to pregnancy

1081

6867

1.61

42.85

2.4

2.3

35.79

35.57

u/l

0.02

919

5881

Lung transplantation

207

6.33

42.69

2.7

43.31

32.15

u/l

1.61

174

Other and unspecified drugs and medicaments

514

2748

2.02

42.60

3.1

2.4

72.03

55.57

u/l

0.15

455

2361

Stroke, excluding SAH

3103

17505

1.33

42.57

2.8

2.5

42.36

48.74

u/l

0.41

2612

14975

Other disorders of glucose regulation and pancreatic internal secretion

504

2676

2.02

42.44

4.7

2.5

28.28

56.90

u/l

0.96

400

2295

Superficial injury of abdomen, lower back and pelvis

830

5077

1.72

42.34

3.1

2.4

38.78

46.99

u/l

0.37

717

4357

Disorders of vitreous body

2587

18971

1.35

42.27

3.1

2.4

42.62

47.16

u/l

0.32

2173

16176

Unstable angina pectoris

1923

10957

1.43

42.22

2.7

2.5

33.40

50.91

u/l

2.30

1630

9372

Malignant neoplasm of kidney, except renal pelvis

449

2292

2.09

42.09

2.9

2.2

65.48

57.98

u/l

0.08

397

1919

Migraine, single triptan purchase ok & required. ICD-code if available is included

4131

22376

1.27

42.05

2.5

33.70

44.11

u/l

3.02

3522

19213

Triptan medication for migraine, single purchase ok

4131

22376

1.27

42.05

2.5

33.70

44.11

u/l

3.02

3522

19213

All influenza (not pneumonia)

789

4769

1.73

41.97

3.1

2.4

29.80

51.15

u/l

1.48

678

4153

Lung transplant status

206

6.28

41.93

2.7

43.31

32.01

u/l

1.63

173

Fall on same level involving ice and snow

3029

23522

1.32

41.76

2.7

2.5

34.33

45.58

u/l

2.20

2565

20146

Cytomegalovirus infection, IBD co-morbidity

179

619

3.41

41.72

5.6

2.4

36.01

112.95

u/l

0.50

163

531

Superficial injury of thorax

823

5053

1.71

41.52

3.0

2.5

32.91

47.67

u/l

0.91

700

4340

Other cataract

2344

13242

1.38

41.47

3.1

2.5

49.63

44.10

u/l

0.23

1968

11358

Biguanides

5223

26104

1.24

41.42

2.7

2.5

46.43

44.52

u/l

0.07

4335

22519

Other general symptoms and signs

295

1274

2.48

41.42

3.0

2.0

39.11

78.87

u/l

0.51

243

1080

Event of undetermined intent

398

1967

2.20

41.39

2.9

2.5

33.54

63.54

u/l

0.67

339

1697

Benign neoplasm: Transverse colon

610

3471

1.88

41.37

3.1

2.4

72.42

52.91

u/l

0.22

533

2968

Secondary uncertain malignant neoplasm

630

3598

1.84

41.22

2.9

2.2

35.06

50.81

u/l

0.61

543

3036

Ulcerative enterocolitis

225

880

2.89

40.98

4.2

2.4

38.41

93.09

u/l

0.50

208

753

Intestinal malabsorption

306

1376

2.47

40.87

5.7

2.3

36.96

72.21

u/l

0.50

252

1171

Diseases of salivary glands

1694

12128

1.44

40.64

2.7

2.5

42.94

43.28

u/l

0.01

1454

10381

Benign neoplasm: Adrenal gland

471

2492

2.06

40.64

2.6

2.4

42.26

57.64

u/l

0.33

421

2147

Stroke, including SAH

3269

18559

1.31

40.61

2.8

2.5

42.94

48.21

u/l

0.34

2758

15874

Poisoning by narcotics and psychodysleptics [hallucinogens]

147

461

3.82

40.50

3.3

2.5

27.90

137.79

u/l

0.55

126

400

Other viral diseases, not elsewhere classified

991

6374

1.62

40.43

3.3

2.5

52.83

44.10

u/l

0.22

842

5490

Benign neoplasm: Duodenum

201

756

3.12

40.27

3.9

2.5

57.83

40.13

u/l

0.52

187

640

Sequelae of injuries of lower limb

552

3071

1.92

40.17

2.9

2.4

123.88

40.16

u/l

0.47

463

2659

Other systemic involvement of connective tissue (FG)

1395

9538

1.50

40.13

2.4

53.24

43.07

u/l

0.27

1175

8087

Malignant melanoma, including Hilmo

821

5071

1.69

40.09

2.8

2.2

32.99

48.59

u/l

0.95

720

4277

Malignant neoplasm of small intestine

157

513

3.57

40.04

3.4

2.1

33.93

35.49

u/l

0.16

143

424

Cytomegaloviral disease

182

651

3.27

39.86

5.6

2.3

35.90

107.48

u/l

0.50

166

565

Other and unspecified visual disturbances

587

3336

1.88

39.79

3.1

2.4

31.14

54.32

u/l

0.97

512

2866

Aortic aneurysm

1131

7390

1.56

39.48

2.5

37.14

44.99

u/l

0.53

972

6332

Enthesopathies of lower limb, excluding foot

1161

7790

1.55

39.29

2.6

2.4

30.87

50.17

u/l

2.37

992

6720

Striking against or struck by other objects

1724

12433

1.43

39.19

2.7

2.6

36.10

42.64

u/l

0.72

1506

10726

Other ulcerative colitis

358

1738

2.24

39.13

3.6

2.4

44.66

66.29

u/l

0.36

334

1487

Disorders of lens

3582

17727

1.29

39.06

3.2

2.5

69.18

43.48

u/l

0.61

3041

15223

Certain disorders involving the immune mechanism

1024

6717

1.60

39.02

2.8

2.5

37.96

44.34

u/l

0.40

893

5766

Postprocedural endocrine and metabolic disorders, not elsewhere classified

663

3909

1.79

39.00

2.7

2.2

43.56

50.45

u/l

0.21

581

3314

Zoster [herpes zoster]

976

6335

1.61

38.98

2.8

2.4

76.81

45.11

u/l

0.42

856

5381

Amputation

542

3020

1.91

38.93

4.0

2.4

32.74

37.75

u/l

1.07

435

2584

Irregular menses

2458

14741

1.35

38.71

2.5

2.3

35.97

37.29

u/l

0.20

2073

12601

Unspecified/other endometriosis

489

2637

1.96

38.69

2.3

51.05

37.35

u/l

0.35

425

2252

Adenocarcinoma and papillary adenocarcinoma of stomach

175

616

3.17

38.52

4.9

2.1

37.54

31.34

u/l

1.37

160

497

Sleep disorders, other/unspecified

240

995

2.69

38.49

2.8

2.4

32.27

85.13

u/l

0.56

202

838

Disorders of choroid and retina

4268

24618

1.26

38.45

3.2

2.5

41.56

46.66

u/l

0.36

3584

21081

Other/unspecified cytomegaloviral diseases

158

535

3.52

38.41

6.1

2.3

37.18

122.48

u/l

0.47

142

458

Disorders of the thyroid gland

5133

27600

1.23

38.35

2.5

36.09

45.62

u/l

1.93

4321

23688

Ptosis of eyelid

614

3577

1.83

38.19

2.6

2.3

34.72

38.57

u/l

0.76

530

3042

Ischaemic Stroke, excluding all haemorrhages

2865

16567

1.32

37.89

2.8

2.5

42.92

48.71

u/l

0.33

2410

14160

Candidiasis

753

4634

1.71

37.86

3.2

2.4

34.99

47.32

u/l

0.61

647

3960

Angina pectoris

2944

15273

1.32

37.80

2.7

2.5

35.65

48.02

u/l

1.99

2503

13067

Disorders of psychological development

618

3337

1.80

37.28

2.3

2.4

29.10

49.45

u/l

0.80

535

2846

Emotional disorders and disorders of social functioning with onset specific to childhood

292

1302

2.37

37.26

2.5

2.2

27.55

69.24

u/l

0.59

242

1100

Toxic effect of other and unspecified substances

116

330

4.25

37.16

4.6

2.4

23.87

173.91

u/l

0.52

100

280

Hypoglycaemia, other or unspecified

406

2099

2.09

37.15

4.7

2.5

28.59

62.26

u/l

0.86

322

1802

Propionic acid derivatives

1482

5161

1.48

37.13

2.3

2.7

70.00

38.34

u/l

0.47

1241

4462

Toxic liver disease

136

431

3.81

37.02

4.8

2.2

49.65

32.33

u/l

0.69

122

366

Other systemic involvement of connective tissue

1434

10143

1.46

37.00

2.4

52.59

41.72

u/l

0.31

1208

8592

Malignant neoplasm of oesophagus, including Hilmo

211

838

2.79

36.84

2.7

2.2

364.90

39.30

u/l

0.49

182

696

Cyst of kidney

418

2197

2.06

36.73

2.8

2.4

65.13

38.48

u/l

0.41

373

1878

Abnormal findings on diagnostic imaging of other body structures

758

4714

1.70

36.63

3.1

2.3

51.72

47.70

u/l

0.10

647

4000

Urticaria

1547

11096

1.44

36.63

2.7

2.5

33.77

41.25

u/l

0.99

1315

9536

Acute pharyngitis

785

4862

1.67

36.54

2.7

2.6

30.86

41.78

u/l

2.12

668

4214

Missing teeth due to accident, extraction or parodontitis

3078

22954

1.29

36.31

2.9

2.5

38.77

47.53

u/l

1.17

2635

19583

Benign neoplasm: Caecum

592

3468

1.82

36.30

2.9

2.4

71.66

38.71

u/l

0.47

525

2959

Other shoulder lesions

534

3027

1.87

36.28

3.1

2.3

31.77

40.53

u/l

2.52

447

2609

Failure and rejection of transplanted organs and tissues

118

348

4.14

36.00

8.1

2.4

47.92

167.83

u/l

0.43

106

304

Other specified/unspecified arthritis

1413

10013

1.46

35.90

2.9

2.5

36.43

45.82

u/l

1.06

1186

8579

Diabetic nephropathy

832

5251

1.65

35.88

7.0

2.8

48.84

61.65

u/l

0.28

703

4356

Bulimia nervosa (incl. atypical)

216

878

2.70

35.83

2.5

2.2

34.03

32.37

u/l

0.17

184

726

Peripheral artery operations in Hilmo

649

3890

1.75

35.76

3.7

2.4

146.55

49.16

u/l

0.40

528

3332

Carcinoma in situ of skin of other and unspecified parts of face

464

2541

1.96

35.72

2.8

2.3

30.83

37.03

u/l

2.46

404

2121

Radiculopathy

833

5319

1.63

35.56

2.8

2.3

33.89

49.23

u/l

1.02

695

4567

Iron deficiency anaemia secondary to blood loss (chronic)

844

5412

1.63

35.54

3.3

2.4

33.36

46.34

u/l

0.81

725

4610

Malignant melanoma

676

4104

1.73

35.48

2.8

2.2

32.83

38.17

u/l

1.31

595

3467

Endocarditis

226

946

2.65

35.46

3.0

2.6

31.75

88.21

u/l

0.59

199

823

Mixed disorders of conduct and emotions, excluding more controls

136

432

3.47

35.43

2.3

23.00

34.12

u/l

5.19

109

370

Malignant neoplasm of other and unspecified female genital organs

128

403

3.87

35.37

2.4

1.9

32.70

35.13

u/l

0.23

110

334

Other extrapyramidal and movement disorders in other diseases

1235

8580

1.50

35.37

2.5

2.4

31.55

43.56

u/l

1.43

1035

7352

Peripheral arterial reconstruction

849

5457

1.63

35.36

2.6

2.4

118.71

37.94

u/l

0.46

703

4635

Unspecified acute lower respiratory infection

794

5025

1.65

35.34

3.2

2.6

75.79

52.63

u/l

0.22

670

4351

Viral and other specified intestinal infections

1025

6674

1.55

35.21

3.5

2.3

37.65

44.71

u/l

0.45

878

5746

Other disorders starting during childhood or adolecense, excluding more controls

226

893

2.58

35.21

2.4

2.3

26.17

34.59

u/l

3.98

193

763

Triptan medication for migraine, min. 3 purchases

2917

17496

1.30

35.20

2.4

2.5

35.99

41.37

u/l

0.65

2488

15061

Non-small cell lung cancer, adenocarcinoma, helper endpoint

358

1809

2.15

35.19

2.7

2.4

32.54

37.97

u/l

0.85

315

1539

Biomechanical lesions, not elsewhere classified

310

1489

2.29

35.19

2.7

2.4

35.46

41.40

u/l

0.44

266

1271

Malignant neoplasm of mesothelium and soft tissue

230

973

2.61

35.15

2.5

2.1

45.01

33.04

u/l

0.57

200

811

Anti-inflammatory and antirheumatic products, non-steroids

1469

5161

1.46

35.14

2.3

2.7

68.88

38.34

u/l

0.45

1239

4462

Thrombocytopenia, unspecified

408

2157

2.04

35.04

3.0

2.4

31.16

60.17

u/l

0.72

343

1842

Erosion of teeth , including avohilmo

1275

8923

1.48

34.83

3.1

2.5

35.55

42.57

u/l

0.66

1089

7681

Other disorders of eyelid

2246

16352

1.34

34.75

2.5

2.4

37.44

47.15

u/l

0.80

1913

13880

Malignant melanoma of skin, including Hilmo

675

4119

1.71

34.71

2.9

2.2

34.09

49.97

u/l

0.73

594

3473

DVT of lower extremities

996

6658

1.56

34.66

3.0

2.4

67.39

47.40

u/l

0.36

865

5695

Other symptoms and signs involving general sensations and perceptions

255

1138

2.47

34.60

3.4

2.3

29.08

79.64

u/l

0.64

225

973

Other neurological diseases

3749

23909

1.26

34.42

2.8

2.5

36.58

46.92

u/l

1.70

3164

20436

Valvular heart disease excluding rheumatic fever

2330

12871

1.34

34.39

2.7

2.5

43.68

51.59

u/l

0.44

1995

11025

Suppurative and necrotic conditions of lower respiratory tract

326

1606

2.21

34.38

3.7

2.5

37.68

38.39

u/l

0.04

290

1380

Clear cell adenocarcinoma of kidney

250

1108

2.47

34.35

3.1

2.2

36.72

39.50

u/l

0.22

221

930

Schizoaffective disorder

438

2382

1.97

34.34

2.5

27.53

60.15

u/l

1.00

369

2070

Extrapyramidal and movement disorders

1907

14304

1.37

34.17

2.4

2.5

32.94

48.58

u/l

1.76

1601

12190

Secondary and unspecified malignant neoplasm of lymph nodes

409

2178

2.00

33.94

2.7

2.2

36.22

37.69

u/l

0.17

348

1837

Superficial injury of ankle and foot

643

3905

1.73

33.89

2.8

2.4

51.85

38.22

u/l

0.28

538

3360

Injuries to the neck

1175

8149

1.49

33.75

3.1

2.5

35.11

43.13

u/l

0.64

998

7004

Toxic effects of substances chiefly nonmedicinal as to source

624

3774

1.74

33.60

3.3

2.5

40.26

50.49

u/l

0.30

533

3250

Intentional self-harm by unspecified means

116

353

3.95

33.60

3.6

2.4

30.49

31.10

u/l

0.08

291

Cervicobrachial syndrome

1118

7684

1.51

33.56

2.8

2.4

46.48

49.64

u/l

0.08

958

6650

Acute and transient psychotic disorders

640

3897

1.73

33.56

2.9

2.5

29.46

51.30

u/l

1.13

548

3379

Mycoses

1368

9766

1.45

33.55

3.1

2.5

33.48

45.00

u/l

1.44

1182

8358

Other specified/unspecified bacterial intestinal infections

387

2044

2.04

33.44

2.9

2.3

32.87

62.06

u/l

0.68

324

1765

Traumatic subdural haemorrhage

662

3888

1.71

33.40

2.9

2.4

42.82

57.10

u/l

0.34

553

3387

Other inflammation of vagina/vulva

232

1012

2.53

33.24

2.2

2.1

29.56

35.57

u/l

1.62

189

849

ILD, hospital admissions 3, with pneumonia sepsis

440

2425

1.93

32.90

3.0

2.3

35.56

41.30

u/l

1.21

399

2082

Rheumatism, unspecified

719

4525

1.67

32.89

3.0

2.2

29.78

38.92

u/l

6.01

595

3835

Acidosis

150

536

3.23

32.78

4.7

2.6

42.98

43.11

u/l

0.00

133

465

Laparoscopic right hemicolectomy

346

1779

2.13

32.76

2.6

2.3

35.36

39.48

u/l

0.51

300

1513

Benign neoplasm of other and unspecified endocrine glands

719

4540

1.67

32.75

2.5

2.4

38.53

48.38

u/l

0.37

636

3870

Senile cataract

3223

15790

1.28

32.71

3.0

2.5

72.57

43.37

u/l

0.62

2727

13546

Other disorders involving the immune mechanism, not elsewhere classified

213

906

2.64

32.67

3.3

2.6

37.29

91.77

u/l

0.53

200

785

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1731

12888

1.38

32.66

2.6

2.5

38.20

42.68

u/l

0.43

1486

11008

Other degenerative diseases of the nervous system

1402

7475

1.44

32.59

2.5

2.4

36.55

48.45

u/l

0.61

1149

6451

Non-rheumatic valve diseases

2303

12801

1.33

32.34

2.7

2.5

43.88

51.59

u/l

0.42

1973

10965

Other and unspecified diseases of blood and blood-forming organs

182

724

2.86

32.29

2.7

2.4

36.08

33.79

u/l

0.23

160

607

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

544

3220

1.79

32.05

2.9

2.4

207.36

53.63

u/l

0.60

463

2758

Malignant neoplasm of bladder, including Hilmo

517

2977

1.80

32.02

2.6

2.1

38.34

37.26

u/l

0.14

444

2477

Other retinal disorders

3250

20401

1.27

31.93

3.5

2.5

42.35

47.71

u/l

0.29

2718

17453

Gastrointestinal stromal tumor and sarcoma

259

4.46

31.75

3.0

2.0

37.78

35.61

u/l

0.11

217

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

894

5770

1.57

31.74

3.0

2.5

43.07

44.86

u/l

0.07

794

4948

Campylobacter enteritis

187

759

2.78

31.72

2.9

2.4

105.51

39.77

u/l

0.48

171

655

Symptoms and signs involving emotional state

200

836

2.66

31.59

3.3

2.4

30.74

93.53

u/l

0.56

177

707

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

254

1172

2.35

31.56

2.5

2.1

33.39

33.86

u/l

0.07

206

971

Other and unspecified disorders of vitreous body

2099

15925

1.34

31.50

2.5

2.4

43.67

48.12

u/l

0.25

1761

13577

Other pleural conditions

534

3159

1.79

31.30

3.0

2.4

38.32

38.51

u/l

0.01

461

2692

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

198

832

2.68

31.22

3.3

2.6

37.89

96.75

u/l

0.53

187

726

Malignant neoplasm of retroperitoneum and peritoneum

188

5.35

31.11

2.8

2.1

36.01

30.45

u/l

0.89

156

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

839

5362

1.58

30.99

3.1

2.5

43.80

45.60

u/l

0.07

747

4608

Amputation of toe

389

2109

1.98

30.95

4.1

2.5

31.43

37.14

u/l

0.95

318

1799

COPD, hospital admissions 1, only main diagnosis

1670

10636

1.38

30.95

2.9

2.4

32.68

51.40

u/l

1.61

1402

9065

Emotional disorders starting during childhood or adolescence

266

1244

2.27

30.93

2.5

2.2

27.43

71.51

u/l

0.59

219

1047

Conduction disorders

1443

8495

1.42

30.79

2.6

2.4

33.54

52.18

u/l

1.20

1231

7287

Pericarditis

218

956

2.50

30.77

3.8

2.6

32.08

91.04

u/l

0.63

182

828

Cluster headache, strict

229

1027

2.45

30.73

2.9

2.5

30.91

36.35

u/l

0.95

200

895

Other acute viral hepatitis

115

370

3.76

30.69

4.0

2.5

25.21

159.03

u/l

0.53

103

316

Exposure to other and unspecified inanimate mechanical forces

415

2302

1.93

30.62

3.3

2.5

30.93

59.92

u/l

0.79

362

1978

Other infective otitis externa

345

1808

2.06

30.53

2.6

2.3

28.67

66.34

u/l

0.81

286

1542

Pruritus

585

3568

1.73

30.52

3.3

2.2

32.60

38.35

u/l

1.76

504

3026

Myocarditis

256

1201

2.28

30.18

2.8

2.3

37.12

41.17

u/l

0.47

225

1059

Disorders of breast

2475

17714

1.30

30.08

2.3

35.33

38.96

u/l

1.00

2129

15015

Diseases of spleen

135

482

3.26

29.75

4.9

2.4

37.07

42.16

u/l

0.21

118

405

Reimbursement for rheumatic diseases

2939

23597

1.27

29.70

2.9

2.4

50.26

44.90

u/l

0.18

2564

20130

Other arthritis (FG)

1599

11931

1.38

29.70

2.8

2.5

35.85

44.86

u/l

1.27

1340

10224

Other and unspecified paralytic syndromes

115

376

3.62

29.63

3.6

2.4

28.82

45.13

u/l

0.73

310

Sequelae of other external causes

322

1665

2.08

29.62

3.2

2.4

124.43

69.90

u/l

0.24

281

1427

Hypothyroidism, strict autoimmune

3825

20718

1.23

29.54

2.5

2.3

35.83

44.68

u/l

1.29

3209

17744

AV-block

840

4882

1.56

29.49

2.5

2.4

33.85

62.75

u/l

1.01

709

4213

Congenital malformations of gallbladder, bile ducts and liver

255

4.41

29.45

6.1

2.2

47.54

29.07

u/l

2.07

211

Superficial injury of hip and thigh

754

4918

1.60

29.40

2.8

2.4

38.28

48.03

u/l

0.38

618

4189

Otitis externa

1128

7974

1.46

29.35

2.8

2.5

32.54

42.82

u/l

1.00

942

6831

Excessive, frequent and irregular menstruation

1934

8023

1.35

29.34

2.6

2.3

32.80

36.80

u/l

1.22

1602

6825

Emphysema

383

2099

1.94

29.26

3.1

2.3

31.76

39.35

u/l

1.62

335

1792

Thoracic aortic aneurysm

703

4530

1.63

29.25

2.5

39.03

49.56

u/l

0.42

600

3929

Barrett oesophagus

281

1396

2.19

29.08

4.1

2.3

32.90

41.68

u/l

1.00

234

1212

Transient ischemic attack

2582

16601

1.29

29.04

2.7

2.5

38.68

49.33

u/l

1.04

2167

14178

Pregnancy examination and test

783

3149

1.60

29.00

2.2

2.4

34.95

36.18

u/l

0.16

660

2682

Speech and linguistic disorders

455

2516

1.82

28.93

2.4

28.11

53.55

u/l

0.74

401

2134

Other protozoal intestinal diseases

151

577

2.96

28.92

2.1

2.3

31.76

35.39

u/l

0.49

136

487

Primary biliary cholangitis (PBC)

159

627

2.90

28.87

3.7

2.1

41.41

35.75

u/l

0.59

150

521

Other enthesopathies

1460

10796

1.39

28.68

2.7

2.4

38.90

40.35

u/l

0.16

1226

9276

Diplopia

675

4334

1.63

28.52

2.9

2.4

32.68

49.90

u/l

0.88

575

3704

General examination and investigation of persons without complaint and reported diagnosis

3099

13017

1.26

28.36

3.0

2.3

67.99

43.56

u/l

0.66

2640

11212

Malignant neoplasm of rectosigmoid junction, including Hilmo

166

669

2.74

28.28

2.1

32.24

31.63

u/l

0.13

147

552

Osteoporosis

1311

8934

1.42

28.23

3.2

2.3

38.39

44.58

u/l

0.41

1143

7548

Malignant neoplasm of head and neck

374

2052

1.92

28.22

2.8

2.2

43.16

37.21

u/l

0.48

317

1731

L01XE Protein kinase inhibitors

317

1666

2.07

28.17

3.0

2.4

72.76

39.94

u/l

0.39

290

1433

Diseases of external ear

1687

12790

1.35

28.16

2.7

2.5

34.33

50.09

u/l

1.59

1423

10977

Dilated cardiomyopathy

604

3795

1.68

28.12

2.4

2.5

38.55

51.89

u/l

0.52

520

3274

Presence of cardiac and vascular implants and grafts

2229

12963

1.31

28.10

2.6

2.5

41.50

43.21

u/l

0.11

1900

11065

Diffuse large B-cell lymphoma

236

1110

2.30

28.04

2.3

2.2

37.63

37.26

u/l

0.02

207

918

Diffuse large B-cell lymphoma, helper endpoint

236

1110

2.30

28.04

2.3

2.2

37.63

37.26

u/l

0.02

207

918

Diffuse large B-cell lymphoma, including Hilmo

236

1110

2.30

28.04

2.3

2.2

37.63

37.26

u/l

0.02

207

918

Hypothyroidism, other/unspecified

4683

25977

1.20

28.03

2.5

35.84

44.80

u/l

1.75

3942

22303

Fracture at wrist and hand level

1727

13111

1.35

27.98

2.8

2.6

76.76

45.12

u/l

0.36

1494

11281

Carcinoma in situ of skin

449

2624

1.82

27.86

2.8

2.4

31.35

40.15

u/l

2.81

387

2208

Disorders of vestibular function (Vertigo)

2356

18364

1.29

27.85

2.6

2.5

41.22

46.64

u/l

0.31

2005

15653

Osteonecrosis

354

1932

1.98

27.84

2.5

2.4

33.02

41.17

u/l

1.29

294

1674

Personal history of malignant neoplasm

388

2176

1.91

27.79

2.1

2.2

68.42

36.28

u/l

0.46

337

1835

Cramp and spasm

279

1407

2.16

27.77

3.4

2.4

31.80

73.93

u/l

0.66

242

1198

Carcinoma in situ of colon

141

536

3.06

27.76

2.4

33.75

33.87

u/l

0.02

118

461

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

520

3136

1.72

27.66

2.5

2.1

34.44

35.66

u/l

0.17

445

2628

Neuromuscular dysfunction of bladder

456

2673

1.80

27.65

2.8

2.4

32.39

57.71

u/l

0.79

391

2306

Pneumonitis due to solids and liquids

424

2435

1.84

27.64

3.1

2.4

33.19

58.05

u/l

0.68

362

2076

Type 1 diabetes

1259

9136

1.42

27.64

5.7

2.4

44.82

40.47

u/l

0.19

976

7953

Cluster headache, wide

237

1125

2.29

27.63

2.9

2.5

30.69

35.96

u/l

0.97

206

976

Agranulocytosis

589

3696

1.68

27.63

3.4

2.4

33.44

51.42

u/l

0.77

521

3149

Late syphilis

124

442

3.28

27.50

3.9

2.4

35.49

143.62

u/l

0.50

377

Open wound of ankle and foot

544

3347

1.71

27.47

3.6

2.4

34.65

38.81

u/l

0.57

452

2871

Malignant melanoma of skin

506

3053

1.74

27.40

3.0

2.2

34.04

37.47

u/l

0.53

448

2579

Other respiratory diseases principally affecting the interstitium

881

6032

1.52

27.35

2.9

2.4

45.66

45.67

u/l

0.00

781

5114

IgA nephropathy (IgA glomerulonephritis)

165

680

2.75

27.29

3.0

2.4

39.34

104.28

u/l

0.47

155

599

Other and unspecified abdominal hernia

242

1167

2.27

27.22

4.0

2.2

38.75

39.29

u/l

0.02

218

995

Other aneurysm

295

1524

2.08

27.17

2.6

2.3

86.44

70.47

u/l

0.11

250

1294

Other surgical follow-up care

207

942

2.41

26.88

4.0

2.3

33.94

39.88

u/l

0.54

182

810

Other diseases of arteries and capillaries

460

2729

1.78

26.77

3.8

2.4

29.36

56.54

u/l

0.92

401

2336

Other orthopaedic follow-up care

306

1608

2.04

26.77

2.8

2.3

30.15

70.86

u/l

0.77

246

1386

Atypical facial pain

310

1647

2.04

26.55

3.0

2.3

29.56

40.67

u/l

2.11

273

1404

Superficial injury of forearm

510

3113

1.72

26.55

2.7

2.4

33.79

52.77

u/l

0.66

438

2675

Fibroblastic disorders

1109

7951

1.44

26.46

2.7

2.4

38.95

39.81

u/l

0.05

938

6791

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

671

4367

1.60

26.44

2.8

2.2

35.54

48.84

u/l

0.63

574

3697

Vitamin B12 deficiency anaemia

526

3238

1.70

26.42

3.7

2.3

36.48

52.67

u/l

0.54

456

2741

Malignant neoplasm, without specification of site, including Hilmo

233

1111

2.24

26.41

3.1

2.2

37.99

82.22

u/l

0.49

200

913

Pyothorax

249

1228

2.21

26.39

3.4

2.4

41.17

38.87

u/l

0.10

220

1059

Manic episode

188

828

2.49

26.37

2.5

2.4

28.60

38.75

u/l

1.14

157

708

Traumatic subarachnoid haemorrhage

213

987

2.34

26.33

2.6

2.3

33.13

37.60

u/l

0.42

181

857

Hypertensive Renal Disease

191

843

2.44

26.33

3.4

2.2

45.93

36.65

u/l

0.53

168

726

Haemorrhoids and perianal venous thrombosis

1386

10267

1.38

26.32

2.7

2.3

33.95

54.63

u/l

1.71

1170

8690

Chronic hepatitis NAS

107

361

3.52

26.32

3.4

2.3

32.77

32.17

u/l

0.07

305

Noninflammatory disorders of female genital tract

2085

8112

1.32

26.22

2.3

33.22

36.68

u/l

1.19

1754

6900

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1415

10565

1.38

26.19

2.5

36.20

43.30

u/l

0.72

1230

9091

Temporomandibular joint disorders, including avohilmo

2181

16999

1.29

26.17

2.5

2.4

35.21

40.31

u/l

0.85

1879

14552

Specific development disorders of scholastic skills

243

1169

2.20

26.11

2.4

30.55

75.13

u/l

0.55

213

987

malignant neoplasm of female genital organs

704

4626

1.58

25.96

2.1

33.42

35.57

u/l

0.49

589

3877

Symptoms and signs involving the nervous and musculoskeletal systems

2910

23776

1.25

25.93

2.8

2.5

46.58

44.35

u/l

0.09

2480

20343

Nephrotic syndrome

196

890

2.44

25.83

4.1

2.5

46.83

93.29

u/l

0.41

174

763

Neuroendocrine tumor and carcinoma of pancreas

157

5.36

25.82

3.7

2.0

122.05

31.19

u/l

0.98

129

Malignant neoplasm of other connective and soft tissue, including Hilmo

221

1049

2.28

25.70

2.6

2.2

47.94

84.67

u/l

0.35

191

873

Dissociative [conversion] disorders

211

982

2.31

25.65

3.4

2.1

36.80

36.82

u/l

0.00

191

813

Fracture of femur

1301

8708

1.39

25.65

2.6

2.4

36.59

42.63

u/l

0.50

1078

7389

Psychotic depression

287

1490

2.03

25.60

2.7

2.3

43.63

36.13

u/l

0.36

246

1312

Non-invasive ventilation

421

6292

0.58

25.55

3.0

2.2

35.28

50.93

u/l

1.57

374

5523

Acute gastritis

386

2209

1.85

25.54

3.4

2.3

32.86

38.93

u/l

1.11

324

1878

Alcoholic gastritis

110

382

3.34

25.48

5.5

2.3

26.17

44.41

u/l

0.97

335

Other salmonella infections

244

1207

2.18

25.44

3.3

2.2

34.88

78.27

u/l

0.57

207

1043

Diagnoses used for exclusion with ILD

1247

9181

1.40

25.43

2.9

2.5

36.21

43.16

u/l

0.65

1059

7845

Other and unspecified tonsillitis

1645

10551

1.34

25.37

2.6

2.5

40.77

40.95

u/l

0.01

1413

9160

Other specified/unspecified hearing loss

460

2774

1.75

25.35

2.5

2.4

34.00

37.87

u/l

0.80

387

2371

Squamous cell neoplasms and carcinomas of the skin

351

1951

1.89

25.26

2.4

2.1

34.94

36.76

u/l

0.17

299

1607

Charcot foot

126

473

3.05

25.21

8.9

2.5

46.80

132.87

u/l

0.41

103

410

Late syphilis

105

359

3.45

25.20

4.4

2.5

35.89

170.98

u/l

0.51

306

Colonic or urogenital fistula

1339

9986

1.38

25.18

2.5

40.19

44.71

u/l

0.23

1167

8574

Hypothyreosis and Thyroxine purchase for inclusion criteria

4832

27063

1.19

25.08

2.5

35.65

44.60

u/l

1.85

4062

23221

Other/unspecified enthesopathies of lower limb, excluding foot

378

2163

1.85

25.06

2.7

2.3

29.50

62.41

u/l

0.89

323

1893

Weight loss

516

3212

1.69

25.05

2.9

2.4

33.88

52.42

u/l

0.67

432

2745

COPD-related respiratory insufficiency

567

3604

1.65

25.04

3.0

2.4

28.39

38.34

u/l

4.72

480

3071

Sacrococcygeal disorders, not elsewhere classified

185

828

2.44

25.01

2.6

2.1

146.45

42.39

u/l

0.43

156

719

Crushed, pushed or stepped on by crowd or human stampede

392

2270

1.82

24.91

2.5

2.7

29.52

59.82

u/l

0.83

343

1962

Pacemaker

1532

11169

1.35

24.86

2.5

2.4

36.04

49.86

u/l

1.05

1314

9514

Malignant neoplasm of oesophagus

146

589

2.74

24.86

2.4

2.3

32.55

40.83

u/l

0.51

129

487

Benign neoplasm of mouth and pharynx

564

3599

1.65

24.67

2.7

2.5

36.00

51.13

u/l

0.59

471

3098

Other and/or unspecified nontoxic goitre

445

2684

1.76

24.60

2.6

2.3

42.55

38.94

u/l

0.17

365

2271

Salpingitis and oophoritis

877

6128

1.49

24.57

2.6

2.3

33.35

36.89

u/l

1.11

735

5204

Disorders of synovium and tendon

2608

18531

1.25

24.45

2.6

2.4

36.00

41.56

u/l

1.48

2191

15926

Necrosis of pulp, including avohilmo

2900

23774

1.24

24.43

2.8

2.5

50.03

43.55

u/l

0.16

2506

20473

Amenorrhoea

336

1865

1.89

24.42

2.8

2.1

29.70

35.33

u/l

2.02

278

1603

Poisoning by medicine, drug-induced

106

371

3.36

24.40

2.8

2.6

30.09

33.94

u/l

0.25

314

Infection of intervertebral disc (pyogenic)

101

344

3.45

24.36

2.8

2.2

28.27

167.55

u/l

0.51

296

Maternal care for known or suspected fetal abnormality and damage

781

4580

1.52

24.15

2.5

2.4

35.41

38.39

u/l

0.37

649

3943

Diseases of the myoneural junction and muscle

611

3988

1.60

24.10

3.1

2.4

74.93

49.49

u/l

0.30

504

3414

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

109

387

3.19

24.03

3.0

2.0

43.48

31.27

u/l

0.71

310

Arterial embolism and thrombosis

297

1601

1.97

23.92

2.7

2.4

49.18

39.63

u/l

0.23

262

1358

Otalgia

434

2620

1.75

23.90

2.7

2.4

29.91

56.76

u/l

0.84

370

2231

Algoneurodystrophy

198

930

2.33

23.89

2.6

2.3

34.60

40.47

u/l

0.41

168

795

D07AA Corticosteroids, weak (group I)

762

5196

1.52

23.89

2.9

2.4

34.93

46.25

u/l

0.61

650

4451

Hepatomegaly and splenomegaly, not elsewhere classified

185

4.35

23.86

4.7

1.9

30.15

59.40

u/l

0.66

157

Left hemicolectomy

152

644

2.66

23.71

3.8

2.5

42.33

33.42

u/l

0.40

135

538

Other congenital malformations of the digestive system

278

1467

2.01

23.57

4.1

2.4

41.56

67.55

u/l

0.36

249

1230

Other protozoal intestinal diseases

108

388

3.21

23.55

1.9

2.4

29.66

35.32

u/l

0.84

336

Fitting and adjustment of other devices

889

11285

0.70

23.53

2.6

2.2

51.19

45.15

u/l

0.15

726

9540

Arthrosis

3717

17084

1.21

23.47

2.6

2.5

37.01

44.74

u/l

1.16

3174

14686

Postmenopausal bleeding

1362

5413

1.38

23.45

2.3

2.4

55.54

38.80

u/l

0.51

1132

4607

Meniscus derangement

2856

15775

1.24

23.42

2.5

42.74

45.54

u/l

0.17

2405

13550

Disorders of parathyroid gland

1020

7287

1.43

23.37

3.2

2.4

46.41

43.84

u/l

0.09

890

6162

Biological medication for rheuma

857

6015

1.48

23.36

3.0

2.5

39.95

45.44

u/l

0.30

756

5198

Glomerulonephritis

504

3173

1.67

23.35

3.7

2.5

81.68

52.54

u/l

0.40

450

2728

Other symptoms and signs involving the urinary system

509

3208

1.66

23.35

2.8

2.5

34.58

55.44

u/l

0.76

444

2761

Immunodeficiencies

268

1418

2.04

23.24

2.9

2.5

33.68

72.57

u/l

0.60

237

1207

Psoriasis

1404

10670

1.35

23.22

2.9

2.5

34.77

44.55

u/l

1.18

1220

9172

Other congenital malformations

631

4174

1.57

23.22

2.6

2.4

30.13

49.15

u/l

1.01

542

3587

Deforming dorsopathies

1330

10019

1.36

23.20

2.5

2.4

35.53

47.50

u/l

1.45

1127

8605

Other congenital malformations of the digestive system

241

1219

2.11

23.20

4.3

2.4

41.57

73.82

u/l

0.38

214

1018

Other superficial mycoses

521

3310

1.65

23.08

2.6

2.4

32.76

52.57

u/l

0.77

446

2856

Benign neoplasm: Liver/bile ducts

164

726

2.51

23.01

3.4

2.4

31.04

37.64

u/l

1.03

137

608

ILD, hospital admissions

727

4967

1.52

23.01

2.8

2.4

35.81

47.19

u/l

0.61

656

4231

Degeneration of macula and posterior pole

2282

14623

1.27

22.91

2.4

44.73

47.50

u/l

0.09

1929

12413

Haemolytic anaemias

204

987

2.26

22.85

3.7

2.4

41.22

87.29

u/l

0.46

184

836

Benign paroxysmal vertigo

1431

10934

1.34

22.85

2.7

2.4

43.77

44.30

u/l

0.02

1215

9329

Non-follicular lymphoma

476

2977

1.68

22.74

2.4

37.90

54.18

u/l

0.50

406

2534

Pneumothorax

359

2085

1.82

22.71

3.1

2.5

43.64

63.21

u/l

0.35

318

1784

Other necrotizing vasculopathies (FG)

322

1816

1.89

22.68

2.4

2.3

33.04

67.98

u/l

0.74

278

1556

Other interstitial pulmonary diseases

733

5030

1.52

22.67

2.8

2.4

35.74

47.11

u/l

0.62

660

4284

Ulcerative rectosigmoiditis

423

2569

1.73

22.61

3.1

2.4

37.06

56.24

u/l

0.52

364

2216

Other necrotizing vasculopathies

378

2235

1.80

22.59

2.5

2.4

34.61

60.05

u/l

0.62

323

1904

Disorders of mineral metabolism

411

2478

1.74

22.56

4.1

2.4

41.73

58.10

u/l

0.39

350

2122

Osteomyelitis

336

1921

1.86

22.55

4.8

2.5

34.24

63.49

u/l

0.62

282

1663

Interstitial lung disease endpoints

733

5036

1.51

22.53

2.8

2.4

35.74

47.05

u/l

0.61

660

4285

Interstitial lung disease

733

5036

1.51

22.53

2.8

2.4

35.74

47.05

u/l

0.61

660

4285

Somnolence, stupor and coma

232

1179

2.11

22.44

4.2

2.4

30.74

81.30

u/l

0.67

196

1005

Schizophrenia

794

5537

1.48

22.43

2.4

2.6

27.09

51.06

u/l

2.03

661

4809

Other diseases of blood and blood-forming organs

366

2149

1.81

22.43

2.5

2.4

33.61

60.90

u/l

0.67

323

1860

Malignant neoplasm of anus and anal canal, including Hilmo

295

3.51

22.38

2.4

2.0

31.01

35.32

u/l

0.51

248

severe traumatic brain injury, does not include concussion

1047

7658

1.41

22.32

2.7

2.5

86.15

37.54

u/l

0.53

875

6556

Open wound of forearm

486

3064

1.66

22.31

2.8

2.5

33.73

52.95

u/l

0.64

419

2636

Dementia in Alzheimer disease

332

4799

0.57

22.31

2.2

2.4

45.70

36.62

u/l

0.23

259

4042

Magnesium deficiency

7.24

22.27

5.4

2.0

29.91

29.04

u/l

0.09

ILD, hospital admissions 1, main diag only

653

4398

1.55

22.26

2.8

2.4

35.47

48.86

u/l

0.65

588

3746

Localized swelling, mass and lump of skin and subcutaneous tissue

1533

11857

1.32

22.23

2.8

2.5

62.04

50.25

u/l

0.20

1312

10124

Abnormal findings in nipple discharge synovial fluid wound secretions

113

430

3.03

22.22

4.5

2.3

35.26

33.51

u/l

0.17

359

Diseases of inner ear

2679

21341

1.24

22.19

2.6

2.5

40.66

45.97

u/l

0.36

2289

18204

Benign neoplasm: Descending colon

370

2188

1.80

22.19

2.7

2.4

34.36

38.99

u/l

0.72

316

1884

Alzheimer’s disease (Late onset), excluding more controls

693

3048

1.54

22.12

2.1

2.3

33.03

61.48

u/l

0.67

556

2630

Toxic effect of ethanol

229

1167

2.11

22.11

4.0

2.6

29.64

80.46

u/l

0.68

188

1008

Premature rupture of membranes

498

5542

0.63

22.11

2.2

2.4

48.73

38.01

u/l

0.39

423

4773

Protozoal diseases

184

871

2.34

22.05

3.4

2.4

36.81

33.92

u/l

0.37

161

754

Pneumocystosis

129

527

2.80

21.98

3.8

2.4

38.31

33.29

u/l

0.57

116

444

Hordeolum and other deep inflammation of eyelid

320

1820

1.87

21.92

2.6

2.4

32.78

65.32

u/l

0.67

276

1569

Other noninflammatory disorders of vulva and perineum

461

2881

1.67

21.85

2.5

2.3

38.74

36.78

u/l

0.15

399

2437

Melanocytic naevi

1434

11021

1.33

21.84

2.8

2.5

34.01

41.93

u/l

1.05

1244

9448

Other symptoms and signs involving the digestive system and abdomen

619

4115

1.55

21.82

2.8

1.8

32.83

39.78

u/l

2.36

526

3417

Oxicams

1063

4369

1.41

21.77

2.4

2.7

80.49

38.42

u/l

0.44

882

3778

Viral pneumonia (known virus, not influenza)

165

751

2.44

21.75

2.6

2.4

27.56

40.50

u/l

1.36

147

630

Intestinal helminthiases, other/unspecified

8.06

21.72

3.4

2.8

28.12

27.10

u/l

0.11

Immunodeficiency with predominantly antibody defects

162

732

2.45

21.68

2.8

2.6

34.38

106.44

u/l

0.55

138

611

Hyperparathyroidism

901

6395

1.44

21.64

3.3

2.4

48.12

45.07

u/l

0.09

782

5420

Vitreous haemorrhage

507

3256

1.63

21.62

6.0

2.4

42.35

53.77

u/l

0.33

424

2803

Abnormal weight loss

464

2921

1.67

21.61

2.9

2.4

33.21

54.43

u/l

0.71

389

2494

Tubulo-interstitial nephritis, not specified as acute or chronic

341

1979

1.81

21.51

3.5

2.2

36.92

39.09

u/l

0.20

281

1655

Lung diseases due to external agents

646

4366

1.53

21.43

3.1

2.4

33.61

49.09

u/l

0.78

553

3721

Diabetic neuropathy

555

3631

1.60

21.41

4.9

3.0

32.82

70.55

u/l

0.92

439

3020

Anosmia

106

377

2.93

21.38

3.6

1.6

31.29

38.10

u/l

0.85

319

Malignant neoplasm of ovary, including Hilmo

316

1803

1.86

21.35

2.1

31.42

37.27

u/l

1.24

272

1528

Other predominantly sexually transmitted diseases, not elsewhere classified

810

5716

1.46

21.35

2.6

2.5

41.54

45.38

u/l

0.15

705

4941

Chondropathies

761

5321

1.48

21.29

3.1

2.5

33.84

46.07

u/l

0.73

653

4595

Other and unspecified iridocyclitis

256

1378

2.00

21.12

2.4

36.40

76.29

u/l

0.59

221

1179

Other specified/unspecified dorsopathies

197

967

2.20

21.12

2.4

2.1

29.74

41.82

u/l

1.51

162

841

Other disorders of the musculoskeletal system and connective tissue

725

5039

1.50

21.05

2.7

2.4

36.68

47.56

u/l

0.55

621

4296

Malignant neoplasm of oral cavity, including Hilmo

223

1144

2.09

21.01

2.8

2.2

36.21

38.25

u/l

0.13

188

961

Sequelae of cerebrovascular disease

1656

11209

1.30

20.98

2.7

2.4

38.78

50.20

u/l

0.75

1368

9582

Diseases of male genital organs

2512

10321

1.25

20.95

2.9

2.8

35.26

60.81

u/l

2.10

2190

8996

Ulcerative proctitis

322

1857

1.84

20.94

3.0

2.3

38.50

64.79

u/l

0.51

280

1586

Crohn disease (strict definition, all UC cases excluded)

277

1531

1.93

20.89

3.1

2.4

33.15

68.66

u/l

0.59

253

1305

Malignant neoplasm of bladder

278

1527

1.90

20.82

2.5

2.2

39.00

37.11

u/l

0.18

233

1242

Anorexia (incl.atypical)

296

1665

1.87

20.72

2.4

2.3

31.85

63.24

u/l

0.55

262

1404

Dissocial personality disorder

112

439

2.89

20.64

3.0

2.8

27.66

150.60

u/l

0.62

391

Non-Hodgkin lymphoma, all

198

979

2.16

20.58

2.4

2.1

35.48

32.41

u/l

0.61

168

807

Cluster headache, strict, including avohilmo

270

1488

1.94

20.57

2.9

2.5

33.09

40.62

u/l

0.99

236

1282

Hypertension, portal

7.01

20.56

4.7

2.4

34.82

31.94

u/l

0.14

Papulosquamous disorders

1903

15259

1.27

20.56

2.8

2.5

37.38

48.70

u/l

1.04

1635

13073

Disorders of sclera, cornea, iris and ciliary body

2699

22422

1.22

20.56

3.0

2.5

54.13

45.05

u/l

0.28

2304

19238

Injury of intra-abdominal organs

154

696

2.43

20.54

3.2

2.5

484.12

110.38

u/l

0.38

133

597

Personal history of risk-factors, not elsewhere classified

102

383

3.05

20.51

3.5

2.0

30.62

160.77

u/l

0.51

318

Discitis, unspecified

110

429

2.90

20.46

2.4

2.2

28.24

138.97

u/l

0.52

379

Abnormal blood-pressure reading, without diagnosis

234

1231

2.02

20.45

3.0

2.1

35.50

79.86

u/l

0.60

189

1065

Other disorders of bladder

541

3564

1.58

20.39

2.5

2.4

31.34

52.77

u/l

0.95

454

3076

Restless leg syndrome

666

4590

1.51

20.29

2.4

31.73

48.34

u/l

0.94

551

3931

Acute posthaemorrhagic anaemia

189

927

2.20

20.29

5.1

2.3

29.69

34.45

u/l

1.38

158

780

Allergic urticaria

420

2619

1.68

20.28

3.0

2.4

33.20

56.65

u/l

0.70

357

2253

Benign neoplasm: Endocrine pancreas

183

4.42

20.23

2.8

2.5

260.02

32.49

u/l

0.55

153

Follicular cysts of skin and subcutaneous tissue

890

6455

1.42

20.18

2.8

2.5

40.64

47.24

u/l

0.34

758

5545

Abnormal results of function studies

448

2844

1.65

20.13

3.6

2.4

35.63

54.90

u/l

0.59

388

2451

Shigellosis

176

4.24

20.09

2.4

2.0

26.72

30.24

u/l

0.89

147

Sleep apnoea

4855

27315

1.16

20.08

2.4

2.6

43.04

44.26

u/l

0.07

4090

23506

Scar conditions and fibrosis of skin

227

1194

2.05

20.07

2.4

2.1

32.09

38.56

u/l

1.13

203

1006

Other bursitis of hip

133

572

2.59

20.02

2.7

2.0

38.24

41.79

u/l

0.26

112

498

Open wound of wrist and hand

2164

17229

1.25

19.98

2.8

2.6

42.25

46.55

u/l

0.24

1864

14872

Unspecified lump in breast

768

5449

1.46

19.94

2.4

2.3

33.28

37.19

u/l

1.11

647

4595

Alcohol induced polyneuropathy

269

3.53

19.90

4.8

2.7

27.61

35.79

u/l

1.22

235

Other diseases of pericardium

233

1238

2.01

19.89

3.0

2.5

28.10

78.96

u/l

0.75

190

1081

Intentional self-harm by sharp object

155

712

2.38

19.81

3.6

2.3

25.47

100.93

u/l

0.58

131

602

Periapical abscess

2204

18025

1.25

19.79

2.8

2.6

36.79

46.81

u/l

1.15

1873

15481

Complications of internal orthopaedic prosthetic devices, implants and grafts

1036

7716

1.38

19.78

2.7

2.3

50.19

43.74

u/l

0.17

836

6539

Artrosis, including avohilmo

4397

20745

1.17

19.73

2.5

2.6

40.22

44.22

u/l

0.33

3751

17889

Other arterial embolism and thrombosis

157

726

2.35

19.68

2.7

2.3

66.60

34.52

u/l

0.48

135

611

Suggestive for eosinophilic asthma

452

2892

1.64

19.62

2.4

32.08

55.68

u/l

0.81

382

2489

Pneumonia due to other infectious organisms, not elsewhere classified

179

873

2.22

19.56

3.8

2.1

36.36

96.90

u/l

0.58

160

758

Persons encountering health services in other circumstances

1783

14176

1.27

19.55

3.2

2.3

41.31

52.14

u/l

0.54

1527

12112

Special screening examination for neoplasms

285

1616

1.86

19.54

3.1

2.3

36.66

44.84

u/l

0.64

244

1386

Excessive attrition of teeth

2744

22941

1.22

19.54

2.6

2.5

37.20

44.79

u/l

1.04

2325

19719

Unspecified event, undetermined intent

158

738

2.35

19.53

3.4

2.5

30.85

106.75

u/l

0.61

138

625

Oesophageal obstruction

190

949

2.16

19.49

3.2

2.3

41.75

42.76

u/l

0.04

161

801

Congenital malformation of biliary tract

7.73

19.49

6.5

3.4

59.14

29.46

u/l

1.10

Valvular operations

630

4317

1.51

19.48

2.5

42.63

67.37

u/l

0.66

547

3758

Viral warts

1016

7567

1.38

19.38

2.8

2.5

36.96

43.90

u/l

0.50

872

6504

Fracture of forearm

2761

21155

1.21

19.32

2.7

2.4

35.95

43.83

u/l

1.62

2339

18082

Neuroendocrine tumor and carcinoma of small intestine

321

3.18

19.31

2.9

2.1

33.44

32.08

u/l

0.13

264

Maltreatment syndromes

270

1515

1.89

19.27

2.7

2.5

31.24

69.49

u/l

0.65

225

1308

Gangrene, not elsewhere classified

171

4.17

19.26

2.2

2.1

36.50

36.86

u/l

0.01

141

Cardiac arrest

292

1419

1.84

19.14

3.2

2.2

67.26

40.62

u/l

0.41

250

1239

Disorders of muscles

491

3215

1.59

19.08

2.7

2.4

84.10

40.18

u/l

0.50

416

2760

Benign neoplasm: Liver

142

641

2.44

19.08

3.1

2.4

31.33

37.99

u/l

0.88

117

539

Deviated nasal septum

1568

12387

1.29

19.08

2.6

37.32

50.76

u/l

1.22

1352

10703

Inguinal or femoral hernia, bilateral

484

3161

1.59

19.05

2.5

41.00

54.94

u/l

0.40

429

2721

Herpesviral [herpes simplex] infections

576

3907

1.53

19.01

3.0

2.4

34.75

50.60

u/l

0.70

501

3346

Tinnitus

1171

8939

1.35

19.00

2.5

35.09

44.57

u/l

1.01

989

7656

Reactive arthropathies

436

2787

1.63

18.94

2.7

2.4

36.22

55.38

u/l

0.57

375

2387

Presence of other devices

602

8652

0.68

18.88

2.5

2.3

59.04

43.78

u/l

0.28

490

7312

Other predominantly sexually transmitted diseases, not elsewhere classified

941

6953

1.39

18.80

2.6

2.4

43.70

43.52

u/l

0.01

814

6028

Cluster headache, wide,, including avohilmo

278

1591

1.86

18.71

2.9

2.5

32.85

40.02

u/l

0.99

242

1372

Chronic nephritic syndrome

212

1118

2.04

18.67

3.4

2.5

99.07

39.86

u/l

0.47

187

968

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

767

5494

1.44

18.65

2.7

2.2

34.48

35.70

u/l

0.19

656

4647

Other salmonella infections

194

991

2.10

18.64

3.6

2.2

36.49

84.65

u/l

0.51

168

854

Unspecified misadventure during surgical and medical care

291

1693

1.83

18.59

3.5

2.4

180.08

67.58

u/l

0.50

261

1443

Carcinoma in situ of skin of scalp and neck

147

683

2.38

18.52

2.6

2.4

31.26

34.66

u/l

0.51

130

573

Inflammatory diseases of the central nervous system

414

2632

1.65

18.51

2.6

2.5

65.85

56.68

u/l

0.10

364

2267

Lactose intolerance

172

844

2.20

18.51

2.5

2.3

37.82

94.98

u/l

0.49

142

708

UC patients in KELA-register (code 208), prior to 1994

237

1301

1.96

18.48

3.5

2.5

36.01

42.31

u/l

0.68

215

1123

Small fibre neuropathy

170

837

2.23

18.41

3.5

2.4

36.68

40.18

u/l

0.23

148

719

Viral agents as the cause of diseases classified to other chapters

135

610

2.45

18.16

3.3

2.3

32.82

34.73

u/l

0.21

115

522

Hypermobility syndrome

274

1574

1.84

18.14

2.4

2.2

30.02

36.73

u/l

1.91

215

1316

Dislocation, sprain and strain of joints and ligaments of knee

2946

22965

1.20

18.10

2.6

2.5

37.00

47.42

u/l

1.52

2542

19782

Dislocation, sprain and strain of joints and ligaments at neck level

719

5124

1.45

18.10

3.0

2.4

36.54

45.74

u/l

0.42

615

4423

Type 1 diabetes, wide definition, subgroup 1

960

7156

1.37

18.01

5.7

2.1

26.09

32.32

u/l

6.46

721

6231

Helminthiases

213

1138

2.01

18.00

2.5

2.2

31.17

78.06

u/l

0.56

178

952

Personal history of allergy to drugs, medicaments and biological substances

306

3.15

17.94

2.9

1.9

32.83

32.36

u/l

0.02

258

Viral agents as the cause of diseases classified to other chapters

148

697

2.32

17.91

3.2

2.3

32.48

34.83

u/l

0.30

127

597

Plantar fascial fibromatosis

469

3087

1.58

17.87

2.6

2.2

50.41

41.09

u/l

0.31

394

2636

Exposure to other and unspecified animate mechanical forces

177

892

2.15

17.83

2.5

2.4

30.11

95.81

u/l

0.64

152

751

Melanocytic naevi of trunk

577

3967

1.51

17.81

2.8

2.4

35.39

50.01

u/l

0.62

507

3398

Enteropathic arthropathies

139

640

2.38

17.77

2.7

2.3

47.33

114.90

u/l

0.44

123

545

Polycystic ovarian syndrome, consortium definition

3570

18125

1.18

17.67

2.5

2.3

36.09

38.87

u/l

0.59

2966

15449

Behavioural disorders, excluding more controls

105

424

2.66

17.62

3.1

2.2

25.13

37.44

u/l

3.33

373

Inguinal hernia, bilateral

469

3096

1.58

17.61

2.6

2.5

41.25

54.92

u/l

0.38

416

2669

Macular pucker

726

5223

1.44

17.54

2.5

2.4

35.25

40.36

u/l

0.88

620

4467

Other and unspecified glaucoma

354

2200

1.70

17.52

3.1

2.3

43.33

58.01

u/l

0.27

288

1867

Alzheimer disease, excluding more controls

787

3730

1.43

17.50

2.2

2.4

39.27

57.91

u/l

0.46

631

3229

Metatarsalgia

457

3006

1.58

17.48

2.9

2.2

32.17

38.97

u/l

1.59

372

2562

Neuralgia and neuritis, unspecified

265

1526

1.84

17.45

2.7

2.2

51.47

42.45

u/l

0.18

218

1320

Other and unspecified immunodeficiencies with predominantly antibody defects

340

3.01

17.45

2.7

2.5

30.18

33.54

u/l

0.29

287

Previous suicide attempt

283

3.22

17.45

3.7

2.2

33.30

30.04

u/l

0.16

229

Sleep apnoea, including avohilmo

5141

28039

1.15

17.45

2.4

2.6

45.97

44.57

u/l

0.07

4334

24111

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

256

1426

1.85

17.44

2.5

2.4

26.04

67.41

u/l

0.66

223

1206

Disorders of calcium metabolism

303

1809

1.76

17.43

3.8

2.4

45.62

66.29

u/l

0.36

263

1546

Thyrotoxicosis

1205

9338

1.32

17.43

2.5

2.4

39.43

41.84

u/l

0.16

1039

7940

Other problems related to primary support group, including family circumstances

523

3438

1.53

17.40

3.1

2.4

34.68

50.48

u/l

0.56

425

2962

Other and unspecified myopathies

419

2711

1.62

17.40

3.1

2.5

89.24

55.82

u/l

0.26

339

2317

Maternal care for (suspected) damage to fetus from alcohol

5.93

17.39

3.1

2.4

37.23

28.74

u/l

0.45

Mixed disorders of conduct and emotions

136

624

2.36

17.37

2.3

2.2

23.00

35.47

u/l

3.67

109

521

Prurigo nodularis

144

680

2.33

17.37

3.3

2.1

30.02

38.19

u/l

1.33

123

571

Contusion of other and unspecified parts of foot

262

1507

1.84

17.28

3.0

2.3

28.64

40.48

u/l

2.72

220

1285

401

2572

1.63

17.25

4.4

2.5

47.03

56.73

u/l

0.21

369

2205

Cervical disc disorders

1677

13522

1.26

17.24

2.8

2.4

43.61

50.25

u/l

0.28

1427

11639

Use of pramipexole

1042

7936

1.35

17.23

2.9

2.4

34.12

43.50

u/l

0.85

888

6780

Sensorineural hearing loss

2866

22919

0.84

17.18

2.6

2.5

40.49

47.51

u/l

0.39

2435

19554

Malignant neoplasm of breast, HER2-negative, including Hilmo

1917

10095

1.25

17.10

2.2

41.14

36.81

u/l

0.83

1640

8511

Female infertility, cervical, vaginal, other or unspecified origin

1233

6188

1.32

17.09

2.2

2.3

33.73

36.02

u/l

0.47

1055

5270

Malignant neoplasm of breast, including Hilmo

1917

10095

1.25

17.08

2.2

41.14

36.81

u/l

0.83

1640

8511

Tumor necrosis factor alpha inhibitors

741

5364

1.42

17.07

3.0

2.5

40.39

45.79

u/l

0.25

656

4621

Other spirochaetal diseases

1456

11582

1.29

17.06

2.3

2.5

35.59

50.28

u/l

1.24

1239

9911

Adalimumab

475

3170

1.56

17.06

3.3

2.5

38.98

54.12

u/l

0.50

417

2736

Diseases of the ear and mastoid process

6265

28013

1.13

17.03

2.6

2.5

42.36

45.09

u/l

0.13

5337

24051

Carcinoma in situ of skin of trunk

173

882

2.13

16.97

2.9

2.3

33.36

35.80

u/l

0.31

144

728

Ehlers-Danlos syndrome

328

2.98

16.82

3.0

2.3

30.50

32.29

u/l

0.16

272

Malignant neoplasm of oral cavity

167

840

2.14

16.80

2.9

2.2

38.89

40.94

u/l

0.09

140

707

Later onset COPD

1239

7681

1.31

16.79

2.6

2.3

33.63

49.33

u/l

0.98

1034

6523

Other and unspecified psoriasis

334

2070

1.70

16.74

3.2

2.4

33.33

62.82

u/l

0.70

287

1787

Internal derangement of knee

1803

14624

1.25

16.72

2.5

83.84

45.75

u/l

0.46

1530

12552

Atopic dermatitis, strict definition with reimbursement

1398

10689

1.29

16.70

2.7

2.4

33.50

44.10

u/l

1.43

1204

9193

Malignant neoplasm of breast

1878

9969

1.25

16.70

2.1

2.2

41.49

36.83

u/l

0.90

1608

8397

Other enthesopathy of foot (+metatarsalgia)

484

3255

1.54

16.66

2.8

2.2

32.08

38.49

u/l

1.60

397

2769

malignant neoplasm of male genital organs

1140

5318

1.33

16.52

2.4

35.63

52.23

u/l

1.01

949

4532

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

442

2931

1.58

16.50

2.8

2.4

38.62

55.74

u/l

0.48

364

2527

Childhood asthma (age<16), excluding more controls

556

3000

1.49

16.45

2.5

2.3

29.88

63.68

u/l

1.16

468

2611

Malignant neoplasm of breast, HER2-negative

1853

9870

1.25

16.44

2.1

2.2

41.55

36.91

u/l

0.88

1588

8310

Assault by other specified means

260

3.23

16.31

3.0

2.4

32.38

28.47

u/l

0.80

221

Other spirochaetal diseases

1433

11442

1.28

16.29

2.3

2.5

35.57

44.16

u/l

1.09

1221

9795

Pedestrian injured in transport accident

342

2147

1.67

16.23

3.3

2.4

45.01

61.56

u/l

0.30

301

1844

Spondyloarthritis

827

6137

1.38

16.19

2.7

2.4

77.13

45.39

u/l

0.34

696

5245

Reactive arthropathies, FINNGEN

353

2235

1.65

16.12

2.7

2.5

36.52

63.00

u/l

0.66

305

1935

Other and unspecified urticaria

919

6941

1.36

16.07

2.7

2.4

33.93

44.39

u/l

0.82

788

5930

Respiratory insufficiency

333

2066

1.67

16.06

2.6

2.3

30.94

64.62

u/l

0.83

281

1754

Childhood asthma (age<16)

556

3017

1.49

16.04

2.5

2.3

29.88

63.42

u/l

1.16

468

2627

Retinal detachments and breaks

1653

13437

1.25

15.93

2.8

2.5

37.39

49.75

u/l

1.13

1407

11519

Gonarthrosis

3214

15685

1.18

15.88

2.5

59.23

45.70

u/l

0.26

2698

13455

Lactose intolerance, other/unspecified

151

749

2.17

15.87

2.6

2.3

39.04

100.65

u/l

0.46

125

628

Other congenital malformations

407

2667

1.59

15.87

2.8

2.4

28.99

56.43

u/l

0.90

362

2279

Assault by unspecified means

126

585

2.36

15.85

3.2

2.6

35.87

122.00

u/l

0.55

110

511

Malignant neoplasm, without specification of site

144

699

2.19

15.82

3.4

2.2

34.59

37.13

u/l

0.14

125

561

Spirochaetal infections, other/unspecified

1425

11412

1.28

15.80

2.3

2.5

35.65

44.30

u/l

1.10

1210

9771

Entropion and trichiasis of eyelid

385

2501

1.60

15.68

2.5

2.3

33.65

38.50

u/l

1.04

325

2108

Open wound of abdomen, lower back and pelvis

171

891

2.06

15.67

3.8

2.5

29.47

92.99

u/l

0.64

144

773

Senility

181

3.49

15.66

2.6

1.9

33.88

30.95

u/l

0.44

147

Other disorders of white blood cells

274

1645

1.76

15.63

2.8

2.4

32.40

70.04

u/l

0.70

242

1396

Abnormal findings on antenatal screening of mother

114

2410

0.46

15.62

2.1

2.2

36.28

35.27

u/l

0.09

2051

Gestational diabetes (for exclusion)

1616

9078

1.26

15.60

2.3

35.48

37.62

u/l

0.24

1373

7777

Benign neoplasm: Other and unspecified parts of small intestine

105

459

2.58

15.51

3.5

2.3

40.43

32.39

u/l

0.62

380

1858

14041

1.24

15.44

2.5

2.4

33.45

45.40

u/l

1.52

1589

11871

Contact with sharp object, undetermined intent

138

671

2.24

15.43

2.4

2.7

37.34

109.76

u/l

0.52

112

588

Other menopausal disorders

1292

5719

1.30

15.42

2.2

2.4

38.24

38.80

u/l

0.07

1094

4875

Arthropathies in other diseases classified elsewhere

195

1067

1.96

15.40

6.7

2.4

39.46

84.79

u/l

0.51

157

916

Bacterial, viral and other infectious agents

443

2979

1.55

15.39

3.3

2.7

44.32

54.71

u/l

0.25

384

2605

Lyme disease

1412

11337

1.27

15.33

2.3

2.5

35.72

44.27

u/l

1.07

1200

9712

Malignant neoplasm of rectosigmoid junction

360

2.73

15.31

2.1

30.79

32.12

u/l

0.24

286

Idiopathic urticaria

125

587

2.33

15.29

2.3

2.1

31.63

33.15

u/l

0.20

105

493

Inguinal hernia

2767

15738

1.19

15.28

2.6

61.68

47.46

u/l

0.24

2398

13524

Acquired haemolytic anaemia

136

663

2.24

15.14

3.9

2.3

43.14

108.36

u/l

0.43

125

561

Other disorders of breast

610

4373

1.44

15.06

2.2

2.3

31.73

37.24

u/l

1.83

536

3673

Thyrotoxicosis, other and/or unspecified

944

7226

1.34

15.06

2.6

2.4

41.16

44.34

u/l

0.17

820

6172

Malignant neoplasm of ovary

225

1293

1.84

15.02

2.1

30.67

34.45

u/l

0.79

192

1087

Female infertility

1323

6354

1.29

14.97

2.2

2.3

33.32

35.83

u/l

0.58

1131

5408

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

102

445

2.54

14.97

4.8

2.2

44.48

30.67

u/l

0.87

371

Malignant neoplasm of prostate, including Hilmo

1124

5175

1.31

14.93

2.3

2.4

35.82

43.20

u/l

0.99

942

4398

Adhesive capsulitis of shoulder

760

5646

1.38

14.91

2.8

2.4

33.53

40.43

u/l

2.43

638

4844

Other diseases of the respiratory system

905

6895

1.35

14.90

2.8

2.4

34.63

44.31

u/l

0.68

773

5851

Other respiratory disorders and diseases

905

6895

1.35

14.90

2.8

2.4

34.63

44.31

u/l

0.68

773

5851

Dissection of aorta

165

864

2.05

14.89

2.6

2.3

56.11

91.92

u/l

0.25

145

720

Excessive vomiting in pregnancy

383

2516

1.58

14.84

2.3

2.2

34.53

35.79

u/l

0.09

328

2135

Vulvovaginal ulceration/inflammation in other diseases

285

1749

1.71

14.80

2.7

2.1

29.99

35.80

u/l

1.68

248

1477

Heart failure and hypertrophic cardiomyopathy

110

500

2.45

14.77

2.5

33.02

33.06

u/l

0.00

422

Polyp of the female genital tract

1443

6637

1.27

14.72

2.3

34.73

37.83

u/l

0.72

1206

5655

Carcinoma in situ of skin of lower limb, including hip

124

594

2.31

14.61

2.4

2.2

29.77

34.80

u/l

0.64

107

495

Other disorders of penis

438

2970

1.53

14.56

3.0

2.8

32.75

57.49

u/l

0.92

373

2611

Psoriasis vulgaris

873

6649

1.35

14.52

3.1

2.5

35.18

47.38

u/l

0.85

774

5709

Other or ill-defined heart diseases

254

1519

1.75

14.51

2.9

2.5

40.56

69.93

u/l

0.45

221

1328

Other mycoses, not elsewhere classified/unspecified

108

491

2.45

14.50

2.4

27.77

33.21

u/l

1.19

416

Other sleep disorders

518

3629

1.48

14.49

2.9

2.5

57.40

49.50

u/l

0.10

439

3136

Malignant neoplasm of other and ill-defined sites, including Hilmo

351

2.69

14.47

3.3

2.0

44.32

29.90

u/l

0.77

284

Burns and corrosions

639

4644

1.42

14.47

2.7

2.6

36.24

47.13

u/l

0.51

540

4024

Dislocation, sprain and strain of joints and ligaments of thorax

177

958

1.97

14.47

3.0

2.4

30.56

89.85

u/l

0.64

160

826

Assault by blunt object

390

2.62

14.42

3.2

2.6

26.37

166.43

u/l

0.62

341

Chronic lymphocytic leukaemia, helper endpoint

131

639

2.20

14.38

2.1

34.52

32.79

u/l

0.30

120

523

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

131

639

2.20

14.38

2.1

34.52

32.79

u/l

0.30

120

523

Chronic lymphocytic leukaemia

131

639

2.20

14.38

2.1

34.52

32.79

u/l

0.30

120

523

Atopic dermatitis, strict definition

1347

10599

1.27

14.35

2.6

2.5

33.56

42.21

u/l

1.05

1159

9127

Disorder of the sleep-wake schedule

109

498

2.40

14.34

2.6

2.4

24.72

32.44

u/l

3.17

424

Abdominal aortic aneurysm (AAA)

409

2713

1.54

14.34

2.4

34.77

35.65

u/l

0.12

357

2273

Pedestrian injured in collision with pedal cycle

166

884

2.01

14.31

3.1

2.3

55.80

93.80

u/l

0.28

147

746

Congenital malformations of the musculoskeletal system, not elsewhere classified

107

486

2.42

14.29

2.7

2.4

31.48

32.16

u/l

0.07

406

Amputation of foot

142

720

2.15

14.26

4.5

2.4

26.37

35.30

u/l

2.06

117

617

Cystic disease of liver

182

3.63

14.24

5.9

2.2

41.02

28.64

u/l

1.67

148

Skin changes due to chronic exposure to nonionizing radiation

1737

13229

1.23

14.23

2.5

2.4

33.02

45.81

u/l

1.55

1492

11194

Multiple myeloma, including Hilmo

193

1076

1.89

14.20

2.8

2.2

55.82

37.66

u/l

0.72

159

888

Other puerperal infections

350

2276

1.60

14.17

2.2

38.57

35.50

u/l

0.17

300

1925

Vitamin deficiency, wide

237

1405

1.78

14.17

3.5

2.4

32.76

38.62

u/l

0.77

208

1213

Vitamin deficiency

237

1405

1.78

14.17

3.5

2.4

32.76

38.62

u/l

0.77

208

1213

Explicit fungal Sepsis

166

3.70

14.15

5.5

2.2

29.13

33.78

u/l

0.42

138

Diseases of tongue

284

1761

1.69

14.15

2.6

2.3

31.38

40.54

u/l

1.96

237

1534

Gingival hyperplasia

184

1017

1.94

14.14

4.1

2.4

41.11

39.15

u/l

0.10

159

867

L04AC Interleukin inhibitors

288

1797

1.68

14.11

3.1

2.5

37.40

65.24

u/l

0.54

248

1569

Chronic conjunctivitis

157

825

2.04

14.08

2.8

2.3

120.73

38.36

u/l

0.47

141

690

Hypothyroidism, strict autoimmune, 3 medication purchases required

4226

25198

1.14

14.08

2.5

2.4

35.69

45.28

u/l

1.85

3522

21618

Abrasion of teeth

1591

13057

1.24

14.07

2.4

2.5

35.01

42.96

u/l

1.25

1366

11199

Otitis externa, unspecified

513

3610

1.47

14.07

2.8

2.4

32.12

50.88

u/l

0.79

434

3111

Procedures for purposes other than remedying health state

135

674

2.17

14.06

2.4

2.1

32.01

36.86

u/l

0.62

119

573

Bacterial, viral and other infectious agents

410

2769

1.54

14.01

3.4

2.7

45.55

56.25

u/l

0.23

354

2425

Contact with heat and hot substances

264

1616

1.72

13.97

2.7

2.5

33.60

69.86

u/l

0.66

224

1387

Olecranon bursitis

290

1816

1.67

13.95

3.1

2.5

65.82

40.72

u/l

0.36

239

1581

Gonarthrosis [arthrosis of knee](FG)

3798

19347

1.15

13.93

2.5

59.55

42.97

u/l

0.40

3187

16611

Hallux valgus (acquired)

1610

9478

1.24

13.89

2.3

2.4

34.84

43.04

u/l

0.90

1373

8076

Adenocarcinoma and Papillary adenocarcinoma of kidney

260

3.01

13.88

2.9

2.0

40.63

49.99

u/l

0.22

213

Other/unspecified disorders of vestibular function

208

1199

1.85

13.88

2.3

29.86

36.51

u/l

1.62

182

1026

Carbimazole or st.post thyroidectomy, condition for graves disease

972

7558

1.32

13.86

2.5

2.4

40.78

42.97

u/l

0.11

841

6445

Blood alcohol or alcohol intoxication level

137

692

2.14

13.83

4.3

2.6

27.05

111.16

u/l

0.65

112

592

Exclusions for E4_PCOS_BROAD

790

5973

1.36

13.76

2.9

2.5

34.26

44.71

u/l

0.66

673

5129

Other noninfective disorders of lymphatic vessels and lymph nodes

189

1064

1.89

13.65

2.7

2.2

33.18

44.15

u/l

0.98

161

905

Pyoderma gangrenosum

214

3.29

13.57

3.5

2.6

44.74

29.10

u/l

0.85

176

Actinic keratosis

1680

12867

1.23

13.56

2.5

2.4

32.97

46.07

u/l

1.55

1443

10880

Other renal tubulo-interstitial diseases

124

607

2.20

13.55

2.7

2.3

31.57

34.58

u/l

0.45

104

505

Malignant neoplasm of breast, ER-positive, including Hilmo

1409

8803

1.26

13.55

2.2

47.90

36.66

u/l

0.91

1200

7398

Intracranial and intraspinal abscess and granuloma

305

2.82

13.54

3.7

2.5

209.65

32.75

u/l

0.49

262

Disorders of oesophagus in diseases classified elsewhere

116

557

2.27

13.48

3.8

2.2

34.14

31.73

u/l

0.30

467

Contact with and exposure to communicable diseases

878

11292

0.76

13.43

2.5

31.35

42.29

u/l

1.71

765

9734

Organic, including symptomatic, mental disorders

2341

14167

1.19

13.39

2.6

2.5

37.27

48.55

u/l

1.01

1932

12098

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

372

2491

1.56

13.35

3.4

2.3

35.54

57.32

u/l

0.58

322

2128

Blepharochalasis

1330

10779

1.26

13.34

2.6

2.4

33.68

51.75

u/l

1.50

1124

9146

Conductive and sensorineural hearing loss

3108

24048

0.86

13.15

2.6

2.5

40.52

47.16

u/l

0.39

2639

20537

Malignant neoplasm of prostate

1065

4987

1.30

13.14

2.3

2.4

35.96

43.57

u/l

0.97

890

4238

Injury of eye and orbit

638

4708

1.39

13.12

3.2

2.5

38.51

48.96

u/l

0.48

555

4081

Malignant neoplasm of breast, HER-positive

1374

8692

1.25

13.06

2.2

48.35

36.75

u/l

0.92

1171

7303

Benign neoplasm: Kidney

179

1007

1.90

13.05

2.5

2.3

53.19

37.02

u/l

0.62

161

862

Keratitis

1665

13825

1.22

13.04

3.0

2.5

42.47

48.02

u/l

0.23

1408

11891

Calcific aortic valvular stenosis, including rheumatic fever

1274

9967

1.26

13.03

2.5

2.4

44.37

51.39

u/l

0.26

1075

8470

Panniculitis affecting regions of neck and back

182

1026

1.88

13.00

3.3

2.2

37.04

86.07

u/l

0.55

161

905

Other and unspecified medical devices associated with adverse incidents

156

3.81

12.99

3.5

2.6

28.24

29.65

u/l

0.10

126

Anaemia in chronic diseases classified elsewhere

131

669

2.12

12.91

5.9

2.5

112.55

105.91

u/l

0.02

113

572

Operations 2 for CAVS

1268

9935

1.26

12.91

2.5

2.4

44.19

51.45

u/l

0.27

1072

8443

Calcific aortic valvular stenosis, diagnosis (helper)

1268

9935

1.26

12.91

2.5

2.4

44.19

51.45

u/l

0.27

1072

8443

Other/unspecified synovitis and tenosynovitis

519

3715

1.44

12.91

2.6

2.3

34.29

40.85

u/l

1.49

431

3172

Dependence on enabling machines and devices, not elsewhere classified

323

2.71

12.89

5.1

2.2

44.20

29.37

u/l

0.96

270

Drug-induced polyneuropathy

261

2.99

12.88

3.9

2.3

27.79

29.00

u/l

0.17

216

Coronary artery bypass grafting

1148

6812

1.28

12.88

2.5

36.87

41.19

u/l

0.75

956

5860

Other zoonotic bacterial diseases, not elsewhere classified

116

4.29

12.85

1.7

2.7

23.88

28.39

u/l

0.92

Cauda equina syndrome

362

2.60

12.83

3.1

2.4

30.68

30.42

u/l

0.03

304

Calcific aortic valvular stenosis

1269

9952

1.26

12.82

2.5

2.4

44.19

51.48

u/l

0.27

1072

8458

Calcific aortic valvular stenosis, operated

1269

9952

1.26

12.82

2.5

2.4

44.19

51.48

u/l

0.27

1072

8458

Other encephalitis

145

767

2.03

12.82

2.2

2.4

38.74

36.13

u/l

0.09

130

646

Acute appendicitis, with complications

899

6992

1.32

12.81

2.6

33.91

47.56

u/l

1.13

782

6006

Carcinoma in situ of skin of ear and external auricular canal

355

2.59

12.80

2.4

2.5

27.52

32.65

u/l

1.26

295

Other and unspecified disorders of white blood cells

201

1175

1.82

12.78

2.9

2.4

33.13

81.48

u/l

0.61

178

987

Benign neoplasm: Rectosigmoid junction

206

1216

1.80

12.71

2.7

2.3

32.70

37.19

u/l

0.85

178

1036

Vasomotor and allergic rhinitis

1747

14323

1.21

12.70

2.3

2.5

36.83

40.35

u/l

0.59

1480

12320

Other disorders starting during childhood or adolescence

227

1353

1.73

12.68

2.4

2.3

26.05

68.32

u/l

0.62

194

1128

Recurrent dislocation and subluxation of joint

328

2158

1.58

12.68

2.5

2.4

31.20

60.26

u/l

0.74

284

1887

Asthma and opportunity respiratory infection

227

1375

1.75

12.67

2.4

2.2

28.30

38.25

u/l

3.92

191

1183

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

110

529

2.25

12.67

2.5

2.2

31.62

41.72

u/l

1.00

435

Malignant neoplasm of tongue, including Hilmo

126

637

2.12

12.64

3.0

2.3

40.79

41.63

u/l

0.03

108

527

Dysplasia of cervi uteri

1053

6015

1.29

12.63

2.4

2.3

36.39

36.53

u/l

0.01

883

5120

Hallux rigidus

643

4787

1.38

12.61

2.2

2.5

38.89

49.34

u/l

0.48

544

4079

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

189

1089

1.84

12.58

9.1

2.1

30.94

32.06

u/l

0.18

146

960

Hypotension due to drugs

371

2.54

12.56

3.0

2.4

25.99

31.93

u/l

1.43

306

Other obstructive and reflux uropathy

201

1178

1.79

12.50

2.9

2.3

34.54

40.72

u/l

0.60

174

988

Urethritis and urethral syndrome

115

565

2.19

12.49

3.6

2.4

30.43

46.53

u/l

1.17

102

476

Molar incisor enamel hypoplasia, with caries

171

3.37

12.48

3.4

2.2

42.11

29.55

u/l

0.46

146

218

3.13

12.48

3.9

2.2

33.00

33.65

u/l

0.05

185

Hypoplasia of dental enamel

199

3.19

12.45

3.6

2.4

41.14

29.34

u/l

0.50

168

Alzheimer’s disease (Late onset)

959

6325

1.30

12.44

2.2

2.3

32.67

37.05

u/l

1.87

785

5326

Other/unspecified enthesopathies, not elsewhere classified

384

2622

1.52

12.41

2.9

2.3

36.36

40.68

u/l

0.40

329

2254

Thyrotoxicosis with toxic multinodular goitre

291

1882

1.62

12.37

2.3

32.15

38.03

u/l

1.35

245

1605

Atrophic disorders of skin

688

5194

1.36

12.32

2.5

2.3

31.05

47.94

u/l

1.14

581

4435

Other and unspecified injuries of lower leg

347

2326

1.55

12.32

2.7

2.3

29.55

57.07

u/l

0.75

296

2004

Arthropathy in ulcerative colitis

350

2.57

12.27

2.4

2.3

56.18

170.79

u/l

0.39

296

Other and unspecified types of non-Hodgkin lymphoma, hilmo

202

1197

1.79

12.24

2.8

2.3

35.62

35.34

u/l

0.03

177

1022

Trigeminal neuralgia

289

1869

1.62

12.24

2.9

2.3

36.87

37.61

u/l

0.04

242

1594

Hyperaldosteronism

151

824

1.97

12.24

2.6

2.5

31.43

41.60

u/l

1.04

129

705

Spirochaetal infections, other/unspecified

400

2768

1.50

12.21

2.0

2.5

32.73

56.46

u/l

0.77

338

2381

Thyroiditis, ILD-related definition

526

3815

1.42

12.18

2.7

2.2

32.31

49.30

u/l

0.73

448

3226

Other follicular disorders

337

2253

1.56

12.16

3.0

2.4

38.20

59.62

u/l

0.50

289

1943

Infarction of spleen

172

3.45

12.14

6.3

2.5

35.60

33.73

u/l

0.10

142

Other/unspecified soft tissue disorders related to use, overuse and pressure

152

831

1.95

12.13

2.4

2.1

34.63

44.46

u/l

0.77

131

719

Burns and corrosions of external body surface, specified by site

491

3523

1.44

12.13

2.5

33.18

51.33

u/l

0.74

415

3043

Malignant neoplasm of other and ill-defined digestive organs

181

3.26

12.09

2.8

2.0

39.15

31.76

u/l

0.75

144

Other and unspecified disorders of adult personality and behaviour

145

3.64

12.07

3.0

2.3

26.26

35.59

u/l

0.72

118

Thiazolidinediones

517

3751

1.42

12.04

3.0

2.4

33.74

40.57

u/l

0.89

419

3252

Rare circulating lymphoid malignancy, including Hilmo

133

698

2.02

11.93

4.3

2.2

31.22

40.32

u/l

0.65

112

563

Unspecified visual impairment (binocular)

418

2.39

11.91

2.8

2.3

29.13

30.15

u/l

0.08

347

Car occupant injured in noncollision transport accident

185

1078

1.82

11.91

3.3

2.4

29.22

80.65

u/l

0.62

162

924

Other/unspecified reactive arthropathies

309

2041

1.58

11.88

2.7

2.4

32.87

62.89

u/l

0.71

264

1764

Superficial injury of shoulder and upper arm

514

3730

1.42

11.87

2.6

2.5

31.89

51.24

u/l

0.88

445

3217

Sequelae of injuries of head

246

1543

1.67

11.86

3.1

2.5

34.77

43.16

u/l

0.96

211

1335

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

370

2531

1.51

11.86

2.4

2.5

31.11

57.50

u/l

0.80

317

2196

Other neurotic disorders

228

1404

1.71

11.86

3.4

2.3

31.90

41.24

u/l

1.36

193

1207

Bicipital tendinitis

226

1389

1.71

11.85

2.5

2.3

32.40

42.91

u/l

1.71

191

1209

Sequelae of intentional self-harm, assault and events of undetermined intent

168

3.37

11.81

5.1

2.5

38.23

32.19

u/l

0.53

139

Postpartum care and examination

298

2855

0.65

11.70

2.7

2.4

34.17

36.68

u/l

0.30

270

2431

Postmenopausal atrophic vaginitis

1229

5478

1.26

11.70

2.2

2.4

39.75

39.14

u/l

0.06

1039

4658

Benign neoplasm of ovary

782

6055

1.33

11.69

2.5

2.3

33.03

36.76

u/l

1.48

671

5115

Caught, crushed, jammed or pinched in or between objects

246

1550

1.66

11.67

2.9

2.6

32.50

71.48

u/l

0.70

219

1347

Chronic diseases of tonsils and adenoids

3904

21934

1.14

11.63

2.6

2.5

50.18

46.23

u/l

0.11

3366

18870

Psoriatic and enteropathic arthropathies

546

4016

1.40

11.62

2.8

2.5

39.42

50.23

u/l

0.42

477

3465

Glaucoma suspect

1143

14054

0.80

11.61

2.7

2.4

73.13

47.28

u/l

0.38

947

11973

Benign neoplasm: Tongue

147

809

1.95

11.61

2.7

2.5

32.85

40.96

u/l

0.73

124

687

Malignant neoplasm of other connective and soft tissue

115

582

2.12

11.54

2.2

2.1

58.40

32.97

u/l

0.58

481

Other and unspecified haemorrhagic conditions

430

2.34

11.54

3.0

2.4

29.81

32.65

u/l

0.64

356

Nasal polyp

846

6626

1.31

11.45

2.4

2.6

36.38

40.05

u/l

0.58

714

5704

Specific development disorders of speech and language

261

1608

1.62

11.42

2.4

27.12

62.96

u/l

0.63

232

1341

Assault by sharp object

478

2.25

11.42

4.4

2.7

32.61

142.83

u/l

0.59

420

Hypocalcemia

122

636

2.08

11.40

4.2

2.4

35.35

41.59

u/l

0.33

108

544

Spondylolisthesis/Spondylolysis

800

6228

1.31

11.36

2.6

2.3

33.35

51.09

u/l

1.45

677

5366

Familial hypercholesterolemia

620

4660

1.36

11.35

3.1

2.4

37.45

64.59

u/l

0.85

515

3990

Disorders of optic nerve and visual pathways

435

3096

1.45

11.35

3.3

2.4

32.80

53.86

u/l

0.77

369

2670

Foreign body entering into or through eye or natural orifice

366

2524

1.50

11.35

2.3

2.6

43.44

56.90

u/l

0.27

311

2187

Benign neoplasm: Ill-defined sites within the digestive system

168

3.39

11.34

3.1

2.5

34.69

28.85

u/l

0.71

140

Somnolence

339

2.51

11.19

3.2

2.5

29.76

32.79

u/l

0.29

282

Benign neoplasm of urinary organs

227

1420

1.68

11.18

2.5

2.3

49.37

36.62

u/l

0.61

203

1207

Injury of other and unspecified intrathoracic organs

295

1955

1.57

11.18

3.4

2.5

57.78

64.30

u/l

0.08

251

1693

Polymyalgia rheumatica

583

4361

1.38

11.17

2.5

2.3

38.01

38.03

u/l

0.00

499

3685

Orchitis and epididymitis

398

2793

1.47

11.15

2.8

2.7

46.83

57.13

u/l

0.24

343

2436

Pain associated with micturition

513

3764

1.40

11.11

2.9

2.3

35.66

51.59

u/l

0.65

447

3192

Ehlers-Danlos syndrome

261

2.75

11.05

3.3

2.4

31.02

32.39

u/l

0.09

218

Endometriosis of pelvic peritoneum

678

4935

1.34

10.99

2.4

2.3

55.26

36.43

u/l

0.65

578

4220

Focal epilepsy

940

7493

1.28

10.96

2.6

2.5

41.71

44.10

u/l

0.11

806

6406

Contusion of toe(s) without damage to nail

128

685

1.99

10.95

3.0

2.2

33.81

38.96

u/l

0.31

110

583

!Aliquae complicationes praecoces traumatis

211

1304

1.70

10.90

3.5

2.5

29.97

74.10

u/l

0.65

181

1127

Early complications of trauma

211

1304

1.70

10.90

3.5

2.5

29.97

74.10

u/l

0.65

181

1127

Other congenital malformations of skin

364

2528

1.49

10.90

2.5

2.4

30.94

57.54

u/l

0.80

305

2168

Fall involving bed

155

884

1.86

10.82

2.9

2.3

26.24

36.57

u/l

2.95

135

745

Nonischemic cardiomyopathy

428

3062

1.44

10.77

2.4

2.5

36.91

55.44

u/l

0.61

364

2659

Injuries involving multiple body regions

185

1109

1.76

10.76

3.2

2.4

38.32

79.40

u/l

0.47

155

951

Other disorders of the genitourinary system

579

4360

1.37

10.69

2.6

2.3

32.83

38.40

u/l

1.84

503

3686

Malignant neoplasm of larynx, including Hilmo

414

2.27

10.68

2.3

2.2

55.49

42.91

u/l

0.23

335

Scoliosis

365

2543

1.48

10.64

2.3

2.1

35.98

57.51

u/l

0.58

309

2170

Disorders of continuity of bone

448

3242

1.43

10.64

3.8

2.4

38.11

53.32

u/l

0.51

359

2801

Meralgia paraesthetica

170

1001

1.80

10.63

3.2

2.3

48.50

42.07

u/l

0.14

151

858

Panniculitis, unspecified

272

2.66

10.62

3.7

2.0

30.36

39.77

u/l

0.85

239

Hyperkinetic disorders (excl. ADHD)

485

2.17

10.59

2.6

26.19

133.08

u/l

0.57

421

Menorrhagia

1541

7136

1.22

10.58

2.6

2.3

33.61

37.65

u/l

1.22

1272

6067

Osteoporosis with pathological fracture (FG)

333

2291

1.51

10.57

3.0

2.3

49.43

40.59

u/l

0.26

296

1953

Nail disorders

380

2678

1.47

10.54

3.5

2.5

33.15

56.02

u/l

0.71

323

2324

Single delivery by forceps and vacuum extractor

423

3536

0.70

10.48

2.1

2.6

43.69

37.89

u/l

0.23

370

3005

LSIL lesion of the cervix uteri, vagina or vulva

614

4670

1.35

10.45

2.3

41.39

35.86

u/l

0.37

527

3973

Degeneration of the brain due to alcohol

114

599

2.05

10.43

4.6

2.6

31.61

43.42

u/l

0.84

101

526

Encephalitis

146

828

1.87

10.41

2.2

2.4

38.62

35.61

u/l

0.11

131

699

Post-traumatic wound infection, not elsewhere classified

139

778

1.91

10.39

4.1

2.5

30.11

38.87

u/l

0.82

119

663

Other and unspecified injuries of wrist and hand

182

1096

1.75

10.39

2.9

2.2

29.81

80.30

u/l

0.59

162

913

Superficial injuries involving multiple body regions

136

756

1.92

10.36

3.4

2.4

40.73

95.74

u/l

0.42

117

649

Social disorders starting during childhood or adolecense, excluding more controls

135

3.34

10.36

2.8

2.7

29.00

34.15

u/l

0.60

119

Dislocation, sprain and strain of joint and ligaments of hip

178

1070

1.76

10.31

2.3

2.4

59.27

33.42

u/l

0.49

143

910

Benign neoplasm: Appendix

315

2.53

10.29

2.9

2.3

31.93

32.06

u/l

0.01

264

Pregnancy with abortive outcome

3132

14427

1.14

10.27

2.3

33.98

39.53

u/l

1.79

2673

12220

Other disorders of adrenal gland

211

1324

1.67

10.26

3.4

2.3

35.37

77.65

u/l

0.60

182

1122

Deficiency of other B group vitamins

105

538

2.09

10.26

3.4

2.3

35.58

32.76

u/l

0.25

452

Adenocarcinoma of small intestine

4.98

10.25

5.3

2.0

35.37

33.12

u/l

0.09

Other congenital malformations of integument

4.45

10.24

1.9

2.1

32.58

31.42

u/l

0.05

Type 1 diabetes, wide definition

981

7915

1.26

10.20

5.7

2.3

26.42

40.70

u/l

6.57

735

6918

Mental retardation, excluding more controls

151

840

1.83

10.19

2.3

2.4

26.21

42.65

u/l

2.27

119

722

Trigger finger

630

4827

1.34

10.17

2.9

2.3

37.89

39.59

u/l

0.16

524

4132

Single spontaneous delivery

1473

9294

0.83

10.17

2.2

2.4

37.14

36.77

u/l

0.05

1260

7829

Vasculitis limited to skin, not elsewhere classified

133

740

1.92

10.15

2.5

2.2

43.97

36.89

u/l

0.34

120

624

Arthropathy in Crohn disease

272

2.63

10.15

3.0

2.4

33.80

29.55

u/l

0.65

222

Perineal laceration during delivery

417

4805

0.71

10.11

2.0

2.3

42.15

35.70

u/l

0.25

363

4080

Pneumonia derived septicemia

164

969

1.79

10.10

3.4

2.3

36.14

83.82

u/l

0.47

135

821

Giant cell arteritis

200

1247

1.69

10.08

2.6

2.3

29.19

36.81

u/l

2.31

164

1045

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1309

10902

1.22

10.08

2.7

2.6

36.68

44.56

u/l

0.89

1107

9422

Persistent delusional disorders

344

2401

1.48

10.08

3.0

2.4

29.00

60.23

u/l

0.95

308

2080

Carcinoma in situ of skin of upper limb, including shoulder

129

715

1.94

10.07

3.2

2.3

31.96

35.40

u/l

0.44

111

594

Hypertrophic cardiomyopathy

199

1239

1.69

10.07

2.9

2.4

37.76

39.03

u/l

0.09

172

1061

Malignant neoplasm of breast, ER-negative, including Hilmo

883

6723

1.28

10.06

2.1

2.2

36.48

36.02

u/l

0.05

748

5637

Drug-induced osteoporosis with pathological fracture

449

2.22

10.04

3.9

2.3

36.34

30.77

u/l

0.59

369

Monoplegia

408

2.27

10.03

3.0

2.3

33.18

34.48

u/l

0.10

345

Marginal zone B-cell lymphoma, including Hilmo

375

2.32

9.97

2.1

2.2

29.26

45.41

u/l

0.72

308

Vascular dementia (subcortical)

150

868

1.82

9.94

2.7

2.4

30.46

36.21

u/l

0.90

126

731

Synovial cyst of popliteal space [Baker]

327

2267

1.49

9.92

2.5

2.2

42.16

40.22

u/l

0.07

275

1924

Tic and related disorders

241

2.63

9.92

2.1

2.2

182.24

37.80

u/l

0.45

206

Macular cyst

147

851

1.85

9.89

2.7

2.4

31.14

41.05

u/l

1.03

125

733

Congenital malformations of the musculoskeletal system, not elsewhere classified

397

2.28

9.87

2.9

2.5

32.41

32.03

u/l

0.03

335

Malignant neoplasm of larynx

317

2.41

9.84

2.3

2.2

36.88

32.82

u/l

0.25

256

Congenital obstruction of the pelviureteric junction

247

2.73

9.82

3.2

2.2

36.37

28.92

u/l

1.20

204

Degeneration of nervous system due to alcohol

114

612

2.01

9.81

4.6

2.6

31.61

42.97

u/l

0.80

101

531

Hyperplasia of prostate

1571

7514

1.20

9.78

2.6

2.7

37.48

65.33

u/l

1.55

1351

6533

Drug-induced neutropenia

327

2278

1.49

9.78

3.4

2.4

30.44

58.11

u/l

0.74

293

1971

Conduct disorder

108

568

2.02

9.74

3.0

2.3

25.24

37.21

u/l

2.47

486

Palmar fascial fibromatosis [Dupuytren]

621

4776

1.33

9.73

2.8

2.4

31.96

41.73

u/l

3.87

524

4083

Renal tubulo-interstitial disorders in diseases classified elsewhere

253

2.65

9.72

4.8

2.4

36.94

33.01

u/l

0.38

214

Other hammer toe(s) (acquired)

777

5671

1.29

9.71

2.4

35.39

46.88

u/l

0.69

660

4813

Any dementia, excluding more controls

1462

8453

1.21

9.71

2.3

36.73

51.10

u/l

0.86

1190

7214

Viral infections of the central nervous system

351

2477

1.47

9.70

2.8

2.4

32.57

56.91

u/l

0.68

299

2139

Essential (haemorrhagic) thrombocythaemia

161

957

1.77

9.67

2.2

2.1

32.12

34.79

u/l

0.44

141

803

Contusion of ankle

183

1125

1.71

9.67

2.6

2.3

31.77

36.29

u/l

0.77

151

963

Other keratitis

509

3817

1.37

9.65

3.0

2.5

61.59

50.65

u/l

0.14

416

3313

Cardiomyopathy in other diseases

127

3.46

9.63

2.1

2.4

608.19

30.15

u/l

0.49

103

Other disorders of prostate

150

875

1.80

9.62

2.5

2.6

48.74

45.41

u/l

0.09

122

761

Pediculosis, acariasis and other infestations

718

5639

1.30

9.60

3.1

2.5

29.22

45.18

u/l

1.22

607

4884

Wide developmental disorders, excluding more controls

117

620

1.93

9.60

2.0

2.4

25.45

34.50

u/l

3.62

541

Other specified/unspecified soft tissue disorders

221

1423

1.62

9.60

3.0

2.0

33.26

42.82

u/l

1.29

184

1215

Abnormal findings on examination of urine, without diagnosis

204

1292

1.66

9.59

3.4

2.4

78.67

76.14

u/l

0.02

182

1106

Pure hyperglyceridaemia

111

594

1.99

9.57

3.0

2.6

49.77

38.83

u/l

0.34

507

Myositis

126

702

1.91

9.55

2.5

2.3

63.18

46.24

u/l

0.28

106

609

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

187

1162

1.69

9.54

2.8

2.4

33.64

80.37

u/l

0.59

157

989

Motor disorders, excluding more controls

248

2.52

9.53

2.2

2.7

23.22

37.85

u/l

3.49

214

Temporal arteritis

177

1087

1.72

9.53

2.4

2.3

29.49

36.34

u/l

1.80

146

911

Collapsed vertebra, not elsewhere classified

189

2.92

9.51

2.6

2.0

33.68

29.22

u/l

0.53

157

Acute laryngitis and tracheitis

505

3720

1.36

9.50

2.7

2.4

41.87

37.81

u/l

0.24

443

3204

Gout due to impairment of renal function

294

2.51

9.49

4.6

2.4

44.30

35.76

u/l

0.87

247

Generalized epilepsy

199

1256

1.66

9.46

2.7

2.4

34.23

77.08

u/l

0.57

180

1061

Viral encephalitis, not elsewhere classified/unspecified

105

555

2.03

9.46

2.8

2.4

30.00

32.38

u/l

0.30

479

Secondary parkinsonism, excluding more controls

108

573

1.99

9.43

2.0

2.3

26.40

37.37

u/l

2.20

506

Complications predominantly related to the puerperium

1113

9190

1.23

9.42

2.3

33.83

36.51

u/l

0.49

943

7823

Other symptoms and signs involving the circulatory and respiratory systems

271

1827

1.53

9.41

3.1

2.2

33.33

67.67

u/l

0.72

236

1568

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

281

1906

1.52

9.41

2.7

2.4

33.32

39.81

u/l

1.07

247

1607

Malignant neoplasm of breast, HER-negative

781

6094

1.28

9.40

2.1

2.2

37.21

36.48

u/l

0.07

660

5100

Isolated proteinuria

142

826

1.83

9.36

3.5

2.4

95.98

96.51

u/l

0.00

128

708

Pyogenic arthritis

292

2004

1.51

9.34

3.1

2.5

268.67

62.75

u/l

0.41

252

1722

Complications of other internal prosthetic devices, implants and grafts

187

1168

1.68

9.31

2.7

2.2

31.71

39.07

u/l

1.38

163

999

FESS (DNB20)

302

4308

0.68

9.29

2.6

2.5

37.70

48.82

u/l

0.46

254

3726

Alzheimer’s disease, strict definition

1020

6871

1.24

9.26

2.2

2.3

37.46

38.24

u/l

0.05

834

5793

Coxarthrosis

2349

13568

1.16

9.25

2.6

2.5

74.57

46.52

u/l

0.43

1978

11609

Focal brain injury

275

1867

1.52

9.23

2.7

2.4

36.95

39.27

u/l

0.13

231

1641

Autonomic disorders

116

638

1.94

9.23

2.7

2.4

32.37

32.58

u/l

0.02

101

539

Complications of cardiac and vascular prosthetic devices, implants and grafts

101

531

2.04

9.21

4.3

2.3

40.35

31.32

u/l

0.90

456

Abscess of lung

422

2.19

9.20

4.0

2.4

28.50

33.85

u/l

0.89

364

Benign neoplasm: Oesophagus

330

2.38

9.19

2.7

2.4

34.11

31.49

u/l

0.33

279

Car occupant injured in other and unspecified transport accidents

830

6668

1.27

9.17

3.0

2.5

115.82

44.85

u/l

0.41

727

5739

Ingrowing nail

244

1624

1.56

9.17

3.6

2.4

33.00

68.44

u/l

0.64

207

1395

Other specified disorders of kidney and ureter

156

936

1.76

9.16

2.6

2.5

37.52

93.37

u/l

0.55

140

793

Drug-induced headache, not elsewhere classified

154

3.16

9.12

3.1

2.2

27.22

27.44

u/l

0.04

128

Benign mammary dysplasia

632

4927

1.32

9.11

2.4

2.3

41.89

37.43

u/l

0.46

545

4138

Burns classified according to extent of body surface involved

267

2.54

9.10

3.7

2.4

32.47

32.85

u/l

0.03

225

Medial epicondylitis

178

1105

1.69

9.09

2.8

2.3

53.91

45.32

u/l

0.18

151

972

Nonalcoholic steatohepatitis

256

2.61

9.09

3.0

2.2

29.82

34.17

u/l

0.34

218

Other injuries of lower limb, level unspecified

255

2.59

9.09

3.7

2.5

24.67

33.69

u/l

1.67

224

Giant cell arteritis with polymyalgia rheumatica

177

1101

1.70

9.08

2.4

2.2

29.49

36.82

u/l

2.02

146

924

Focal epilepsy, strict definition

854

6890

1.26

9.07

2.6

2.5

41.57

44.69

u/l

0.13

727

5888

Bronchiectasis

338

2401

1.46

9.05

2.4

29.47

40.46

u/l

4.26

282

2037

Other abnormalities of plasma proteins

440

2.15

9.00

3.4

2.2

29.31

31.11

u/l

0.32

371

Anankastic personality disorder

183

1147

1.67

9.00

2.9

2.4

37.92

82.05

u/l

0.53

158

985

Congenital malformations and deformations of the musculoskeletal system

464

3447

1.37

8.99

2.4

38.00

50.22

u/l

0.36

384

2956

Mouth breathing

1793

15470

1.17

8.98

2.5

2.6

49.85

48.33

u/l

0.04

1502

13318

Ganglion

908

7380

1.25

8.98

2.4

33.50

38.50

u/l

1.36

751

6330

Redundant prepuce, phimosis and paraphimosis

863

6909

1.26

8.93

3.2

2.8

39.41

65.73

u/l

1.28

752

6054

Evidence of alcohol involvement determined by blood alcohol level

427

2.16

8.93

3.2

2.6

27.56

146.60

u/l

0.55

367

Adrenocortical insufficiency

168

1036

1.71

8.87

3.5

2.3

36.73

88.87

u/l

0.58

146

880

Peroneal tendinitis

427

2.14

8.86

2.6

2.1

31.15

149.19

u/l

0.55

371

Achilles tendinitis

443

3297

1.38

8.86

2.7

2.4

33.25

53.33

u/l

0.79

382

2868

Open wound of hip and thigh

154

928

1.74

8.85

3.0

2.6

30.41

85.80

u/l

0.56

135

798

Benign neoplasm: Anus and anal canal

135

787

1.82

8.83

2.4

2.3

35.04

36.58

u/l

0.11

112

669

Osteonecrosis due to drugs

410

2.20

8.83

2.3

2.4

29.19

32.27

u/l

0.51

341

Other and unspecified erythematous conditions

152

916

1.75

8.81

2.6

2.2

38.36

34.78

u/l

0.24

137

772

Diabetes mellitus in pregnancy

1362

7337

1.20

8.80

2.6

2.3

32.35

37.25

u/l

1.02

1156

6281

Generalized epilepsy, strict definition

113

625

1.92

8.80

2.7

2.4

27.40

37.97

u/l

1.87

101

522

Sulfasalazine

1267

10658

1.21

8.79

2.5

2.4

63.22

44.74

u/l

0.30

1099

9103

Sub-endpoint used in defining T1D endpoints

1293

10713

1.20

8.79

5.6

2.4

43.86

43.41

u/l

0.02

990

9242

Visual impairment including blindness (binocular or monocular)

293

2040

1.49

8.74

3.8

2.3

29.65

62.94

u/l

0.78

247

1711

Allergic rhinitis

1351

11299

1.20

8.74

2.2

2.5

37.12

42.61

u/l

0.54

1153

9729

Other and unspecified vasculitis limited to skin

117

658

1.89

8.68

2.6

2.3

46.51

35.65

u/l

0.51

105

556

Lymphoid leukaemia

246

1661

1.54

8.68

3.3

2.4

31.69

38.41

u/l

1.19

220

1401

Acquired absence of organs, not elsewhere classified

331

2.32

8.67

3.5

2.0

30.76

30.47

u/l

0.04

274

Benign neoplasm of meninges

457

3435

1.37

8.66

2.5

2.3

29.95

38.09

u/l

3.98

395

2919

Myocardial infarction, with ST-elevation

714

5677

1.28

8.66

2.8

2.5

40.83

46.17

u/l

0.26

626

4848

Disorders of speech understanding and production

185

1151

1.64

8.60

2.3

27.52

32.11

u/l

1.78

165

957

Other bursopathies

554

4274

1.33

8.59

2.5

2.4

41.39

41.03

u/l

0.02

466

3664

L02BA Anti-estrogens

730

5835

1.28

8.55

2.2

2.3

52.47

37.39

u/l

0.63

631

4945

Other otitis externa (chronic)

288

2011

1.48

8.52

2.6

2.4

30.24

61.40

u/l

0.72

241

1726

Complications of the puerperium, not elsewhere classified

183

1162

1.64

8.51

2.2

31.52

37.91

u/l

0.89

155

971

Lichen simplex chronicus and prurigo

280

1946

1.49

8.51

3.2

2.2

31.48

63.95

u/l

0.74

241

1682

Myelodysplastic syndrome, including Hilmo

117

659

1.86

8.50

2.3

2.1

47.54

30.99

u/l

0.61

534

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

391

2.15

8.50

2.4

2.1

32.40

30.70

u/l

0.21

310

Use of antiglaucoma preparations and miotics

348

2514

1.43

8.46

3.3

2.3

37.79

54.68

u/l

0.40

292

2118

Malignant cancer of tonsil and base of tongue, including Hilmo

106

582

1.93

8.46

3.4

2.4

43.48

41.62

u/l

0.06

488

Seborrhoeic keratosis

966

7963

1.24

8.45

2.8

2.4

32.93

39.01

u/l

3.38

830

6781

Molar incisor enamel hypoplasia

143

822

1.75

8.43

2.8

2.3

33.81

28.62

u/l

0.55

124

676

Foreign body in alimentary tract

244

1655

1.53

8.42

2.6

2.4

80.12

66.82

u/l

0.10

207

1407

Other bursitis of elbow

220

2.64

8.40

2.9

2.1

33.27

35.89

u/l

0.20

187

Wet age-related macular degeneration

731

5676

1.27

8.38

2.3

36.10

36.93

u/l

0.09

596

4799

Antenatal screening

965

4426

1.24

8.37

2.1

2.4

35.89

37.21

u/l

0.19

846

3768

Viral conjunctivitis

108

600

1.92

8.36

2.9

2.3

31.89

35.68

u/l

0.51

516

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2205

14640

1.15

8.35

2.4

2.3

34.02

37.88

u/l

1.08

1893

12464

SLE (Finngen)

161

998

1.69

8.33

2.8

2.2

39.75

42.34

u/l

0.17

138

841

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

342

2.25

8.33

3.4

2.4

28.75

33.01

u/l

0.66

286

Eosinophilic disease (BM)

334

2.24

8.32

2.8

2.0

29.77

174.39

u/l

0.51

286

Lesion of lateral popliteal nerve

223

1489

1.56

8.32

3.8

2.4

38.27

40.60

u/l

0.16

199

1285

Bursitis of shoulder

121

696

1.84

8.31

2.7

2.2

40.65

45.67

u/l

0.17

103

608

Other misadventures during surgical and medical care

117

668

1.87

8.30

3.9

2.3

40.77

103.08

u/l

0.41

107

568

Malignant neoplasm of anus and anal canal

128

3.28

8.30

2.4

1.9

30.86

30.44

u/l

0.04

105

Postzoster neuralgia

447

2.09

8.26

2.6

2.4

29.24

30.38

u/l

0.19

370

Rheumatoid arthritis

1439

11023

1.19

8.25

2.4

36.56

44.32

u/l

0.93

1227

9422

Vascular dementia

361

2535

1.41

8.21

2.4

29.77

35.55

u/l

2.63

298

2110

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

134

795

1.77

8.21

2.6

2.1

31.81

39.63

u/l

1.23

112

684

Habit and impulse disorders

454

2.05

8.18

2.7

2.8

34.87

150.01

u/l

0.56

388

Mixed hyperlipidaemia

169

1064

1.66

8.16

2.4

2.5

32.71

38.59

u/l

0.62

143

920

Suppurative and unspecified otitis media

1601

12223

1.17

8.16

2.7

2.5

61.21

41.06

u/l

0.30

1368

10551

Ill-defined and unknown causes of mortality

168

2617

0.62

8.15

2.9

2.4

33.09

38.11

u/l

0.93

128

2230

Chronic ulcer of skin, not elsewhere classified

292

2061

1.46

8.14

3.8

2.3

35.04

39.70

u/l

0.64

237

1766

Calculus of lower urinary tract

220

1471

1.55

8.13

2.7

2.5

30.87

71.04

u/l

0.66

192

1245

Shock, not elsewhere classified

216

2.58

8.12

3.3

1.9

29.00

30.64

u/l

0.15

185

Hypothyroidism due to medicaments and other exogenous substances

314

2.31

8.09

2.7

2.3

27.81

29.37

u/l

0.33

261

Alcoholic cardiomyopathy

118

3.28

8.08

3.1

2.7

29.86

36.84

u/l

0.46

101

All dysplastic lesions of the cervix uteri, vagina or vulva

1229

10235

1.20

8.08

2.5

2.3

37.20

36.92

u/l

0.03

1035

8738

Brain meningioma

200

1312

1.58

8.07

2.5

2.1

31.84

34.74

u/l

0.66

172

1094

Benign neoplasm of middle ear and respiratory system

338

2451

1.42

8.07

2.5

34.02

58.06

u/l

0.66

277

2113

447

2.03

8.07

2.8

2.2

29.48

29.62

u/l

0.02

366

Drug-induced cataract

118

682

1.84

8.06

5.2

2.5

40.21

34.85

u/l

0.44

107

591

LSIL lesion of the cervix uteri

480

3667

1.34

8.05

2.3

2.2

40.61

34.67

u/l

0.33

411

3127

Speech disturbances, not elsewhere classified

371

2731

1.40

8.04

3.0

2.4

34.02

38.72

u/l

0.87

324

2333

Other disorders of patella

764

6177

1.26

8.04

2.5

35.99

48.73

u/l

0.84

657

5324

Left bundle-branch block

300

2132

1.45

8.01

2.4

38.75

38.60

u/l

0.01

247

1839

Benign neoplasm: Cerebral meninges

417

3132

1.37

8.00

2.5

2.3

30.20

38.62

u/l

3.67

363

2663

Scabies

586

4597

1.30

8.00

3.1

2.4

28.46

47.07

u/l

1.14

493

3982

Other noninflammatory disorders of vagina

341

2479

1.42

7.98

2.4

2.2

64.24

37.24

u/l

0.80

289

2110

Lesion of ulnar nerve

617

4879

1.29

7.96

3.2

2.6

42.40

38.28

u/l

0.20

505

4236

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

139

841

1.74

7.95

2.4

30.87

98.18

u/l

0.63

111

720

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

515

1.96

7.93

2.7

2.1

40.92

42.39

u/l

0.04

430

Dementia in other diseases classified elsewhere

199

1311

1.58

7.92

2.6

2.3

45.80

37.31

u/l

0.39

161

1120

Defect, injury or illness of neck

148

3.00

7.92

3.2

2.7

30.61

27.96

u/l

0.41

123

Nonhereditary hypogammaglobulinemia

297

2.33

7.92

2.5

2.3

33.25

28.94

u/l

0.40

251

Diffuse brain injury

158

985

1.67

7.91

3.0

2.4

32.98

37.64

u/l

0.77

133

872

Impaction of intestines

153

2.90

7.90

4.1

2.1

30.44

30.01

u/l

0.05

133

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

106

594

1.88

7.89

2.6

2.1

38.99

40.21

u/l

0.05

477

Multiple myeloma

106

594

1.88

7.89

2.6

2.1

38.99

40.21

u/l

0.05

477

Hypertrophy of breast in women and men

846

6932

1.24

7.87

2.4

32.94

37.48

u/l

0.94

727

5876

Hyperhidrosis

128

757

1.76

7.85

2.1

1.9

71.61

39.05

u/l

0.40

111

630

Sarcoidosis

579

4553

1.30

7.85

2.6

2.5

39.89

48.33

u/l

0.35

487

3914

Cardiomyopathies, Secondary/extrinsic

172

2.81

7.84

3.1

2.4

33.58

29.56

u/l

0.38

147

Glucagon-like peptide-1 (GLP-1) analogues

1260

10713

1.19

7.84

2.6

2.5

38.84

47.74

u/l

0.55

1037

9311

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1260

10713

1.19

7.84

2.6

2.5

38.84

47.74

u/l

0.55

1037

9311

Malignant neoplasm of tongue

475

2.00

7.82

2.9

2.2

32.53

34.49

u/l

0.13

397

Family history of malignant neoplasm

476

3649

1.34

7.82

2.6

2.2

47.25

50.87

u/l

0.09

425

3090

Dystonia

246

1698

1.50

7.81

2.2

2.3

29.78

68.98

u/l

0.78

207

1451

Other disorders of optic [2nd] nerve and visual pathways

279

1971

1.47

7.80

3.5

2.3

32.18

62.55

u/l

0.68

240

1685

Benign neoplasm: Skin of eyelid, including canthus

669

5357

1.28

7.78

2.3

2.4

36.97

45.80

u/l

0.46

534

4554

Contact with other hot fluids

148

916

1.70

7.77

2.5

2.4

31.28

88.72

u/l

0.57

128

786

Hypoplasia of dental enamel , including avohilmo

134

782

1.74

7.73

2.9

2.2

34.75

28.59

u/l

0.65

117

646

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

330

2401

1.42

7.73

3.2

2.3

30.93

37.15

u/l

1.81

284

2033

Contracture of joint

332

2.21

7.72

3.6

2.3

37.47

39.25

u/l

0.08

273

Melanocytic naevi of other and unspecified parts of face

260

1817

1.48

7.72

2.4

2.3

33.74

64.35

u/l

0.61

216

1552

Malignant cancer of tonsil and base of tongue

477

1.99

7.71

3.3

2.4

32.88

43.85

u/l

0.52

404

Other and unspecified injuries of ankle and foot

189

1238

1.59

7.71

2.6

2.3

35.76

36.89

u/l

0.07

160

1049

Other congenital malformations of circulatory system

126

752

1.78

7.66

2.1

2.4

32.19

43.02

u/l

0.88

109

636

Ectopic pregnancy

724

5855

1.26

7.65

2.5

2.3

32.29

37.51

u/l

1.79

621

4978

Viral conjunctivitis

173

1115

1.62

7.64

2.6

2.4

31.63

78.65

u/l

0.57

149

952

Benign neoplasm: Parotid gland

337

2467

1.41

7.64

2.6

2.4

36.48

57.58

u/l

0.56

295

2129

Hydrocele

465

3561

1.33

7.64

3.3

2.7

43.86

77.02

u/l

0.75

396

3093

Benign neoplasm: Other and unspecified parts of mouth

154

968

1.67

7.61

2.4

36.53

37.81

u/l

0.09

131

813

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

352

2593

1.40

7.61

2.4

2.2

35.18

35.62

u/l

0.04

317

2216

Brain meningioma, including Hilmo

203

1355

1.55

7.58

2.5

2.1

31.81

34.80

u/l

0.71

175

1129

Diabetic maculopathy, excluding more controls

463

3552

1.34

7.58

7.1

2.4

43.53

38.43

u/l

0.37

356

3100

Exposure to other and unspecified forces of nature

170

2.81

7.56

3.4

2.5

50.42

34.38

u/l

0.54

143

Malignant neoplasm of floor of mouth, including Hilmo

193

2.63

7.55

2.9

2.1

53.70

31.62

u/l

0.58

165

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

279

1979

1.45

7.54

2.4

2.1

35.49

35.45

u/l

0.00

249

1696

Delivery

1525

9316

0.85

7.51

2.2

2.4

36.30

36.74

u/l

0.06

1309

7847

Drug-induced hypoglycaemia without coma

433

2.03

7.49

5.0

2.3

28.25

33.47

u/l

0.71

360

Acute myeloid leukaemia and myelodysplastic syndromes

445

1.99

7.49

2.3

2.0

33.81

30.53

u/l

0.41

356

Malignant neoplasm of hypopharynx, including Hilmo

134

2.98

7.48

3.1

2.0

33.74

69.57

u/l

0.51

109

Hidradenitis suppurativa

166

1065

1.63

7.47

3.2

2.4

38.47

86.50

u/l

0.54

148

911

Viral infections of the central nervous system

316

2299

1.42

7.44

2.7

2.4

33.33

58.41

u/l

0.65

270

1994

Nontoxic goitre/thyroid nodule

1302

11153

1.18

7.44

2.4

39.38

44.02

u/l

0.34

1075

9450

Congenital malformations of the circulatory system

606

4676

1.28

7.41

2.5

35.84

46.75

u/l

0.52

529

4028

Generalized epilepsy, mode (most common among epilepsy diagnosis)

143

888

1.69

7.39

2.6

2.3

34.14

41.33

u/l

0.49

132

748

Behavioural disorders

105

601

1.84

7.35

3.1

2.4

25.13

36.30

u/l

2.31

506

Congenital ovarian cysts

191

1268

1.57

7.35

2.4

2.2

31.40

35.67

u/l

0.91

162

1069

Other localized connective tissue disorders

537

1.91

7.34

3.1

2.2

28.14

36.58

u/l

1.51

449

Other erythematous conditions

163

1048

1.63

7.34

2.6

2.3

37.66

37.22

u/l

0.02

144

888

Other ill-defined and unspecified causes of mortality

149

2324

0.62

7.33

3.0

2.4

33.46

37.64

u/l

0.65

112

1973

Other injuries of upper limb, level unspecified

333

2.18

7.33

2.7

2.4

28.61

28.96

u/l

0.05

285

Glaucoma-related operations

250

1755

1.48

7.32

2.2

2.3

39.86

36.20

u/l

0.21

211

1494

Diabetic retinopathy, excluding more controls

1134

5356

1.21

7.31

5.0

2.8

37.92

48.84

u/l

0.55

903

4462

Hypertrophy of breast

737

6006

1.25

7.28

2.3

33.49

36.41

u/l

0.44

631

5064

Ankylosing spondylitis

369

2758

1.37

7.26

2.7

2.5

129.85

55.63

u/l

0.36

316

2419

Toxic effect of alcohol

102

583

1.86

7.23

5.0

2.5

81.64

122.95

u/l

0.18

502

Benign neoplasm of major salivary glands

412

3137

1.35

7.20

2.5

2.4

35.92

53.00

u/l

0.58

358

2695

Pneumococcal septicemia

151

958

1.65

7.18

3.2

2.3

37.93

83.26

u/l

0.43

122

810

Astigmatism

264

1872

1.45

7.17

2.6

2.4

33.45

64.32

u/l

0.63

235

1587

Paranoid personality disorder

504

1.92

7.17

2.4

31.49

129.64

u/l

0.52

429

Dependent personality disorder

101

578

1.86

7.17

3.1

2.4

28.64

36.61

u/l

1.47

487

ILD-related respiratory insufficiency

147

929

1.66

7.14

3.0

2.4

37.20

39.72

u/l

0.18

133

778

Retinal detachment with retinal break

544

4298

1.29

7.13

2.9

2.5

35.11

50.48

u/l

0.76

462

3709

Nonsuppurative otitis media

985

7140

1.21

7.12

2.8

2.4

79.04

41.22

u/l

0.36

835

6142

Embolic stroke with flimmer

107

620

1.81

7.12

2.4

2.5

39.63

39.09

u/l

0.02

513

Other noninflammatory disorders of uterus, except cervix

954

5359

1.22

7.09

2.5

2.3

60.03

38.83

u/l

0.46

808

4544

Fracture of neck

254

1797

1.46

7.09

3.4

2.5

31.10

66.86

u/l

0.74

214

1533

Disorder of external ear, unspecified

148

939

1.65

7.05

2.7

2.4

32.63

37.87

u/l

0.78

128

795

Recurrent dislocation of patella

219

1506

1.50

7.04

2.9

2.3

28.31

67.92

u/l

0.67

191

1285

Other disorders of pigmentation

195

1315

1.54

7.03

2.8

2.3

35.42

40.52

u/l

0.52

163

1119

Acne

402

3052

1.34

6.98

3.5

2.5

33.64

51.59

u/l

0.59

354

2620

Other injuries of spine and trunk, level unspecified

246

2.37

6.97

4.1

2.5

28.81

32.45

u/l

0.37

206

Perforation of oesophagus

117

3.09

6.97

2.9

2.6

19.77

33.55

u/l

3.57

Superficial injury of neck

560

1.85

6.96

2.4

32.29

124.02

u/l

0.54

469

Other specified/unspecified systemic involvement of connective tissue

255

1813

1.46

6.95

2.4

2.3

38.75

37.19

u/l

0.09

220

1543

Endometriosis of ovary

697

5534

1.25

6.94

2.2

2.4

37.30

37.05

u/l

0.02

591

4718

Muscle strain

148

942

1.64

6.93

2.7

2.1

31.02

45.41

u/l

1.83

130

824

Acute nasopharyngitis (common cold)

498

3877

1.30

6.92

3.5

2.8

140.13

43.43

u/l

0.52

436

3374

Bell's palsy

512

4035

1.30

6.87

2.5

2.4

124.13

39.03

u/l

0.46

448

3473

Tongue abnormality

264

1895

1.44

6.83

2.6

2.3

31.55

40.24

u/l

1.97

222

1622

Gluteal tendinitis

169

1112

1.58

6.83

2.4

2.1

27.53

42.76

u/l

2.67

140

975

Thyroiditis

312

2300

1.40

6.83

2.2

2.3

44.11

39.52

u/l

0.16

264

1962

Striae atrophicae

294

2.21

6.83

2.3

2.2

29.38

32.19

u/l

0.28

243

Malignant neoplasm of base of tongue, including Hilmo

196

2.52

6.82

3.8

2.1

62.47

40.85

u/l

0.49

160

Frontotemporal dementia

155

2.80

6.78

2.5

35.15

36.59

u/l

0.06

125

Arterial embolism and thrombosis of lower extremity artery

150

962

1.62

6.77

2.7

2.3

31.97

35.27

u/l

0.49

136

812

Benign neoplasm: salivary glands, exclude unknown (D119)

367

2776

1.36

6.76

2.6

2.4

36.20

55.64

u/l

0.59

322

2392

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

162

1060

1.60

6.76

2.9

2.4

34.83

86.94

u/l

0.60

141

902

Otitis media, unspecified

455

3253

1.31

6.72

2.7

2.3

28.52

35.54

u/l

3.46

382

2781

Systemic lupus erythematosus

161

1054

1.60

6.71

2.8

2.2

39.75

40.96

u/l

0.08

138

885

Carrier of infectious disease

116

703

1.74

6.69

3.1

2.3

27.24

103.04

u/l

0.56

103

582

Female genital prolapse

1281

6207

1.18

6.68

2.4

37.98

38.28

u/l

0.02

1099

5282

Injury of blood vessels at neck level

3.31

6.66

1.9

2.2

43.78

27.83

u/l

1.73

Circumscribed brain atrophy

101

591

1.81

6.66

2.6

2.4

31.70

34.26

u/l

0.31

501

Disorders of ocular muscles, binocular movement, accommodation and refraction

2105

18600

1.13

6.65

2.5

34.91

41.30

u/l

1.25

1771

15986

Ethmoidectomy

337

4466

0.74

6.65

2.6

2.5

37.57

48.50

u/l

0.48

286

3856

Use of donepezil

535

6411

0.79

6.64

2.1

2.3

32.88

36.52

u/l

1.31

433

5414

Disorders in reading

429

1.96

6.64

2.5

26.41

152.25

u/l

0.57

357

Acute suppurative otitis media

1114

8863

1.19

6.64

2.8

2.5

74.88

40.05

u/l

0.38

954

7702

Ovarian dysfunction

302

2221

1.39

6.63

2.5

2.2

36.98

35.03

u/l

0.11

251

1876

Injury of nerves at wrist and hand level

165

1088

1.58

6.62

2.8

2.4

45.59

78.85

u/l

0.35

145

935

Helminthiases

481

1.91

6.62

2.5

2.6

36.45

33.55

u/l

0.14

395

Dermatitis due to substances taken internally

237

1679

1.46

6.58

3.1

2.2

35.57

66.75

u/l

0.55

204

1431

Marginal zone B-cell lymphoma

219

2.40

6.57

2.3

2.1

30.67

35.36

u/l

0.51

180

Primary adrenocortical insufficiency

320

2.14

6.57

3.0

2.1

28.17

34.36

u/l

0.77

270

Oligomenorrhoea

150

969

1.61

6.56

2.7

2.1

36.20

38.79

u/l

0.12

116

831

Allergic purpura

136

861

1.65

6.56

2.5

2.4

34.17

91.93

u/l

0.52

124

729

Retinal vascular occlusion

480

3776

1.30

6.55

2.7

2.4

34.83

38.57

u/l

0.70

395

3213

Chronic tubulo-interstitial nephritis

159

1042

1.58

6.54

3.4

2.2

41.78

39.37

u/l

0.21

138

865

Other hearing loss

1235

10417

1.18

6.51

2.6

2.4

35.11

51.70

u/l

1.29

1022

8839

Burn and corrosion of wrist and hand

166

1102

1.57

6.47

2.2

2.5

31.11

81.49

u/l

0.62

139

954

Melanocytic naevi of lower limb, including hip

195

1339

1.51

6.46

2.8

2.3

33.88

72.07

u/l

0.55

175

1140

Ulcer of oesophagus

270

1961

1.42

6.46

2.9

2.3

35.99

39.47

u/l

0.27

233

1667

Fibrosis of liver

216

2.44

6.45

3.7

2.3

45.24

35.86

u/l

0.38

185

Other pulmonary heart/vessel disease

192

1314

1.52

6.45

2.4

2.3

54.10

35.08

u/l

0.71

166

1106

Retinal vascular disorders

486

3838

1.29

6.43

2.7

2.4

34.77

38.40

u/l

0.68

401

3267

Disorders of magnesium metabolism

196

2.49

6.42

4.5

2.7

39.92

31.75

u/l

0.30

167

Prophylactic surgery

189

2.50

6.41

2.6

2.2

32.06

32.63

u/l

0.03

164

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

216

2.41

6.39

3.0

2.4

30.59

34.04

u/l

0.26

184

Other and unspecified disorders of skin and subcutaneous tissue

125

1959

0.62

6.38

2.7

2.3

36.19

40.48

u/l

0.32

108

1683

Persons encountering health services in circumstances related to reproduction

2654

16135

1.12

6.38

2.4

2.7

37.18

44.87

u/l

1.17

2302

13918

Psoriatic arthropathies

428

3331

1.31

6.37

2.9

2.5

36.33

53.25

u/l

0.60

374

2863

Burns and corrosions of multiple and unspecified body regions

105

628

1.76

6.37

2.9

2.6

29.49

115.19

u/l

0.60

548

Fistulae involving female genital tract

458

1.91

6.36

3.0

2.1

35.97

43.20

u/l

0.49

398

Wegener granulomatosis

437

1.94

6.35

2.0

2.4

35.78

31.63

u/l

0.62

368

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

554

1.81

6.34

2.7

2.3

48.35

31.07

u/l

0.89

454

Complications following infusion, transfusion and therapeutic injection

408

1.97

6.33

2.5

2.3

39.39

33.83

u/l

0.28

348

Torsion of ovary, ovarian pedicle and fallopian tube

106

636

1.75

6.33

2.2

2.1

33.08

42.51

u/l

0.90

543

Sicca syndrome [Sjögren]

372

2849

1.34

6.33

2.2

2.3

42.97

38.91

u/l

0.32

307

2424

Other and unspecified acquired haemolytic anaemias

263

2.25

6.33

4.2

2.4

45.90

34.03

u/l

0.81

218

Urethral stricture

218

1531

1.47

6.33

2.4

2.5

33.44

73.22

u/l

0.70

188

1321

Chalazion

475

3749

1.29

6.33

2.3

2.4

41.64

51.19

u/l

0.30

393

3217

Dermatographic urticaria

284

2089

1.40

6.32

2.5

2.3

31.05

59.22

u/l

0.66

232

1784

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

173

2.62

6.32

3.2

2.5

31.11

35.78

u/l

0.30

146

Congenital malformations and deformations of the musculoskeletal system

356

2690

1.35

6.32

2.5

2.4

40.47

54.03

u/l

0.30

294

2289

Insulin, fast-acting (human)

600

4861

1.26

6.31

7.3

2.4

33.32

38.67

u/l

0.80

447

4254

Malignant neoplasm of gum, including Hilmo

236

2.31

6.30

2.5

2.1

35.40

32.15

u/l

0.22

187

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

257

2.27

6.30

2.8

2.2

30.39

33.55

u/l

0.26

209

Parkinson's disease, excluding more controls

502

3750

1.28

6.30

2.3

2.4

37.82

57.45

u/l

0.49

417

3250

Primary open-angle glaucoma

1013

11467

0.84

6.27

2.3

2.4

72.04

45.47

u/l

0.34

848

9720

SLE, strict definition

153

1007

1.59

6.26

2.7

2.2

38.49

37.26

u/l

0.13

129

840

SLE, ICD10

153

1007

1.59

6.26

2.7

2.2

38.49

37.26

u/l

0.13

129

840

Parkinson's disease, strict definition, excluding more controls

469

3516

1.29

6.26

2.3

2.4

39.66

58.17

u/l

0.42

391

3048

Nontoxic multinodular goitre

842

7065

1.21

6.26

2.2

2.4

36.32

41.10

u/l

0.43

705

5999

Personal history of medical treatment

285

2.17

6.21

2.7

2.3

30.85

31.90

u/l

0.10

234

Other and unspecified acute skin changes due to ultraviolet radiation

114

702

1.71

6.20

2.5

2.3

42.69

32.05

u/l

0.88

590

Dentofacial anomalies [including malocclusion]

3271

24012

1.10

6.20

2.5

34.50

46.22

u/l

2.29

2807

20633

Lower leg

187

2.51

6.18

2.4

43.77

29.95

u/l

0.74

155

Effects of foreign body entering through natural orifice

1035

8842

1.19

6.18

2.5

2.6

47.87

46.09

u/l

0.06

890

7671

Other specified/unspecified spondylopathies

107

648

1.73

6.18

2.5

2.1

31.52

34.50

u/l

0.32

552

Pulmonary oedema

446

1.89

6.17

3.3

2.5

145.33

33.59

u/l

0.49

376

Other female pelvic inflammatory diseases

669

5500

1.24

6.17

2.6

2.2

32.16

36.10

u/l

1.07

584

4667

Varicella [chickenpox]

224

1589

1.45

6.17

3.1

2.7

34.68

69.40

u/l

0.62

204

1387

Other congenital malformations of intestine

328

2.08

6.15

3.8

2.3

34.54

28.91

u/l

0.82

279

Myeloproliferative diseases

342

2600

1.35

6.13

2.3

2.4

32.48

57.28

u/l

0.75

296

2231

Graves ophthalmopathy, strict

105

636

1.74

6.13

2.2

28.69

39.49

u/l

2.00

536

Diseases caused by chlamydiae

376

1.98

6.12

2.2

2.3

30.77

34.70

u/l

0.55

317

Other bacterial agents as the cause of diseases classified to other chapters

357

2.03

6.10

4.4

2.2

46.95

31.69

u/l

0.39

300

Other and unspecified vaccines and biological substances

175

2.54

6.10

2.5

2.1

30.48

29.59

u/l

0.08

138

Operations for atrial fibrillation

422

1.94

6.09

2.9

2.5

37.46

34.34

u/l

0.31

360

Vitamin D deficiency

493

1.85

6.09

4.0

2.4

27.41

34.12

u/l

1.48

424

Injury of nerves and spinal cord at neck level

106

645

1.74

6.09

2.7

2.5

30.13

40.42

u/l

0.81

561

Embolic stroke

183

1252

1.51

6.09

2.5

2.4

37.43

36.16

u/l

0.10

152

1045

Other acute skin changes due to ultraviolet radiation

151

997

1.58

6.09

2.8

2.3

39.06

36.59

u/l

0.17

124

839

Contact with other sharp object(s)

282

2085

1.39

6.07

2.7

2.5

32.40

63.37

u/l

0.76

248

1803

Intercostal neuropathy

221

2.35

6.06

2.6

2.5

27.08

29.27

u/l

0.28

191

Injury of muscle and tendon at hip and thigh level

408

3181

1.31

6.05

2.4

2.5

42.92

53.40

u/l

0.25

345

2747

Other congenital malformations of skin

172

1168

1.53

6.04

2.6

2.3

29.35

79.39

u/l

0.64

151

978

Mixed connective tissue disease

274

2024

1.40

6.00

2.5

2.3

38.09

35.51

u/l

0.17

235

1725

Other benign neoplasms of skin

1623

14349

1.14

5.99

2.5

37.99

48.76

u/l

0.97

1330

12263

Amyloidosis, other/unspecified

444

1.88

5.99

2.6

2.5

45.97

32.14

u/l

1.13

381

Frontotemporal dementia, wide, incl. Pick's disease

177

2.52

5.97

2.4

2.5

35.03

34.69

u/l

0.02

144

Coxarthrosis [arthrosis of hip](FG)

2534

16126

1.11

5.95

2.6

2.5

71.41

43.72

u/l

0.47

2141

13801

Degenerative diseases of the nervous system

1447

9309

1.15

5.93

2.4

35.55

39.78

u/l

0.51

1191

7886

Other mental disorders due to brain damage and dysfunction and to physical disease

469

3729

1.28

5.92

2.6

2.4

32.49

51.83

u/l

0.86

389

3195

Secondary right heart disease

175

1198

1.52

5.92

2.4

2.3

56.57

35.32

u/l

0.73

151

1012

Complications of genitourinary prosthetic devices, implants and grafts

106

648

1.71

5.91

4.0

2.2

29.19

34.39

u/l

1.00

554

Malignant neoplasm of heart, mediastinum and pleura

282

2.12

5.90

2.5

2.0

34.04

30.88

u/l

0.33

232

Erectile dysfunction

309

2329

1.36

5.90

2.9

2.6

33.59

38.93

u/l

0.79

270

2004

Mantle cell lymphoma, including Hilmo

317

2.05

5.89

2.7

2.1

33.38

32.95

u/l

0.04

264

Other acquired deformities of musculoskeletal system and connective tissue

197

1381

1.48

5.89

2.3

2.5

41.23

72.50

u/l

0.42

172

1191

Polypectomy (DHB20)

277

2055

1.39

5.89

2.3

2.5

36.91

63.06

u/l

0.59

237

1778

Tobacco use

224

1606

1.44

5.88

3.2

2.4

30.94

41.34

u/l

1.88

189

1379

Sequelae of injuries of neck and trunk

132

855

1.61

5.83

4.1

2.5

27.93

43.18

u/l

1.92

107

736

Cardiomyopathy, Hypertrophic obstructive

485

1.83

5.83

2.8

2.4

44.32

34.71

u/l

0.49

417

Osteopathy in diseases classified elsewhere

212

2.36

5.81

5.1

2.3

36.30

36.04

u/l

0.01

181

Aortic valve malfunction, age under 60 years

393

3068

1.31

5.81

3.1

2.7

44.41

59.84

u/l

0.40

335

2694

Malignant neoplasm of testis, including Hilmo

455

1.85

5.81

3.4

2.4

31.03

141.15

u/l

0.55

397

Personal history of allergy to analgesic agent

173

2.51

5.79

2.1

2.3

39.55

29.34

u/l

0.32

142

Disorders of orbit

186

1294

1.49

5.78

2.4

2.3

30.50

39.99

u/l

1.58

155

1103

Other abnormal products of conception

1293

7440

1.16

5.78

2.2

2.3

37.51

37.31

u/l

0.02

1101

6357

Iridocyclitis

965

8248

1.19

5.78

3.3

2.5

77.08

44.09

u/l

0.44

829

7077

Primary open-angle glaucoma, strict

811

9575

0.83

5.78

2.3

2.4

78.13

47.28

u/l

0.32

681

8119

Acute generalized exanthematous pustulosis

190

1328

1.48

5.77

2.8

2.3

36.75

39.01

u/l

0.13

166

1119

Certolizumab pegol

510

1.80

5.74

2.6

2.0

38.49

32.04

u/l

0.74

427

Other disorders of amniotic fluid and membranes

351

4427

0.76

5.74

2.3

2.4

34.84

36.69

u/l

0.14

296

3807

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

352

2713

1.33

5.72

2.4

2.2

35.18

36.24

u/l

0.12

317

2308

Impetigo

183

1271

1.49

5.71

3.1

2.2

30.04

72.86

u/l

0.59

155

1082

Shoulder region

386

1.94

5.71

2.8

2.4

27.54

35.26

u/l

1.26

330

Erythema nodosum

132

860

1.60

5.70

2.3

2.2

35.35

37.56

u/l

0.11

107

722

Gastrojejunal ulcer

300

2.06

5.69

5.2

2.3

28.63

31.39

u/l

0.43

246

Other congenital malformations of urinary system

143

2.66

5.69

2.9

2.1

70.52

28.89

u/l

0.84

122

Other and unspecified injuries of abdomen, lower back and pelvis

393

1.92

5.69

4.0

2.4

27.74

29.47

u/l

0.41

331

Use of biperiden

217

1557

1.44

5.68

2.5

2.4

29.37

72.00

u/l

0.79

186

1348

Intracerebral haemorrhage

495

3976

1.27

5.68

2.6

2.4

36.93

48.68

u/l

0.45

417

3372

Encephalopathy

274

2.14

5.68

5.9

2.6

32.59

31.99

u/l

0.04

231

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

152

1022

1.55

5.68

2.6

2.4

30.82

39.49

u/l

1.08

139

862

Pollen allergy

763

6316

1.21

5.68

2.2

2.5

34.99

44.71

u/l

0.64

646

5460

Degenerative macular diseases

482

3865

1.27

5.67

2.4

34.80

50.19

u/l

0.65

405

3292

Open wound of shoulder and upper arm

580

1.74

5.67

3.2

2.4

36.84

127.17

u/l

0.55

488

Carcinoid syndrome

261

2.18

5.67

2.3

2.6

31.87

32.11

u/l

0.01

223

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

252

2.16

5.67

2.5

2.0

36.50

38.44

u/l

0.08

215

Malignant neoplasm of palate, including Hilmo

162

2.53

5.65

3.2

2.1

31.50

33.59

u/l

0.21

133

Peritonsillar abscess

872

7401

1.19

5.65

2.6

37.67

38.07

u/l

0.04

746

6420

Other specified and unspecified retinal disorders

153

1032

1.54

5.62

3.3

2.4

42.88

38.65

u/l

0.19

138

880

Systemic lupus erythematosus, unspecified

132

864

1.60

5.60

2.8

2.3

39.13

38.20

u/l

0.08

113

713

Serous carcinoma of ovary, including Hilmo

137

904

1.58

5.58

2.2

2.0

33.94

35.12

u/l

0.12

122

768

Anorexia

418

1.88

5.58

2.7

2.4

47.88

31.35

u/l

0.74

350

Malignant neoplasm of testis

403

1.89

5.54

3.6

2.4

30.02

153.64

u/l

0.55

353

Polyarthrosis

856

6746

1.20

5.54

2.5

2.4

38.62

38.59

u/l

0.00

716

5729

Undefined dementia

260

3212

0.73

5.52

2.4

2.3

30.28

35.86

u/l

1.73

215

2672

Methotrexate

594

4883

1.24

5.52

2.9

2.3

38.35

47.68

u/l

0.43

511

4147

Foreign body in respiratory tract

215

1549

1.43

5.51

2.3

34.05

69.91

u/l

0.59

194

1317

Disorders of porphyrin and bilirubin metabolism

312

2.03

5.49

2.6

2.5

29.37

33.21

u/l

0.44

272

Polyarthritis, unspecified

157

1069

1.52

5.49

2.8

2.4

33.37

42.13

u/l

1.53

122

912

Aspergillosis

223

2.25

5.48

2.6

2.7

31.50

33.63

u/l

0.16

189

Premenstrual syndrome

283

2.07

5.48

2.0

2.1

39.83

41.23

u/l

0.04

243

Other peripheral vertigo

382

2996

1.31

5.47

2.7

2.4

33.04

54.44

u/l

0.70

321

2565

Other diseases caused by chlamydiae

405

1.88

5.47

2.3

30.33

35.69

u/l

0.85

340

Other congenital malformations of intestine

244

2.19

5.46

3.6

2.4

31.64

29.24

u/l

0.27

203

Other disorders of conjunctiva

563

4611

1.24

5.45

3.0

2.4

58.39

47.79

u/l

0.17

496

3929

Dronedarone medication

124

806

1.61

5.44

2.6

2.3

41.26

38.55

u/l

0.16

695

Optic neuritis

179

1253

1.48

5.42

3.4

2.3

34.88

40.37

u/l

0.56

149

1057

Primary hyperparathyroidism

457

3667

1.27

5.42

2.5

2.3

42.46

37.54

u/l

0.44

395

3113

All dysplastic lesions of the cervix uteri

1038

8891

1.17

5.41

2.4

2.3

36.69

35.92

u/l

0.07

874

7594

Cushing syndrome

314

2.02

5.41

3.0

2.3

30.96

34.03

u/l

0.30

271

Autoimmune hyperthyroidism

261

1945

1.38

5.40

2.9

2.1

39.40

35.40

u/l

0.26

222

1654

Other disorders of peripheral nervous system

172

2.45

5.40

2.7

2.3

84.23

30.10

u/l

0.46

145

Myelodysplastic syndrome

223

2.20

5.38

2.3

2.0

38.25

30.20

u/l

0.67

180

Status epilepticus

156

1065

1.52

5.38

3.3

2.5

33.84

34.40

u/l

0.06

128

918

Spondylopathies (FG)

578

4752

1.24

5.37

2.6

2.5

96.92

49.16

u/l

0.36

491

4111

Radial styloid tenosynovitis [de Quervain]

234

1716

1.40

5.37

2.8

2.1

34.92

41.45

u/l

0.76

184

1480

Evidence of alcohol involvement determined by level of intoxication

294

2.04

5.33

6.5

2.6

26.47

34.91

u/l

1.06

245

Other and unspecified disorders of binocular movement

148

2.55

5.28

2.0

2.3

37.00

28.20

u/l

0.64

126

Myeloproliferative diseases (CML excluded)

305

2335

1.34

5.28

2.3

2.4

32.76

38.93

u/l

1.45

262

2002

Malignant neoplasm of base of tongue

129

2.65

5.27

3.5

2.1

39.72

37.92

u/l

0.05

106

conjunctival haemorrhage

305

2335

1.34

5.27

3.2

2.5

81.75

59.30

u/l

0.19

265

2000

Nail dystrophy

174

2.42

5.27

2.3

37.29

30.35

u/l

0.52

144

Rosacea

477

3856

1.26

5.26

2.6

2.3

45.62

37.22

u/l

0.47

408

3283

All dysplastic lesions of the vulva

183

1295

1.46

5.26

2.7

2.2

31.01

36.91

u/l

1.28

155

1102

Otorrhagia

194

2.33

5.24

2.6

2.4

27.53

36.11

u/l

1.21

162

Retinal breaks without detachment

675

5652

1.22

5.24

2.4

42.18

47.79

u/l

0.25

583

4838

L02BX Other hormone antagonists and related agents

208

1506

1.43

5.23

2.4

2.5

31.72

41.53

u/l

1.33

179

1293

Idiopathic pulmonary fibrosis

298

2276

1.34

5.23

2.5

2.4

33.90

39.78

u/l

1.11

267

1917

Lack of expected normal physiological development

361

1.83

5.22

2.4

1.9

25.34

30.47

u/l

1.82

296

Impotence

215

1565

1.42

5.21

3.3

2.7

33.76

72.30

u/l

0.70

186

1376

Amyloidosis

539

1.73

5.20

2.6

2.4

44.00

38.54

u/l

0.30

455

Benign neoplasm: Tonsil

333

1.97

5.19

2.7

2.4

31.26

34.40

u/l

0.34

281

Varicella [chickenpox]

192

1373

1.44

5.16

3.0

2.7

35.73

75.65

u/l

0.62

176

1201

Noise effects on inner ear

1229

0.57

5.16

2.6

35.46

78.25

u/l

0.58

1081

Tibial collateral bursitis [Pellegrini-Stieda]

269

2.06

5.15

2.2

1.9

29.02

34.62

u/l

0.56

234

Ectropion of eyelid

155

1066

1.50

5.13

2.3

2.4

39.23

37.09

u/l

0.14

133

876

Myasthenia gravis

475

1.79

5.12

2.3

47.11

31.74

u/l

0.93

402

Bitten or struck by other mammals

467

3780

1.26

5.09

2.9

2.4

32.38

50.84

u/l

0.83

400

3246

Diseases of middle ear and mastoid

2594

19383

1.10

5.09

2.8

2.5

51.56

40.52

u/l

0.26

2205

16684

Disorders of refraction and accommodation

1122

9756

1.16

5.09

2.5

34.17

44.49

u/l

1.12

955

8372

Meningitis

207

1504

1.42

5.08

2.5

2.4

31.61

71.48

u/l

0.68

181

1283

Other appendicitis

354

2777

1.30

5.08

2.5

32.67

56.42

u/l

0.78

307

2414

Open wound of thorax

438

1.81

5.08

2.2

2.4

34.39

152.87

u/l

0.57

381

Unknown and unspecified causes of morbidity

130

1926

0.66

5.07

3.2

2.1

33.29

67.73

u/l

0.77

119

1639

Intrahepatic Cholestasis of Pregnancy (ICP)

279

2120

1.35

5.07

2.4

2.2

35.49

36.30

u/l

0.07

249

1804

Orthopaedic devices associated with adverse incidents

519

0.37

5.05

1.6

2.3

36.27

33.81

u/l

0.18

435

Mandibular retrognathia AND surgery (BSSO)

731

0.46

5.05

2.9

2.3

33.37

110.51

u/l

0.61

615

Left ventricular outflow tract obstruction (LVOTO), broad definition

416

3331

1.28

5.04

3.1

2.7

43.34

57.82

u/l

0.40

356

2924

Arthropathic psoriasis

468

3796

1.26

5.04

2.9

2.4

37.99

51.16

u/l

0.51

411

3278

Bilateral sagittal split ramus osteotomy operation

992

0.54

5.01

2.6

2.4

30.50

89.20

u/l

0.65

844

Pervasive developmental disorders excl. Autism + Asperger

311

1.95

4.98

2.1

2.4

24.43

33.16

u/l

2.16

254

Disorders of lacrimal system and orbit in diseases classified elsewhere

108

695

1.62

4.98

2.2

28.57

39.71

u/l

2.30

587

Acne vulgaris

305

2349

1.32

4.98

3.7

2.5

35.01

55.39

u/l

0.50

272

2011

Malignant neoplasm of cervix uteri, including Hilmo

102

647

1.64

4.98

2.7

2.0

37.17

35.78

u/l

0.07

536

1218

9318

1.15

4.97

2.3

2.4

53.53

47.34

u/l

0.13

1022

7883

Retrobulbar neuritis in diseases classified elsewhere

2.93

4.97

3.6

2.1

28.00

28.26

u/l

0.02

Drug-induced osteoporosis

368

1.89

4.96

3.7

2.3

35.97

30.73

u/l

0.68

314

Benign neoplasm of breast

508

4165

1.24

4.96

2.2

2.3

33.11

37.50

u/l

0.93

440

3501

Other fall from one level to another

921

7942

1.17

4.95

2.7

2.6

108.97

39.65

u/l

0.70

787

6847

Acne varioliformis

3.33

4.95

2.0

2.9

22.47

28.57

u/l

0.91

Other specified transport accidents

166

2.39

4.91

5.4

2.2

39.68

28.98

u/l

0.36

136

Other hereditary haemolytic anaemias

173

2.36

4.90

3.5

2.3

28.94

32.20

u/l

0.40

142

Congenital malformations of ovaries, fallopian tubes and broad ligaments

228

1692

1.38

4.90

2.4

2.2

32.09

37.74

u/l

1.19

195

1433

Exclusion endpoint for clefts

540

1.71

4.90

2.9

2.4

29.54

31.83

u/l

0.39

457

Whooping cough

353

1.89

4.90

2.3

1.9

32.29

32.74

u/l

0.04

297

Pyoderma

511

1.73

4.88

3.3

2.3

30.09

34.52

u/l

0.70

438

Polymyositis

227

2.16

4.87

2.3

2.4

518.73

32.84

u/l

0.49

191

Malignant neoplasm of thyroid gland, including Hilmo

276

2107

1.34

4.86

2.5

2.2

30.23

37.04

u/l

1.86

238

1783

Golimumab

151

1048

1.49

4.85

2.6

2.4

41.91

86.25

u/l

0.48

129

900

Nontraumatic intracranial haemmorrhage

786

6707

1.19

4.85

2.7

2.4

39.95

44.23

u/l

0.19

671

5702

Epidural haemorrhage

226

2.12

4.84

2.8

2.3

1397.23

31.52

u/l

0.49

198

Postviral fatigue syndrome

220

2.16

4.84

3.0

2.4

30.26

32.79

u/l

0.22

183

Vascular dementia (mixed)

466

1.76

4.84

1.7

2.4

30.88

32.59

u/l

0.29

403

Nonspecific lymphadenitis

248

1869

1.36

4.82

2.8

2.5

35.88

66.44

u/l

0.64

214

1615

Acute bronchiolitis

213

1406

1.39

4.82

3.0

2.3

26.09

30.31

u/l

1.96

189

1168

Gonarthrosis,primary

4241

24373

1.08

4.80

2.4

2.5

40.92

47.13

u/l

0.59

3560

20913

Tonsillectomy and adenotomy

2532

16115

1.10

4.79

2.5

2.6

53.54

40.41

u/l

0.31

2186

13907

Toxic colitis

106

2.85

4.78

3.5

2.1

35.46

28.36

u/l

0.56

Other diseases of peritoneum

188

1361

1.43

4.77

3.4

2.2

40.21

36.86

u/l

0.15

164

1165

Cerebral cysts

232

1734

1.37

4.77

3.5

2.4

30.67

64.49

u/l

0.66

199

1476

Amputation of ankle bones

592

1.66

4.77

5.8

2.3

33.51

34.37

u/l

0.07

500

Other disorders of cornea

395

3169

1.27

4.73

2.6

2.5

33.96

53.73

u/l

0.72

338

2752

Malignant neoplasm of adrenal gland, including Hilmo

168

2.32

4.73

2.4

2.0

24.79

37.65

u/l

1.28

139

Retained placenta and membranes, without haemorrhage

329

4167

0.78

4.73

2.5

2.3

33.36

36.08

u/l

0.48

278

3515

Kela reimbursement Agammaglobulinemia (D80-84)

244

2.09

4.71

2.9

2.5

32.12

27.20

u/l

0.37

205

Other maternal disorders predominantly related to pregnancy

2498

14322

1.10

4.70

2.5

2.3

38.26

37.56

u/l

0.09

2128

12173

Other retinal artery occlusion

626

1.64

4.69

2.9

2.4

35.34

32.20

u/l

0.36

535

Foreign body in ear

533

1.69

4.67

2.2

2.4

40.75

33.13

u/l

0.40

454

Bullous disorders

235

1768

1.37

4.66

2.8

2.3

38.30

37.14

u/l

0.06

202

1497

Multiple delivery

227

3005

0.74

4.66

2.1

2.5

30.64

35.03

u/l

1.46

198

2524

Other and unspecified injuries of shoulder and upper arm

129

876

1.53

4.64

2.9

2.4

27.40

40.62

u/l

1.65

109

746

Endometriosis diagnosis and infertility diagnosis occurring together

421

3408

1.26

4.63

2.1

2.2

28.69

35.81

u/l

3.99

366

2903

Other symptoms and signs involving the nervous and musculoskeletal systems

1478

16496

0.89

4.58

2.9

2.5

48.55

46.67

u/l

0.04

1281

14132

Supervision of normal pregnancy

875

4295

1.18

4.58

2.2

2.4

33.75

37.44

u/l

0.87

758

3658

Malignant neoplasm of brain, including Hilmo

178

1283

1.42

4.58

2.0

2.3

35.87

74.91

u/l

0.52

149

1086

Autism spe, excluding more controls

486

1.70

4.58

2.0

2.4

26.43

35.86

u/l

2.61

423

Focal epilepsy, mode (most common among epilepsy diagnosis)

757

6477

1.18

4.56

2.5

2.4

44.89

44.33

u/l

0.02

649

5534

Unspecified dementia

254

2982

0.75

4.55

2.4

30.35

35.83

u/l

1.59

209

2496

Other and specified injuries of hip and thigh

623

1.63

4.54

2.8

2.4

31.23

32.63

u/l

0.10

525

Disorder of pancreatic internal secretion, other and/or unspecified

220

2.14

4.54

3.0

2.2

20.91

28.58

u/l

1.45

185

LeFortI or BSSO operation

1237

0.60

4.53

2.5

2.4

32.66

77.13

u/l

0.61

1067

Social disorders starting during childhood or adolescence

205

2.15

4.52

2.8

29.00

30.32

u/l

0.12

174

Residual foreign body in soft tissue

202

1492

1.39

4.50

2.5

2.2

385.96

41.06

u/l

0.48

169

1304

Other disorders of nervous system

273

2109

1.33

4.50

3.6

2.4

32.10

59.92

u/l

0.66

233

1823

Melanocytic naevi of scalp and neck

105

689

1.59

4.49

2.8

2.5

27.03

34.78

u/l

1.99

581

Amputation of thigh

115

768

1.55

4.47

3.1

2.4

37.22

34.48

u/l

0.21

646

Infectious mononucleosis

319

2511

1.29

4.45

2.3

2.4

35.23

56.00

u/l

0.56

274

2164

Pediculosis, acariasis and other infestations

240

1824

1.35

4.44

3.7

2.5

30.49

63.25

u/l

0.69

205

1586

Other abnormal findings of blood chemistry

184

1345

1.41

4.42

3.0

2.4

32.97

40.77

u/l

1.14

155

1138

L02BB Anti-androgens

333

2640

1.29

4.42

2.3

2.5

31.71

38.12

u/l

1.35

276

2243

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS